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|Chapter 1
Introduction  
Food is an essential element in our lives; it is essential for staying alive and it is 
an important part of our cultural identity. For patients with a food allergy some 
sources of food may be fatal 1;2. Consequently, the lives of these patients may be 
seriously disrupted by the continuous vigilance required to avoid foods to which 
they are allergic. 
Adverse food reactions or hypersensitivities include any abnormal reaction 
resulting from the ingestion of food and might be the result of food intolerance 
(nonallergic food hypersensitivity) or food allergy 3;4. Food intolerance is a non-
immunologic response, such as may be seen in certain metabolic disorders (e.g., 
lactase deficiency). Food allergy is an adverse immunological reaction that may be 
due to IgE- or non-IgE-mediated immune mechanisms and the symptoms may 
involve the skin, gastrointestinal tract, respiratory tract, and cardiovascular system  5. 
Although any food may provoke a reaction, relatively few foods are responsible for 
the vast majority of food allergic reactions: milk, egg, peanuts, tree nuts, fish and 
shellfish 6.
Prevalence of food allergy
The prevalence of food allergy is the greatest in the first few years of life. It has been 
estimated that up to six per cent of children less than three years of age experience 
food-induced  allergic  disorders  7.  Most  children  outgrow  their  sensitivity  and 
approximately  two  per  cent  of  the  adult  population  experience  food-induced 
allergic disorders 8. Although it was once thought that peanut, tree nut and, seafood 
allergies  were  never  outgrown,  it  has  become  apparent  that  clinical  tolerance 
develops in about 20% of young children with peanuts allergy 9;10. However, many 
studies show that food allergy prevalence is increasing in most Western countries. 
The prevalence of peanut allergy was found to have doubled in American children 
less than five years old in a five-year period 11. Emergency room visits due to food 
allergy have increased by a factor of six in the United Kingdom. This increase in 
prevalence of food allergy is also accompanied by an increase of anaphylaxis caused 
by food allergy, which is potentially fatal 12.
Management of food allergy
Tools for diagnosis and management of food allergy have not changed much in 
the past two decades. The diagnosis includes clinical history, physical examination, 
tests for specific IgE antibody to suspected foods, elimination diets and oral food 
challenges. The management includes restriction diets and provision of medications 
such as epinephrine for emergency treatment  13. Once properly diagnosed by 
double-blind placebo-controlled food challenges (DBPCFC), strict avoidance of 
the implicated food or foods is the only proven form of treatment. In addition, 
proper patient education about their allergy, avoidance strategies and dealing with 
reactions in cases of accidental exposure, allows patients to control their disease as 
much as possible. In many patients clinical tolerance will develop over time, and Introduction
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therefore follow-up food challenges are often indicated 14. Promising new methods 
for diagnosing food allergy such as individualised analysis of allergenic epitope 
recognition patterns 15 and novel strategies for treatment, including immunotherapy, 
are under development but are not yet commonly available 16.
Health-related quality of life
Quality of life has various meanings, which encompasses factors such as financial 
security, freedom, spiritual contentment, quality of environment, health, and the 
way these factors interrelate. It has been defined by the World Health Organisation 
(WHO) as ‘the individual’s perception of their position of life in the context of 
the culture and value systems in which they live and in relation to their goals, 
expectations, standards and concerns’  17. A simpler definition of quality of life 
is ‘the subjective value a person places upon satisfaction with his or her own 
life’ 18. The component of overall quality of life that pertains to an individual’s 
health is called health-related quality of life (HRQL) and may be defined as ‘the 
effects of an illness and its consequent therapy upon a patient, as perceived by 
the patient’  19. HRQL incorporates the definition of health of the WHO; ‘a state of 
complete physical, mental, and social well-being and not merely the absence of 
disease and infirmity’ 20. HRQL can be seen as a multidimensional concept that 
includes physical status and functional abilities, psychological status and well-
being, social and professional interaction, and the patient’s health perception 21. It 
is important to understand that a similar level of objective clinical impairment may 
have a different impact on HRQL in different patients because individuals vary in 
their tolerance level. In addition, unlike objective clinical measures, HRQL focuses 
on the patient’s perspective of their disease and measures the impairments that 
patients consider to be important 19. 
Impact of food allergy on quality of life
There is no cure currently available for patients with food allergy. Food allergic 
patients must carefully avoid the causal foods every day, and this is a great burden 
to themselves and their families. Despite taking precautions, accidental exposure 
may occur and for some patients this may be fatal. Once a patient has experienced 
anaphylaxis, there is a great risk that he or she will experience recurrence 22. This 
may create an additional burden of fear. In daily life, food allergic patients are 
burdened with a variety of tasks, including careful label reading of manufactured 
products, obtaining information about cross-contamination of foods with allergens, 
avoiding accidental exposures that may occur and limiting common social activities 
associated with eating. 
Joshi et al. 23 found that most parents of children on restricted diets are unable 
to identify common allergenic food ingredients. Only seven per cent of the parents 
correctly identified milk, 22% correctly identified soy protein and 54% correctly 
identified peanut. Most parents correctly identified wheat and egg. These findings 
strongly support the need for improved labelling and education for patients and 
parents about reading labels. These recommendations are in accordance with the 14
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findings of Gowland 24. She discusses food allergen avoidance from the patient’s 
viewpoint and states that the vigilance required to avoid food allergens depends on 
information that is often hidden or misleading. This uncertainty may lead to stress 
and social exclusion. In order to reduce the allergen risk and in addition to improve 
the quality of life of food allergic patients, Gowland 24 states that there should be 
clear food allergen labelling on manufactured products. Moreover, there should be 
integration of food allergy into all primary professional training for cooks, caterers 
and all those who prepare food for the public. And finally, there should be clear 
allergen management in food hygiene controls for all food businesses.
Accidental exposure to allergenic food often occurs outside the home and it 
accounts for the majority of deaths reported from food allergy 1;2. In Britain 14% 
of food allergic patients reported reactions in restaurants 25 and in the United States 
almost 14% of self-selected registered peanut and / or tree nut allergic patients 
reported reactions in restaurants or other food establishments 26. Establishments 
commonly reported in the latest study were Asian food restaurants (19%), ice 
cream shops (14%), and bakeries / doughnut shops (13%). Among meal courses, 
desserts were a common cause (43%). In most of the cases (78%) someone in the 
establishment knew that the food contained peanut or tree nut as an ingredient; 
in 50% of these incidents the food item was ‘hidden’ in sauces, dressing etc. 
In 22% of the cases, exposure resulted from contamination caused primarily by 
shared cooking or serving supplies 27. These data show that patients with a food 
allergy are faced with a number of challenges when eating in restaurants and other 
food establishments. Given the effort required to avoid accidental exposures and 
the inherent uncertainty of success, living with a food allergy may be expected to 
have a negative influence on the quality of life.
Why measure HRQL?
HRQL measurements offer the opportunity to study the impact of disease from 
the patient’s perspective. Measurement of an objective disease parameter provides 
information to clinicians, but are of limited interest to patients. These measures 
are often poorly correlated with areas in which patients are most interested and 
familiar, such as functional capacity and well being. Moreover, two patients with the 
same objective clinical impairment may have very different degrees of impairment 
in their HRQL  28. For example, two patients with the same severe reaction to 
peanut  following  accidental  exposure  may  have  different  social  function  and 
well-being. Although some patients may continue going to social events without 
anxiety, others may stay at home and feel isolated. Therefore, HRQL instruments 
allow quantification of differences between patients with similar objective disease 
burdens. 
HRQL measurements also offer the opportunity to study the effect of a 
treatment from the patient’s perspective. HRQL instruments allow quantification of 
changes within patients over time due to diagnostic or therapeutic interventions 28. 
Especially in allergic diseases where mortality is low, HRQL issues are of importance 
in the management of patients. This is also true in food allergy, especially in cases Introduction
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where patients only intermittently have symptoms and need to undertake extensive 
measures in order to prevent exposure to foods to which they are allergic.
These considerations explain why measuring HRQL is important in general 
and especially in patients with food allergy. It gives clinicians additional information 
about the impact of disease from the patient’s perspective and it can be used for 
measuring clinical effectiveness of management strategies.
Approaches to study quality of life
Types of HRQL instruments
There  are  two  major  types  of  HRQL  instruments  used  in  clinical  trials  and 
practice:  generic  and  disease-specific  questionnaires.  Generic  instruments  can 
be used to evaluate and compare different disease states, treatment interventions 
and, populations. The disadvantages of generic instruments are that they are by 
design comprehensive, so they may not focus adequately on problems specific to a 
particular disease. Furthermore, they may not be responsive enough to detect small 
but clinically meaningful changes in HRQL in a given disease state 28. 
Disease-specific instruments are more responsive than generic instruments 
and they can by targeted to a specific population, disease, or function. This allows 
evaluation of HRQL restricted solely to the disease studied. These disease-specific 
instruments are much more likely than generic instruments to detect clinically 
important changes in patients’ impairments. However, disease-specific instruments 
do not allow comparison between different diseases 28. 
In some situations both generic and disease-specific instruments are of value 
and can be used in combination to compare populations (generic) and identify 
specific areas of problems within patient groups (disease-specific) 29.
Structure and administration of HRQL instruments
HRQL questionnaires are made up of items, grouped into a number of domains. 
A domain refers to a set of HRQL behaviours or experiences that one is trying to 
measure. HRQL questionnaires can be self-completed, or may be administered by 
a face-to-face or telephone interview. In some cases a surrogate responder such as 
a parent, completes the questionnaire. A face-to-face interview maximises the rate 
of response, minimises missing items and errors of misunderstanding, but requires 
more resources and training of the interviewer and may reduce willingness to 
acknowledge problems. Telephone interviews, are less resource intensive than face-
to-face interviews. On the other hand, there is a greater likelihood of low response 
rates, missing items and misunderstanding, if questionnaires are self-completed. 
Surrogate completion reduces stress for the target group (e.g. in very elderly or 
sick persons), but the surrogate’s perception of HRQL may differ from the patient 
group’s perception  28. Parents may complete HRQL questionnaires by proxy in 
young children. Older children can make judgements about their own health 16
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state and may complete HRQL questionnaires by themselves. Obvious discrepancy 
between the judgements of children and parents about quality of life is often cited 
as a problem, but children differ from adults in their understanding of health 
and have their own views about quality of life. In addition, children’s view about 
quality of life changes with age 30.
Development of disease-specific HRQL instruments 
The fundamental characteristics of a good instrument are reliability, validity and 
responsiveness 31. A measure is regarded as reliable if the same result is obtained 
when the same unchanged subject is measured again. Validity is a measure of 
the  instrument’s  ability  to  actually  measure  what  it  is  intended  to  measure. 
Responsiveness  relates  to  the  ability  of  the  questionnaire  to  detect  small  but 
potentially important changes in HRQL over time, which is important for use in 
clinical settings. 
The development of a disease-specific measure may involve a number of 
steps: item generation, item reduction, cross-sectional validation and longitudinal 
validation. Translation and cross-cultural validation are necessary for application 
of the instrument in different languages and in different cultural settings. Each of 
these steps will now be described in more detail.
Item generation
Item generation is a process by which all potential items for a new measure are 
assembled.  Sources  for  possible  items  are  patients  or  parents,  experts  and  the 
literature. Items can be generated through interviews and focus groups. Patients or 
parents are asked to think of quality of life items related to their own or their child’s 
disease. Experts may be asked which HRQL items their patients cite in the clinical 
setting. Individual interviews and focus group sessions can be used. Focus groups 
involve a small number (usually less than ten) of people who discuss a certain 
subject (in this case HRQL) freely, under the guidance of a experienced facilitator 32. 
Items are generated and organised into domains or groups of related items, such as 
emotions, social functioning, or activities of daily living. The number of items that 
may be generated is in principal unlimited, but item generation is complete when 
no important new items are named or identified. It is important to ensure that the 
spectrum of patients contributing items (i.e. with regard to the limits of the age 
group and difference of severity of disease) is complete, or as complete as possible. 
The end product of this first step, called the extended instrument, is a relatively 
long list of HRQL items worded as problems.
Item reduction
This aims to eliminate redundant or personal items and to reduce the questionnaire 
to a manageable and feasible number of items. The extended instrument is presented 
to other patients or parents to indicate which items are troublesome for themselves 
or their children. The answer to this question is a simple ‘yes’ or ‘no’, followed by 
a grading of importance for the ‘yes’ answers on a five-point response scale with Introduction
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responses varying from ‘almost unimportant’ to ‘extremely important’. Alternate 
wordings may be tested. 
Each candidate item is than scored for overall importance, which is the 
product of the frequency with which an item is identified as being important by 
patients and the mean impact of that importance using the five-point scale 33;34. This 
allows for a selection of items for a prototype instrument. The number of items 
selected depends on the need to cover all areas of HRQL and the need to produce 
a manageable instrument. In general, HRQL instruments become unmanageable if 
they take more than 20 minutes to complete 35. The prototype HRQL instrument is 
now suitable for validation. 
It  is  important  that  the  questionnaire  is  appropriately  formatted.  Each 
question should be easy to understand, free of medical jargon and inconsistencies, 
clear with respect to the time frame to which they refer, and encompass only one 
item. Also, the response options should be clear, brief and consistent. In paediatric 
questionnaires these formatting details are even more important. Moreover, it is 
extremely important that the reading level of the questionnaire is age-appropriate. 
Pilot  testing  the  questionnaire  will  assess  whether  the  format,  wording,  and 
feasibility are appropriate 32. 
Cross-sectional validation
Validation may occur by comparing the HRQL questionnaire with an independent 
measure. This measure is independent of HRQL and is often a disease-specific 
parameter that reflects the severity of disease (e.g. FEV1 in asthma). However, in 
patients with food allergy such a disease-specific parameter is not available, because 
symptoms caused by foods only occur following exposure, and such accidental 
exposures are relatively infrequent. Therefore, the perceived risk of the chance of 
and consequences of accidental exposure is the driving force of quality of life and 
this perceived expectation of outcome may be used as the independent measure. A 
specific instrument that is capable of capturing this expectation may be developed: 
the Expectation of Outcome measure 36. 
The Expectation of Outcome measure asks patients or parents what they 
expect the outcome to be of their disease in the future. For example, in patients 
with food allergy a possible question that could be considered for the Outcome 
Expectation measure is: What chance do you think you have/your child has of 
accidentally  ingesting  the  food  to  which  you  are  allergic? Answers  to  these 
questions are expressed on a seven-point scale with responses varying from ‘a 
negligible chance’ to ‘a very great chance’. The correlation between the Expectation 
of Outcome measure and the answers to the individual questions of the HRQL 
questionnaire are calculated. This method allows for selection of a small number of 
items having the best correlation for use in the final instrument. Consistency of the 
questionnaire can be further confirmed by calculating the correlation between an 
individual item and the other items of the questionnaire (i.e. Cronbach’s alpha). The 
end product of this third step is a cross-sectionally validated HRQL instrument.18
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Longitudinal validation
In order to investigate if a cross-sectionally validated instrument will be capable 
of  measuring  within  patient  differences  over  time,  the  instrument  must  be 
longitudinally validated. This can be done in patients in whom HRQL is expected 
to change because of diagnostic and / or therapeutic interventions 37. With regard 
to food allergy, one can think of studies involving improved diagnosis, counseling, 
and expert dietary intervention. Food allergic patients in these studies would be 
expected to have an improvement in their HRQL if they would be included in 
the active intervention group. Patients would receive the HRQL instrument and 
the Expectation of Outcome measure at the beginning of the study.   After the 
intervention, patients would need to be followed for a period of time during which 
they could become accustomed to their new health state.  This usually requires several 
months. After this period, the HRQL instrument and the Expectation of Outcome 
measure  could  be  re-administered.  Changes  in  the  average  score  for  the  total 
instrument are then correlated to changes in the Expectation of Outcome measure, 
comparing values before and after the intervention described. Good correlation 
between the Expectation of Outcome measure and the HRQL scores validate the 
instrument longitudinally and simultaneously demonstrate the impact on HRQL of 
the intervention used. The final product is the definitive HRQL instrument and the 
impact of the intervention on HRQL can be reported.
Translation and cross-cultural validation
In order to use the HRQL instrument in different languages and cultural settings, 
translation of the questionnaire to the language of the patient population studied 
is required to reliably compare data across populations. Forward and backward 
translation  may  be  used  in  order  to  check  content  comparability.  However, 
translation  alone,  without  consideration  of  cultural  differences,  may  not  be 
sufficient.  Cross-sectional  validation  in  the  new  language  and  cultural  setting 
allows for the assessment of the performance of individual items in that language 
and culture 38;39. Good cross-sectional correlation coefficients indicate validity for 
that particular language setting. Low correlation coefficients may be encountered if 
the translation is inaccurate or if the item does not appear to be a problem in the 
new cultural context. If cultural comparisons are made before the item reduction 
phase, it may be possible to identify items that are applying to only certain cultural 
settings or countries. Following successful cross-sectional validation in the new 
language and cultural setting, a final instrument can be generated by incorporating 
it into a longitudinal study in the new language as indicated above.Introduction
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Current knowledge regarding food allergy and quality 
of life
Studies on quality of life and food allergy 
There are only a few studies that have measured the HRQL in patients with a food 
allergy. Of the published five studies, three used general questionnaires to measure 
quality of life and two used disease-specific questionnaires. In three of these five 
studies the parents or caregivers completed the questionnaires. 
Primeau  et  al.  40  compared  the  quality  of  life  and  family  relations  of 
children and adults with a peanut allergy to that of children and adults with a 
rheumatological disease. To quantify the impairment in quality of life, they used 
a vertical visual analogue scale (VAS) adapted from the European Quality of Life 
questionnaire (EQ-5D)  41. The impact of the peanut allergy or rheumatological 
disease on the family was measured by the Impact on Family Questionnaire (IFQ) 42. 
This questionnaire contains four dimensions of family life: familial-social, personal 
strain, financial burden, and mastery. They found that the parents of peanut-allergic 
children reported that their children had significantly more disruption in their daily 
activities as compared to the parents of children with a rheumatological disease. 
Furthermore, the parents of peanut-allergic children reported more impairment 
in the familial-social dimension of the IFQ. According to the authors this parental 
perception of considerable disruption of daily and social activities of the peanut-
allergic child may be due to the perceived risk of death of their child. The lose 
of parental mastery when someone else cares for the child makes some parents 
even refuse to allow their child to go, for example, to birthday parties or school 
excursions. 
Sicherer et al.  43 studied the impact of childhood food allergy on quality 
of life. The parental perceptions of physical and psychological functioning of the 
food-allergic child were measured with the Child Health Questionnaire (CHQ-
PF50) 44. This questionnaire contains twelve scales of general health: 1) physical 
functioning, 2) role social / emotional, behavioural, 3) role social / physical, 4) 
bodily pain, 5) general behaviour, 6) mental health, 7) self-esteem, 8) general 
health,  9)  parental  impact-emotional,  10)  parental  impact-time,  11)  family 
activities, and 12) family cohesion. They showed that the parents of children with 
food allergy scored significantly lower on the scales of general health perception, 
emotional impact on the parent and limitation on family activities as compared to 
established norms.     
Marklund  et  al.  45  studied  the  HRQL  among  adolescents  with  allergy-
like  conditions,  with  emphasis  on  food  hypersensitivity. They  investigated  the 
magnitude of self-reported allergy-like conditions and used the Medical Outcome 
Trust Short Form 36 Health Survey (SF-36) to measure HRQL 46. The SF-36 consists 
of 36 items divided into eight scales: 1) physical functioning, 2) role functioning-
physical, 3) bodily pain, 4) general health, 5) vitality, 6) social functioning, 7) 
role functioning-emotional, and 8) mental health. The adolescents with allergy-20
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like conditions reported significantly lower HRQL on seven of the eight SF-36 
scales (not on physical functioning), compared with adolescents without allergy-
like conditions. This finding was regardless of whether the condition had been 
doctor-diagnosed  or  not.  Nineteen  percent  of  the  respondents  reported  food 
hypersensitivity.  Females  with  food  hypersensitivity  scored  significantly  lower 
on bodily pain, general health, and social functioning than females with other 
allergy-like conditions. Males with food hypersensitivity did not show this HRQL 
impairment.
In contrast to the above-mentioned studies, Avery et al. 47 used a disease-
specific  questionnaire  that  was  self-completed  by  the  children.  Avery  et  al. 
compared the quality of life in children with a peanut allergy to that of children 
with insulin-dependent diabetes mellitus. To measure quality of life, they used two 
disease-specific quality of life questionnaires. One was designed by themselves and 
the other was adapted from the Vespid Allergy Quality of Life Questionnaire  36. 
However, they do not describe how they designed or adapted these questionnaires. 
Moreover, these two questionnaires were not tested for reliability and validity. 
Therefore, caution is needed by the interpretation of these results. The results of 
this study were that children with a peanut allergy reported a poorer quality of 
life than children with insulin-dependent diabetes mellitus. Children with peanut 
allergy reported more fear of an adverse reaction and more anxiety about eating 
and only peanut allergic children reported fear of death.
Recently Cohen et al. 48 developed a disease-specific questionnaire to measure 
quality of life in families with a child with food allergy: the Food Allergy Quality of 
Life – Parental Burden (FAQL-PB) questionnaire. This questionnaire is completed 
by the parents and measures the parental burden associated with having a child 
with food allergy.  They used the principles of item generation, item reduction 
and cross-sectional validation previously established in the development of other 
disease-specific HRQL questionnaires 49-51. They reported strong internal and cross-
sectional validation. However, the instrument was not longitudinally validated. 
Is quality of life affected by food allergy, how much and by what?  
The few studies that have measured the HRQL in patients with a food allergy all 
showed that the HRQL is negatively affected in these patients. There may be some 
variables that influence the magnitude of the impact of food allergy on HRQL. 
First,  the  food  to  which  one  is  allergic.  Primeau  et  al.  and Avery  et  al. 
investigated solely peanut-allergic patients while the other studies included patients 
with different food allergies although peanut and tree nut were most frequently 
reported. From these latest studies, only Sicherer et al. compared the HRQL of 
patients with peanut allergy to those with other food allergies, but found no 
differences. The other studies have not investigated the differences between different 
food allergies. Hence, it is not known if for example milk allergy has a greater 
negative impact on quality of life than, for example, peanut allergy. However, it is 
a fact that some foods are easier to avoid than others and may make living with a 
food allergy easier. Introduction
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 Second, the severity of the allergy, because it is reasonable that the lives of 
patients who have experienced an anaphylactic reaction are more disrupted than 
patients who have only experienced dermal reactions. Only Cohen et al. studied 
this and found that parents who reported an anaphylactic reaction in the past 
scored significantly lower on the FAQL-PB questionnaire than parents not reporting 
anaphylaxis. 
Third,  the  number  of  foods  to  which  one  is  allergic. This  topic  was 
investigated in two of the above mentioned studies. Sicherer et al. found that seven 
of the twelve CHQ-PF50 scales were significantly lower in families with multiple 
food allergies as compared to families with one or two food allergies. Also Cohen et 
al. found a significantly lower total score on the FAQL-PB questionnaire in families 
whose children had three or more food allergies compared to those with two 
or fewer food allergies. Moreover, the mean score of thirteen of the seventeen 
individual questions of the FAQL-PB questionnaire differed significantly in these 
two populations.
Fourth,  many  allergic  patients  have  co-morbid  conditions  (e.g.  atopic 
dermatitis, allergic rhinitis, or asthma) and this may have an additional negative 
impact on quality of life. Sicherer et al. showed that only the CHQ-PF50 scale 
general health was significantly impacted by co-morbid conditions. In agreement 
with  this,  Marklund  et  al.  showed  that  adolescents  with  food  hypersensitivity 
who also reported allergic diseases, scored significantly lower on the SF-36 scales 
bodily pain and general health compared to adolescents who only reported food 
hypersensitivity. However, co-morbid conditions will affect outcome using generic 
HRQL instruments, but it should not affect outcome of disease-specific HRQL 
instruments.
Fifth, gender may play a role in the impact of food allergy on quality of 
life. Most of the above-mentioned studies did not take this topic into account. 
Only Marklund et al. gave special attention to gender differences and, as previously 
stated,  they  found  that  females  with  food  hypersensitivity  scored  significantly 
lower on the SF-36 scales bodily pain, general health, and social functioning than 
females with other allergy-like conditions. Males with food hypersensitivity did 
not show this HRQL-deterioration. Unfortunately, Marklund et al. did not make a 
comparison between females and males within the food hypersensitivity condition. 
However, in patients allergic to yellow jacket venom HRQL was significantly more 
impaired in women than in men 51.
Finally, it is interesting that Marklund et al. found that adolescents with allergy-
like conditions had similar scores on the SF-36 whether they had verified allergy 
or not. Apparently, the perception of having a food allergy with the consequences 
of  food  avoidance  is  associated  with  deterioration  in  HRQL  comparable  to  a 
verified food allergy. This underlines the importance of a correct diagnosis in order 
to abandon self-perceived but unproven food allergies and to prevent needless 
deterioration of HRQL.22
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Future priorities for research
As described above, there are only a few studies that have investigated the quality of 
life in patients with food allergy. This is remarkable because food allergy appears to 
have a significant negative impact on the quality of life. It is important to develop 
good food allergy specific HRQL questionnaires in order to identify the specific 
disabilities and problems of food allergic patients. Such questionnaires can provide 
additional information to the measurements of usual outcomes namely, insight 
into the burden and consequences of food allergy. It can also be used to study the 
relationship between management strategies and the improvement in HRQL 52.
Currently, there is only one HRQL questionnaire specific for food allergy 
available.  This has only recently been published and represents a significant milestone 
in this field. However, this FAQL-PB questionnaire developed by Cohen et al. 48 has 
some significant limitations. First, it was developed to measure HRQL in children. 
Therefore, it can not be used in adults with food allergy. Second, the questionnaire 
is completed by parents and measures the parental burden associated with having 
a child with food allergy. Therefore, it provides no information about the impact of 
having a food allergy on quality of life perceived by the child. Third, the instrument 
is used for children across all age groups (range two months to seventeen years). 
No distinction is made between the problems associated with having a newborn, 
schoolchild, or teenager with food allergy, in which the problems are presumably 
different. Fourth, the questionnaire is not longitudinally validated. This means that 
the capability of this questionnaire to measure within patients differences over time 
is not documented. And finally, the questionnaire was developed and validated in 
the United States of America and may therefore not suitable for Europe. Moreover, 
it should be noted that the term food allergy covers a spectrum of disorders and 
perceived disorders. Over time it might be necessary to examine the impact on 
quality of life of specific food allergies, such as milk or peanut, whose impacts on 
quality of life may differ significantly.
In the scope of a large European multicenter research project funded by 
the  European  Union  known  as  EuroPrevall,  several  new  food  allergic-specific 
HRQL instruments will be developed. In order to overcome the limitations of the 
FAQL-PB, questionnaires will be developed that will be completed by the parents 
and questionnaires that will be completed by the child. It may be interesting to 
compare the outcomes of the questionnaires completed by the patents to the 
outcomes  of  the  questionnaires  completed  by  children  themselves.  Moreover, 
different questionnaires for different age groups of childhood and also a specific 
questionnaire  for  adults  with  food  allergy  will  be  developed. A  questionnaire 
specific for adults with oral allergy may be developed when it turns out that these 
patients experience other quality of life items than patients with a systemically 
reaction. 
The new HRQL questionnaires will be cross-sectionally and longitudinally 
validated by the method described above. The longitudinal study will investigate if 
these questionnaires are capable of measuring within-patient differences over time. Introduction
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It will also aim to show the impact of quality of life following the intervention 
(diagnosis by double-blind placebo-controlled food challenges). HRQL may be 
negatively influenced in patients with self-perceived food allergy. A good diagnosis 
may give certainty to the patient and HRQL may improve, even when the diagnosis 
is verified and even more if the diagnosis is rejected. This hypothesis has never been 
investigated and will be one of the topics of this study.
The  new  questionnaires  will  be  subsequently  translated  into  different 
languages  followed  by  cross-sectional  and  longitudinal  validation  in  the  new 
language in different European countries. By doing so, reliable and valid disease-
specific  HRQL  questionnaires  will  be  provided  for  patients  with  food  allergy 
that can be used in different age groups and in different European countries. 
These instruments will be usable to measure changes in quality of life in food 
allergic patients from any cause, including spontaneous fluctuation or following 
interventions. Next to this, other possibilities for future research are comparison 
of HRQL measured by disease-specific instruments and generic instruments or to 
combine the measurement of HRQL with economic calculations.
Aims and outline of this thesis
The main aim of this thesis was to develop and validate disease-specific health-
related quality of life (HRQL) questionnaires for children (8-12 years), adolescents 
(13-17 years) and adults (18 years and older) with food allergy (chapters 3, 4 and 
5). Additional aims were to investigate the reliability of these three questionnaires 
(chapter 6)  and  to  investigate  HRQL  outcomes  measured  with  these  disease-
specific questionnaires as compared to other generic questionnaires (chapter 7). 
Finally, this thesis aims to give an overview of current knowledge in the field of 
food allergy and HRQL at the beginning of the EuroPrevall project (chapter 2) and 
towards the end of the project (chapter 8).
Chapter 2
Chapter 2 contains a EuroPrevall state of the art paper describing a framework for 
measuring the social impact of food allergy across Europe. It describes the current 
knowledge on food allergy and HRQL at the beginning of the EuroPrevall project 
and how HRQL could be measured in food allergy. Finally, relevance and practical 
implementation of HRQL questionnaires are discussed.
Chapter 3
In chapter 3, we describe the development and validation of the Food Allergy 
Quality of Life Questionnaire - Child Form (FAQLQ-CF) in the Dutch language. 
This questionnaire was specially developed for food allergic children aged 8 to 12 
years and the questionnaire is completed by the children themselves.24
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Chapter 4
Chapter 4 describes the development and validation of the Food Allergy Quality 
of Life Questionnaire - Teenager Form (FAQLQ-TF) in the Dutch language. This 
questionnaire was specially developed for food allergic adolescents aged 13 to 17 
years and the questionnaire is completed by the adolescents themselves.
Chapter 5
In chapter 5 we describe the development and validation of the Food Allergy 
Quality of Life Questionnaire - Adult Form (FAQLQ-AF) in the Dutch language. 
This questionnaire was specially developed for food allergic adults 18 years and 
older. 
Chapter 6
Chapter 6 contains the results of test-retest reliability of the FAQLQ-CF, -TF, -AF. 
The questionnaires were completed by the same patients twice with a 10-14 day 
interval and we investigated the reproducibility of the questionnaires over time 
when no change in the condition has taken place.
Chapter 7
In chapter 7, a study is presented on HRQL of food allergic patients measured with 
generic and disease-specific questionnaires. The aim of this study was to compare 
generic HRQL of food allergic patients with the general population and other 
diseases. In addition, it compares the HRQL of food allergic patients measured 
with generic and disease-specific questionnaires.
Chapter 8
In chapter 8, we present a review on how HRQL can be measured in food allergy 
and we discuss recent findings on how food allergy might impact HRQL.
Chapter 9
In chapter 9, a general summary and discussion are provided and future perspectives 
are discussed.Introduction
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Abstract 
This state of the art paper has been developed through EuroPrevall, a European 
multi-centre research project funded by the European Union (EU) which aims 
to improve quality of life for food allergic individuals. Food allergy (whether 
clinically diagnosed or self-perceived) represents a major health issue in Western 
societies and may have a considerably greater impact on society than was previously 
believed. However, the social impact of food allergy has never been systematically 
investigated using validated instruments. Combining the information from studies 
on health-related quality of life (HRQL) with epidemiological data on prevalence 
will ultimately give some indication of the magnitude of the social impact of food 
allergy in Europe. HRQL can be assessed with disease-specific questionnaires, which 
are being developed in EuroPrevall. These instruments will be used to identify 
HRQL problems associated with food allergy, and to assess the effectiveness of 
interventions and to guide the development of regulatory policies. Social impact of food allergy across Europe
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Introduction
Adverse reactions to foods, including IgE-mediated food allergies, represent a major 
health-issue in Western societies. It has been estimated that in the general population 
approximately 4-6% of children and 1-3% of adults experience food allergy  1. 
There is some evidence to suggest that the prevalence has increased over the last 
10 years 2. This is demonstrated by the increase in emergency room visits due to 
food allergy in the United Kingdom, which have increased by a factor of six over a 
decade, accompanied by an increase in the incidence of anaphylaxis caused by food 
allergy 3. Another remarkable observation is that the prevalence of perceived food 
allergy seems to be much higher than verified food allergy, up to 22% of the adult 
population 4. This may be related to inadequate diagnosis of food allergy, in part 
reflecting the lack of adequate provision of relevant health services. 
Adverse  reactions  to  foods  (including  IgE-mediated  allergies),  clinically 
or self-diagnosed, may have a considerably greater impact on society than has 
previously been believed. The social functioning of individuals with a food allergy, 
or activities in families with an allergic child or family member, may be seriously 
disrupted by the need for continuous vigilance to avoid foods to which they are 
(or believe to be) allergic 5. In cases of individuals with self-diagnosed food allergy, 
the majority may be restricting their diet unnecessarily and consequently running 
the risk of nutritionally compromising themselves or becoming deficient in specific 
nutrients 6;7. Furthermore, such dietary management disrupts social or family life, 
and could be costly to implement both in time and money 8. However, the effects 
of food allergy are not only limited to individuals or households. The food industry 
may also experience an extra burden of costs due to food allergy 9. This may, for 
example, result from legislative changes aimed at improving consumer protection 
such as the new EU-legislation on food labelling that came into force in November 
2005 (EU Directive 2003/89/EC amending Directive 2000/13/EC). The onus of 
responsibility falls to the food manufacturer, who is required to manage production 
processes to ensure allergenic ingredients are labelled. At the present time, the 
potential social impact and economic costs of food allergy on the individual, 
families, related health services and food industry are not well understood. 
EuroPrevall is a European multidisciplinary and multi-centre research project 
funded by the European Union (EU). Its mandate is to investigate the prevalence, 
cost, and basis of food allergy, and to improve quality of life for food allergic 
people 10. In order to assess the socio-economic impact of food allergy, and provide 
benchmarks  to  assess  the  effectiveness  of  interventions  developed  to  manage 
the disease, validated instruments are needed. One of the major objectives of 
EuroPrevall is to develop and validate instruments to determine the impact of food 
allergy on the health-related quality of life (HRQL) of allergy sufferers and their 
families, and to assess the economic costs. A framework for measuring costs of food 
allergy to society has already been published 11. However, there is an urgent need 
to initiate a similar enquiry into the social impact of food allergy. We will provide 
an overview of current knowledge and limitations in this area, and describe the 32
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research strategies being developed in the EuroPrevall project to obtain this missing 
information. Finally, the importance of assessing the social impact of food allergy 
and the practical implications will be discussed.
Social impact of food allergy
The social impact of food allergy can be assessed using measurements of HRQL 
in food allergic individuals. Quality of life is a broad concept that pertains to an 
individual’s overall satisfaction with his or her life. It has been defined by the World 
Health Organisation (WHO) as “the individual’s perception of their position of 
life in the context of the culture and value systems in which they live and in 
relation to their goals, expectations, standards and concerns” 12. The component of 
overall quality of life that pertains to an individual’s health is called health-related 
quality of life and is defined as the functional effect of an illness and its consequent 
therapy upon a patient, as perceived by the patient 13. It contains three domains: 
the social, the psychological and the physical state. It is important to understand 
that a similar level of objective clinical impairment may have a different impact on 
HRQL in different patients because individuals vary in their tolerance levels and 
subjective perceptions of ill-health 14. In addition, HRQL measures the impairments 
that patients themselves consider to be important, rather than focusing on what is 
considered important by external observers such as doctors or nurses 15. 
HRQL is measured using specially designed and tested instruments, which 
measure people’s ability to function in their everyday lives. There are two major 
types used in clinical trials and practice: generic and disease-specific instruments. 
Generic instruments can be used to evaluate and compare different disease states. 
Disease-specific instruments do not allow comparison between different diseases, 
but are more responsive than generic instruments and therefore more likely to 
detect small but clinically important changes in patients’ impairments resulting 
from a specific disease or disorder 16. 
There are only a few studies that have investigated the impact of food allergy 
on  HRQL.  By  using  generic  questionnaires  (Impact  on  Family  Scale  (IFS))  it 
has been shown that daily life is significantly more disrupted in peanut allergic 
individuals than in individuals with a rheumatic disease 17. Moreover, general health 
perception, emotional impact on the parent and limitation of family activities 
of parents with food-allergic children were found to be impaired compared to 
established norms, using the Child Health Questionnaire (CHQ) 18. In addition, 
it has also been reported, using the Medical Outcome Trust Short Form 36 Health 
Survey (SF-36), that females with food allergy showed significantly more bodily 
pain and impairment of general health and social functioning in comparison with 
females with other allergy-like conditions 19. Recently, two studies were published 
on the development of preliminary questionnaires to asses the parental adjustment 
to and coping with children’s food allergy 20 and to determine the impact of food Social impact of food allergy across Europe
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allergy on the daily activities of food allergic children and their families 21. Both 
questionnaires are administered to the parents. The last study reported that food 
allergy had a significant impact on almost all aspects of daily life. 
Currently, there is only one validated HRQL questionnaire specific for food 
allergy available: the Food Allergy Quality of Life – Parental Burden (FAQL-PB) 
questionnaire 22. It is administered to the parents and measures the parental burden 
associated with having a child with food allergy. Internal validity, reliability and 
cross-sectional validity were established, but the instrument was not longitudinally 
validated. This questionnaire represents a milestone in the field of food allergy and 
quality of life. However it has some significant limitations. First, the questionnaire 
was developed for allergic children and is therefore not suitable for allergic adults. 
In addition, the questionnaire measures the parental quality of life, not the quality 
of life of the child, and third no distinction was made between different age groups 
of children in the development of the questionnaire. Moreover, the questionnaire 
is time bound, inquiring only about allergic incidents during the week preceding 
administration. 
Assessing HRQL in EuroPrevall
In order to complement the existing instruments, and to develop instruments that 
can assess broader questions related to the quality of life of food allergic patients, new 
HRQL questionnaires will be developed and validated within the EuroPrevall project 
in the Netherlands and Ireland. These questionnaires will cover all ages in childhood 
and adulthood. Questionnaires for the youngest children will be parent-administered 
and  questionnaires  for  the  older  children,  adolescents  and  adults  will  be  self-
administered. In addition, the reporting period will be less restricted.  The development 
of these questionnaires will start with item generation in which all possible problems 
associated with food allergy are generated, followed by item reduction in which 
the most important items are selected. These prototype questionnaires will be cross-
sectionally validated followed by longitudinal validation. The final questionnaires 
will be translated into the languages used in different European countries enabling 
cross-cultural comparison of the questionnaires. A more detailed description of the 
development of these questionnaires can be found elsewhere 23. 
In  EuroPrevall  it  will  be  of  interest  to  compare  the  outcomes  of  the 
questionnaires completed by the parents to the outcomes of the questionnaires 
completed by the children themselves in order to investigate the agreement or 
disagreement between them. In addition, special emphasis will be put on the 
gender  dimension,  because  there  may  be  considerable  differences  between 
men and women in how they experience and cope with their food allergy  24. 
To date, one study has assessed gender differences in the quality of life of the 
family members of children with peanut allergy. The results showed that mothers 
experienced significantly poorer psychological quality of life, greater anxiety and 34
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stress than fathers or sibling(s). In addition, mothers rated their child’s quality of 
life significantly worse compared to the peanut allergic child’s own ratings or the 
proxy ratings of the sibling and father 25. 
In addition to the development of questionnaires to measure HRQL, research 
will be conducted to assess how the quality of life of food allergic consumers can 
be improved. One of the research topics will focus on how to optimise information 
provision through effective allergen labelling. The existing literature indicates that 
food allergic consumers experience stress and potentially impaired quality of life 
as a result of poor labelling practices and lack of information about their food 
allergy 26. Despite the new EU labelling legislation, allergic consumers are still not 
completely sure about the safety of products. This uncertainty could be caused by 
fear of cross-contamination, unlabelled products (for example those which are not 
packaged), changes in ingredients, and the difficulty of understanding product 
labels 27-31. It has been suggested that improved product ingredient labelling will 
reduce allergic reactions and simplify allergy management. However, it may also 
increase choice restriction when allergen-derived ingredients are indicated on the 
label that are tolerated by allergic individuals 32. In addition to the EU labelling 
legislation, companies use precautionary labelling to alert consumers on the chance 
of contamination during the production process, which may increase the choice 
restriction of food allergic consumers even more 33. 
In order to improve labelling practices, consumer preferences for different 
food  labelling  strategies  will  be  investigated,  as  well  as  the  benefits  of  new 
Information  and  Communication Technology  (ICT)  approaches  to  delivering 
targeted  information.  Consumer  preferences  for  the  implementation  of  such 
new approaches, together with feasibility of adoption, will be assessed. This will 
provide the basis for a tested and implementable set of guidelines underpinning 
the development of new approaches to deliver necessary information to the allergic 
consumer, which is essential if food allergic consumers are to lead a life which is as 
normal as possible 34. Such information interventions may have a positive effect on 
the quality of life of food allergic consumers, which can be assessed using ‘before 
and after’ evaluations of the HRQL instruments.
Relevance and practical implementation
Magnitude of social impact of food allergy across Europe
One of the major aims of the EuroPrevall project is to assess the social impact of 
food allergies, and their potential mitigation, to the European Community. In order 
to realise this, it is important to combine the information from studies on HRQL 
with epidemiological data on prevalence. This will ultimately give some indication 
of the magnitude of the social impact of food allergy in Europe. The impact of food 
allergy on HRQL may differ according to the type of food to which a particular 
individual is allergic, the severity of allergy symptoms, and the number of foods Social impact of food allergy across Europe
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to which one is allergic (single or multiple). Furthermore, the impact may also be 
dependent on threshold (the amount of an allergic food that is needed to trigger 
an allergic reaction), or the age and gender of the allergic individual in question. 
This information is essential if health-care planning and food safety assessments 
are to be deployed with best effect to support the allergic consumer in managing 
their condition. 
In a European context, it is important to determine whether cross-cultural 
differences in the social impact of food allergy can be identified. A case in point, it 
has been shown that the prevalence of perceived food allergy differs significantly 
across multiple countries, ranging from 4.6% in Spain to 19.1% in Australia 35. This 
is probably due to differences in the prevalence of real food allergy, but may also 
be due to cultural differences. In addition, the impact of food allergy on quality of 
life may differ due to cultural differences. It is important to take this into account 
when measuring HRQL in different countries.
Determinate problems, effectiveness of interventions and prioritising
The effect of legislation regarding food allergy on the social impact of food allergies, 
on both allergy sufferers and the wider community, has never been assessed. For 
example, it is not understood to what extent the new labelling legislation improves 
the quality of life of allergy sufferers. Nor has an assessment been made of how 
resulting benefits to consumers can be balanced against the costs to the food 
industry when implementing much more stringent hazard control procedures in 
food manufacturing. Such costs are ultimately passed on to the consumer. In order 
to assess the impact of (regulatory) interventions, it is important to first quantify 
the impact of food allergy on HRQL. 
By  using  HRQL  questionnaires,  it  may  for  example  be  ascertained  that 
the quality of life of food allergic patients is negatively affected by the need for 
continuous vigilance when eating outside the home. In this case, regulations need 
to be developed that enforce the need for effective training in the catering sector. 
If some food allergies have a greater impact on quality of life, these should be 
prioritised in terms of regulatory interventions and legislative measures. Other 
applications of HRQL measures include the identification of the effectiveness of 
interventions in clinical trials. For example, if proper diagnosis, expert dietary 
interventions, counselling regarding accidental exposure management, or a future 
treatment is found to have a positive effect on HRQL, then resources can be directed 
towards these interventions. 
Conclusions
 
A necessary first step to assess the social impact of food allergy is the development 
of new HRQL instruments. When these instruments are available, HRQL problems 
associated with food allergy can be identified and this may be followed by the 36
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development of improved approaches to manage these problems. The instruments 
may also be used to assess the usefulness of new legislation and guidelines regarding 
allergen management in food manufacturing and catering industries. Finally, HRQL 
measurement may also facilitate the more efficient allocation of resources within 
health services, for example to support more effective clinical diagnostic methods, 
if these can be demonstrated to have a significant positive impact. Continuous 
application of such instruments and analysis of changes with time may identify 
emerging social problems associated with food allergy, and identify differences 
across European populations.
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Abstract
Background: 
Having a food allergy may affect Health-Related Quality of Life (HRQL). Currently 
no  validated,  self-administered,  disease-specific  HRQL  questionnaire  exists  for 
children with food allergy. 
Objective: 
To develop and validate the Food Allergy Quality of Life Questionnaire - Child 
Form (FAQLQ-CF) in the Dutch language.
Methods: 
Interviews with food allergic children (n=13, 8-12 years) generated 139 HRQL 
items. The most important items were identified by 51 food allergic children using 
the clinical impact method. This resulted in the FAQLQ-CF containing 24 items 
(total score range 1 ‘not troubled’ to 7 ‘extremely troubled’). The FAQLQ-CF, the 
Food Allergy Independent Measure (FAIM) and a generic HRQL questionnaire 
(CHQ-CF87) were sent to 115 food allergic children for cross-sectional validation 
of the FAQLQ-CF. 
Results: 
Construct validity was demonstrated by the correlation between the FAQLQ-CF 
and the FAIM (rho=0.60, p<0.001). The FAQLQ-CF had an excellent internal 
consistency (Cronbach α=0.94) and discriminated between children who differed 
in number of food allergies (>2 food allergies vs. <2 food allergies, total FAQLQ-CF 
score, 4.3 vs. 3.6; p=0.036), but did not discriminate between reported anaphylaxis 
or not. The total FAQLQ-CF score correlated with 8 of the 11 CHQ-CF87 sub-scales 
which demonstrated convergent/discriminant validity.
Conclusion: 
The FAQLQ-CF is the first self-administered disease-specific HRQL questionnaire 
for food allergic children. This questionnaire has strong internal consistency and 
cross-sectional validity. It discriminates between children who differ in number of 
food allergies and it was short and easy to use in the population studied. Therefore, 
the FAQLQ-CF may be a useful tool in clinical research. Food Allergy Quality of Life Questionnaire - Child Form
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Introduction
Avoidance of foods causing allergic reactions and emergency treatment are the only 
proven forms of treatment of food allergy 1. Children with food allergy and their 
families thus need to be continuously alert with regard to food in numerous situations 
and settings and this may have an impact on daily life 2. The avoidance of implicated 
foods along with the fear of an allergic reaction following possible exposure may 
have a negative impact on the quality of life of food allergic children.
Quality of life can be measured with generic or disease-specific questionnaires. 
While generic questionnaires are useful and allow for comparison of quality of life 
between different diseases, their limitation is that they are generally less sensitive 
than disease-specific questionnaires, so that potentially important differences or 
changes may be missed. This is particularly true in the case of food allergy, where, 
unless they are exposed to the relevant food, patients will have no symptoms other 
than those related to the need to avoid foods or fear of accidental ingestion. In 
addition, generic questionnaires are sensitive to co-morbidities, whereas disease-
specific questionnaires allow assessment of a single disease. This is also relevant 
to allergic diseases such as food allergy where many patients also have atopic 
dermatitis, asthma and/or allergic rhino conjunctivitis. 
There are a few studies that have investigated the impact of food allergy on 
Health-Related Quality of Life (HRQL) in children and all found that HRQL was 
impaired. However, these studies used generic HRQL questionnaires 3-6 or disease-
specific  HRQL  questionnaires  which  were  not  validated  7-9.  By  using  generic 
questionnaires  (Child  Health  Questionnaire-Parent  Form  (CHQ-PF28))  it  was 
found that quality of life was more impaired in children with food allergy than in 
children with allergic diseases other than food allergy or non allergic children 3, and 
that food allergy by itself was associated with a deterioration of children’s quality of 
life regardless of additional allergic diseases 4. Moreover, general health perception, 
emotional impact on the parent and limitation of family activities of parents with 
food-allergic children were found to be impaired compared to established norms, 
using the CHQ-PF50 5. By using the Impact on Family Scale (IFS) it has been shown 
that daily life is significantly more disrupted in peanut allergic children than in 
children with a rheumatic disease 6.
A  few  studies  describe  the  development  of  preliminary  disease-specific 
questionnaires to assess the parental adjustment to and coping with children’s food 
allergy 7, to determine the impact of food allergy on the daily activities of food 
allergic children and their families 8 and to compare quality of life of food allergic 
children with children with diabetes mellitus 9. The first two questionnaires were 
completed by the parents, the last one by the child. However, these questionnaires 
have  not  been  validated  which  is  critical  in  order  to  determine  whether  the 
questionnaire is measuring that part of quality of life which is determined by the 
target disorder 10. The only validated disease-specific HRQL questionnaire for food 
allergy which is currently available, is administered to parents and measures the 
parental burden associated with having a child with food allergy 11. 42
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Since no validated food allergy specific HRQL questionnaire exists which 
can be administered to children, we developed such a questionnaire. We targeted 
children old enough to complete the questionnaire themselves (> 8 years) but 
not yet teenage (< 13 years) where social and developmental differences were 
likely to result in differences in content of the questionnaire. This questionnaire 
was developed as part of the EuroPrevall project, a European multi-centre research 
project on food allergy 12. This article will describe the development and cross-
sectional validation of the Food Allergy Quality of Life Questionnaire – Child Form 
(FAQLQ-CF) in the Dutch language. Validation was accomplished by ascertaining 
construct  validity  between  the  items  of  the  FAQLQ-CF  and  the  Food Allergy 
Independent Measure (FAIM) as well as a generic quality of life instrument, the 
Children’s  Health  Questionnaire-Child  Form  (CHQ-CF87).  In  both  cases  only 
moderate correlations were expected, as disease-specific questionnaires cover a 
wider range of issues than most independent measures can capture 13 and generic 
instruments cover a wider range of issues than disease-specific instruments can 
capture 14. In addition, the FAQLQ-CF was tested to see if it could discriminate 
between children who had previous anaphylactic reactions and those who had not 
as well as children allergic to many foods and those allergic to only a few foods.
Methods
Participants
During all stages of questionnaire development and validation children aged 8 to 12 
years were included. All common food allergies and different types and severities of 
symptoms were represented. During the item generation, children were recruited 
from  our  outpatient  paediatric  allergy  clinic.  During  the  item  reduction  and 
cross-sectional validation, children were recruited from our outpatient paediatric 
allergy clinic or were recruited through food allergy support organisations (the 
Dutch Foundation for Food Allergy and the Dutch Anaphylaxis Network) and by 
advertisement in local newspapers.  
Procedure
During  the  item  reduction  and  cross-sectional  validation  phase,  children  and 
their parents were instructed that the children should fill out the questionnaire by 
themselves. Parents were allowed to explain a question when needed, but they were 
not allowed to tell the child which answer to give. In addition, during all stages of 
questionnaire development, descriptive characteristics were asked on age, sex, type 
and number of food allergies, type of symptoms, time since most severe allergic 
reaction, and diagnosis. For completing these descriptive questions, parents were 
allowed to help their child when needed. Food Allergy Quality of Life Questionnaire - Child Form
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Item generation
Potential  items  for  the  new  questionnaire  were  assembled  during  the  item 
generation phase. A semi-structured interview was administered to thirteen food 
allergic children (aged 8-12 years). Such interviews are flexible while a framework 
of themes, concerning unpleasant or troublesome things about having a food allergy 
in daily life, is explored. Additional sources for items were literature review and 
expert opinion. This resulted in an extended item list of 139 items. The items were 
divided into the following themes: shopping/labelling (5 items), food preparing 
(5 items), eating in general (10 items), eating out (20 items), social activities (29 
items), emotions (35 items), holidays (21 items), school/leisure activities (10 
items) and medication (4 items).
Item reduction
Subsequently, item reduction was carried out by using the clinical impact meth-
od 15;16. The clinical impact method asks patients to identify the impairments that 
are most important to them in their everyday lives. Items identified most frequently 
and rated the most important are selected for the final questionnaire. The extended 
item list was sent to a different group of 54 food allergic children (aged 8-12 
years). Items were formulated as questions to which the answer was ‘yes’ or ‘no.’ 
For example, ‘Do you read labels because of your food allergy?’ The children could 
indicate whether an item was applicable to them or not and, if applicable, they were 
asked to indicate on a five-point scale ranging from ‘not’ to ‘extremely’ the impact 
of that item on their life. The five-point scale was illustrated by drawings of faces 
(smileys) ranging from a smiling face to a sad face. For each item we counted the 
number of times that an item was applicable (i.e. frequency). Frequency divided by 
the total number of children gives the percentage by which an item was identified as 
being important. Then, we calculated the mean importance (MI) for each item. The 
MI of an item is the sum of impact scores (based on the five-point scale) divided by 
the frequency. The overall importance (OI) of each item was calculated by multiply-
ing the percentage with the MI.  The maximum possible OI score was 5.0 17;18. 
The items with the greatest OI were selected for the Food Allergy Quality of 
Life Questionnaire – Child Form (FAQLQ-CF). To prevent redundancies, one of any 
pair of items with an inter-item correlation >0.85 and/or overlapping content (face 
validity) was eliminated. Our goal was to create a brief questionnaire that could be 
administered within half an hour, taking into account that it takes one minute to 
complete one item 19. The selected items were worded as questions with a seven-
point response scale ranging from ‘not troubled’ to ‘extremely troubled’ 16;18 and 
were illustrated by drawings of faces (smileys) ranging from a smiling face to a sad 
face. A consultant/teacher for sick children and a linguist reviewed the FAQLQ-CF 
for clarity and ease of use. 
Cross-sectional validation
The complete questionnaire packages, containing the FAQLQ-CF, the Food Allergy 
Independent Measure (FAIM) and a generic HRQL questionnaire (CHQ-CF87), 44
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were pretested in three children (aged 8, 10 and 12 years). No major problems 
emerged during this pretest. The 8 year old child reported that her parents read the 
questions aloud and that she marked the right answers herself. The questionnaire 
packages were then sent by mail to 115 food allergic children. A part of these 
children had participated in the item generation (10%) or item reduction phase 
(45%). For the children recruited from our clinic, we checked the patient records 
to determine whether or not the food allergy was diagnosed by a double-blind 
placebo-controlled food challenge (DBPCFC). 
Reliability
The internal consistency of the FAQLQ-CF and the domains were measured by 
calculating Cronbach’s alpha. An alpha greater than 0.70 indicates good internal 
consistency 20.
The test-retest reliability of the FAQLQ-CF was assessed by administering 
the questionnaire to 28 children on two occasions 10 to 14 days apart and the 
intraclass correlation coefficient (ICC) of the repeated FAQLQ-CF measurement 
was calculated. An ICC greater than 0.70 indicates good test-retest reliability 21.
Cross-sectional validation
Construct validity
In order to demonstrate the construct validity of the FAQLQ-CF, correlations were 
calculated between the FAQLQ-CF and a Food Allergy Independent Measure (FAIM). 
The FAIM was developed for this study and includes four Expectation of Outcome 
(EO) questions and two Independent Measure (IM) questions. The use of EO and 
IM  questions  to  validate  disease-specific  HRQL  questionnaires  has  already  been 
successfully implemented to validate HRQL questionnaires 11;18 and it is of special use 
in anaphylactic disorders where no objective measurement of the extent or severity 
of disease exists 13. The four EO questions concern the chance of accidental exposure, 
chance of having a severe reaction when accidentally exposed, chance of dying 
when accidentally exposed and chance of not acting effectively when accidentally 
exposed. Children could indicate their answer on a seven-point scale ranging from 
‘never’ (0% chance) to ‘always’ (100% chance). The two IM questions concern the 
number of foods one needs to avoid (question 5) and the impact of food allergy on 
social life (question 6). Children could indicate their answer on a seven-point scale 
ranging from ‘almost none’ to ‘almost all’ (question 5) and ranging from ‘so little I 
don’t actually notice it’ to ‘a very great deal’ (question 6). We expected a moderate 
correlation coefficient (0.40-0.70) 22 between the FAQLQ-CF and the FAIM. 
 
Discriminative ability
In order to establish the discriminative ability of the FAQLQ-CF, we compared 
the total FAQLQ-CF score for children who reported anaphylaxis versus children 
who did not. Anaphylaxis was defined as children who reported two or more of 
the following cardiovascular symptoms; dizziness, feeling your heart beat fast, Food Allergy Quality of Life Questionnaire - Child Form
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loss of vision, inability to stand, light headedness, collapse, loss of consciousness/
passing out. In addition, we compared the total FAQLQ-CF score for children who 
reported many food allergies versus children who reported fewer food allergies. 
We investigated which cut off in number of reported food allergies revealed a 
significant difference in the total FAQLQ-CF score. Additionally, the total FAQLQ-
CF score was compared for girls versus boys, since gender may influence quality 
of life 23. Finally, we compared the total FAQLQ-CF score for children who were 
recruited from our clinic versus children who were recruited by advertisement. 
Convergent and discriminant validity
In order to demonstrate convergent and discriminant validity, a generic HRQL 
questionnaire  was  administrated:  the  Child  Health  Questionnaire-Child  Form 
(CHQ-CF87). The  CHQ-CF87  was  developed  in  the  USA  and  has  since  been 
validated in several other countries and languages 24;25. This questionnaire is self-
administrated by the child and contains 87 items divided into twelve sub-scales: 
physical functioning, role functioning-emotional, role functioning-behaviour, role 
functioning-physical, bodily pain, general behaviour, mental health, self-esteem, 
general health perceptions, change in health (single item), family activities, and 
family cohesion. The Dutch version was found to be reliable and valid with good 
internal consistency (only one sub-scale had a Cronbach’s alpha below 0.70) and 
with good test-retest reliability (only two sub-scales had non significant intraclass 
correlation coefficients). Finally, all sub-scales were able to differentiate between 
subgroups with and without two or more reported chronic conditions  25. We 
expected a low correlation coefficient (0.10-0.30) between the FAQLQ-CF and the 
CHQ-CF87, because the FAQLQ-CF is a disease-specific quality of life questionnaire 
whereas the CHQ-CF87 measures generic quality of life. 
Translation
The Dutch FAQLQ-CF was translated into English using the guidelines of the World 
Health Organization 26. The Dutch FAQLQ-CF and the FAIM were translated into 
English by a native English speaker and back translated by a native Dutch speaker. 
The original Dutch version was compared with the back translated Dutch version. 
No important differences in content or meaning of questions emerged. The English 
version of the FAQLQ-CF and the FAIM may be found as Appendix 1 and 2.
Statistical analyses
The raw FAQLQ-CF and FAIM scores 0 to 6 were recoded as 1 to 7. The total 
FAQLQ-CF score is the mean score of all items with a range of 1 ‘no impairment’ to 
7 ‘maximal impairment’. The dataset was not normally distributed, therefore non-
parametric tests were used. In order to demonstrate construct validity, Spearman’s 
correlation coefficients were calculated for the individual items and total FAQLQ-
CF scores with the individual FAIM questions and the mean of the FAIM. The items 
of the FAQLQ-CF were allocated to domains based on factor analysis (principal 
component analysis with Varimax rotation) 27 and face validity determined by a 46
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clinical expert panel (BMJFdB, JNGOE and AEJD) 28;29. The discriminative ability of 
the FAQLQ-CF was analysed by using the Mann-Whitney test. Finally, convergent 
and discriminant validity was demonstrated by calculating Spearman’s correlation 
coefficients for the domain and total FAQLQ-CF scores with the CHQ-CF87 sub-
scales. Statistical analyses were performed with SPSS for Windows (version 14).
Ethical approval
The study was approved by the local medical ethics review commission (METc 
2005/051) who deemed that permission from the commission was not required. 
Parents and children received written information indicating that participation in 
the study was voluntary.
Results
Item generation and item reduction
Descriptive characteristics of the children involved in the item generation and item 
reduction are shown in Table 1. The extended item questionnaire was returned by 
51 children (response rate 94%). The OI scores of all 139 items of the extended 
item  questionnaire  ranged  from  0.00  to  3.22. The  25  non-overlapping  most 
important  items  (OI>1.57)  were  selected  for  the  FAQLQ-CF  (Table  2). These 
selected items came from the following original themes: shopping/labelling (4 
items), food preparing (1 item), eating in general (5 items), eating out (4 items), 
social activities (4 items), emotions (6 items), holidays (0 item), school/leisure 
activities (1 item) and medication (0 item). Although children did bring up items 
concerning sadness, embarrassment and teasing, most of these items did not reach 
a high enough OI for inclusion in the questionnaire.
Cross-sectional validation
Participants
The FAQLQ-CF with the FAIM and the CHQ-CF87 were returned by 84 children 
(response rate 73%). The questionnaires of three children were excluded from the 
analysis because no current food allergies were reported and one questionnaire was 
excluded because the descriptive characteristics were missing. For one child the 
CHQ-CF87 was missing. Forty-eight children (60%) were recruited from our clinic, 
of which 25 (31%) had a food allergy confirmed by a DBPCFC. The other children 
from our clinic had a physician-diagnosed food allergy (skin prick and/or blood 
test) and the majority was awaiting DBPCFC. All children recruited by advertisement 
(40%) reported physician-diagnosed food allergies. Descriptive characteristics of 
the children involved in the cross-sectional validation are shown in Table 1. There 
were no significant differences in descriptive characteristics between boys and girls 
or between children who were recruited from our clinic and children who were 
recruited by advertisement.Food Allergy Quality of Life Questionnaire - Child Form
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Construct validity
Most items of the FAQLQ-CF correlated significantly with at least one of the FAIM 
questions and most items correlated significantly with the mean of the FAIM 
questions. One item (‘Jealous of other people who don’t have a food allergy’) 
did not correlate with any of the FAIM questions and was therefore excluded. The 
validated FAQLQ-CF therefore consists of 24 questions. The total FAQLQ-CF score 
correlated significantly with the mean FAIM (rho 0.60, p<0.001) and with the 
individual FAIM questions (Table 3). The correlation coefficients for the FAQLQ-CF 
with the FAIM were the same for children with a food allergy diagnosed by DBPCFC 
and children with a physician-diagnosed food allergy (total FAQLQ-CF score with 
the mean FAIM, rho 0.56, p=0.003 and rho 0.59, p<0.001, respectively). These 
results demonstrated the construct validity of the FAQLQ-CF, i.e. the FAQLQ-CF is 
measuring quality of life that is affected by food allergy. 
Table 1. Descriptive characteristics of the children involved in the item generation, item reduction and cross-
sectional validation.
Item generation Item reduction Cross-sectional validation
Patients (n) 13  51 80
Sex (m/f) 9/4  29/22 46/34
Age, mean in years (SD) 10.1 (1.3) 9.8 (1.3) 10.2 (1.3)
Food allergy, n (%)
   Peanut 10 (76)  33 (65) 60 (75)
   Tree nuts 11 (85) 38 (75) 58 (73)
   Egg 8 (62)  19 (37) 30 (38)
   Milk 5 (38)  17 (33) 22 (28)
   Fish 1 (8)  3 (6) 2 (3)
   Shell fish 0  6 (12) 7 (9)
   Wheat 4 (31)  6 (12) 10 (13)
   Sesame 2 (15)  7 (14) 15 (19)
   Soy 2 (15)  6 (12) 12 (15)
  Celery 0  1 (2) 1 (1)
Number of food allergies, n (%)
   1 food 1 (8) 12 (24) 20 (25)
   2 foods 3 (23) 16 (31) 22 (28)
   3 foods 3 (23) 8 (16) 18 (24)
   >3 foods 6 (46) 15 (29) 20 (25)
Type of symptoms, n (%)
   Cardiovascular1 2 (15) 10 (20) 15 (19)
   Respiratory tract2 8 (62) 28 (55) 40 (50)
   Gastrointestinal tract3  2 (15) 8 (16) 14 (18)
   Skin4 1 (8) 5 (9) 8 (10)
   Other5 0 0 3 (4)
1 dizziness, feeling your heart beat fast, loss of vision, inability to stand, light headedness, collapse, loss of 
consciousness / passing out. 2 tightening throat, difficulty swallowing, hoarseness / hoarse voice, difficulty 
breathing in, shortness of breath, wheezing, cough. 3 sick to your stomach, stomach cramps, vomiting, 
diarrhoea. 4 itchy skin, red rash, hives, worsening eczema, swelling of the skin. 5 oral allergy, swollen 
tongue or lips, symptoms of the nose or eyes.48
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Domain structure 
The  24  items  of  the  FAQLQ-CF  were  subjected  to  factor  analysis  (principal 
component analysis) and revealed 5 components with eigenvalues >1. To aid in the 
interpretation of these components, Varimax rotation was performed for 5, 4 and 
3 factors. An expert panel reviewed these groupings and based on face validity the 
grouping of 4 factors made the most sense, explaining 66% of the variance. This 
revealed the domains: Allergen Avoidance (AA), Risk of Accidental Exposure (RAE), 
Emotional Impact (EI), and Dietary Restrictions (DR). All factors showed a number 
of strong loadings (AA, 0.807-0.578; EI, 0.818-0.516; RAE, 0.768-0.611 and DR, 
0.877-0.497)). Based on face validity, the expert panel allocated 3 items to a more 
appropriate domain (Table 3). The domains correlated significantly (p<0.001) with 
the mean FAIM (AA, rho 0.42; RAE, rho 0.60; EI, rho 0.68; and DR, rho 0.38). 
Table 2. Selected items for Food Allergy Quality of Life Questionnaire - Child Form (FAQLQ-CF).
Item % MI OI
Can eat fewer things 94 3.42 3.22
Must always watch what you eat 98 3.04 2.98
The ingredients of a food change 76 3.77 2.88
Limited in buying things you like 80 3.22 2.59
Frightened of an allergic reaction 65 3.88 2.51
Tasting or trying fewer things when eating out 84 2.95 2.49
Frightened of eating the wrong food by accident 69 3.43 2.35
Hesitate eating certain foods when you doubt that it is safe 90 2.59 2.33
Concerned that you will never get rid of your food allergy 57 3.79 2.16
The label states: “May contain traces of….” 67 3.15 2.10
Disappointed when people don’t take your food allergy into account 59 3.53 2.08
Not knowing how things taste which you can’t eat 67 3.06 2.04
Frightened of eating something you have never eaten before 69 2.94 2.02
Less easily stay for a meal with someone 53 3.74 1.98
Checking yourself whether you can eat something when eating out 80 2.46 1.98
Having to read labels 86 2.16 1.86
Jealous of other people who don’t have a food allergy 51 3.62 1.84
Others can eat the food you are allergic to when you do things with other people 82 2.24 1.84
Don’t get anything when someone is giving treats at school 47 3.88 1.82
Feeling disappointed because you have a food allergy 59 3.03 1.78
Having to tell beforehand about what you are not allowed to eat when eating out 73 2.43 1.76
Having to explain to people around you that you have a food allergy 88 2.00 1.76
Watching out when touching certain foods 59 2.87 1.69
People around you forget that you have a food allergy 55 3.04 1.67
Refusing food when you do things with others 49 3.20 1.57
MI, mean importance. OI, overall importance.Food Allergy Quality of Life Questionnaire - Child Form
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Table 3. Spearman correlation coefficients for the FAQLQ-CF with the FAIM and internal consistency (Cronbach’s α) 
of the FAQLQ-CF.
FAIM α
EO1 EO2 EO3 EO4 IM1 IM2 Mean
Total FAQLQ-CF 0.34 0.35 0.46 0.38 0.43 0.56 0.60 0.94
Allergen Avoidance (AA) 0.88
Checking yourself whether you can eat something 
when eating out
0.12 0.07 0.11 0.34 0.29 0.25 0.21
Having to tell beforehand about what you are not 
allowed to eat when eating out
0.13 0.14 0.17 0.29 0.28 0.28 0.25
Hesitate eating certain foods when you doubt that 
it is safe
0.22 0.07 0.14 0.15 0.23 0.21 0.23
Less easily stay for a meal with someone 0.29 0.26 0.28 0.35 0.52 0.48 0.47
Having to read labels 0.27 -0.02 0.08 0.38 0.17 0.18 0.15
Tasting or trying fewer things when eating out 0.26 0.26 0.24 0.35 0.35 0.47 0.42
Having to explain to people around you that you 
have a food allergy*
0.18 0.42 0.41 0.36 0.31 0.49 0.50
Risk of Accidental Exposure (RAE) 0.82
People around you forget that you have a food 
allergy
0.18 0.42 0.45 0.15 0.32 0.54 0.57
Others can eat the food you are allergic to when you 
do things with other people
0.22 0.34 0.40 0.32 0.42 0.47 0.52
The label states: “May contain traces of….” 0.19 0.18 0.41 0.06 0.21 0.33 0.37
The ingredients of a food change 0.37 0.36 0.45 0.09 0.23 0.32 0.49
Watching out when touching certain foods** 0.13 0.31 0.51 0.34 0.30 0.58 0.51
Emotional Impact (EI) 0.87
Frightened of an allergic reaction 0.37 0.42 0.53 0.29 0.29 0.34 0.55
Frightened of eating the wrong food by accident 0.31 0.49 0.60 0.28 0.28 0.43 0.60
Concerned that you will never get rid of your food 
allergy
0.36 0.40 0.40 0.40 0.27 0.44 0.53
Feel disappointed because you have a food allergy 0.32 0.27 0.29 0.46 0.25 0.40 0.43
Frightened of eating something you have never 
eaten before
0.24 0.43 0.52 0.27 0.23 0.51 0.56
Disappointed when people don’t take your food 
allergy into account***
0.25 0.31 0.43 0.28 0.31 0.45 0.49
Dietary Restriction (DR) 0.83
Can eat fewer things 0.12 -0.01 0.01 0.16 0.30 0.33 0.19
Refusing food when you do things with others 0.05 0.10 0.10 0.28 0.34 0.32 0.28
Not knowing how things taste which you can’t eat 0.23 0.05 0.06 0.37 0.13 0.21 0.18
Must always watch what you eat 0.25 0.17 0.29 0.28 0.27 0.45 0.40
Limited in buying things you like 0.22 0.30 0.36 0.29 0.41 0.41 0.45
Don’t get anything when someone is giving treats 
at school
0.19 0.17 0.15 0.29 0.28 0.25 0.33
Bold  indicates  p<0.05.  FAQLQ-CF,  Food  Allergy  Quality  of  life  Questionnaire-Child  Form.  FAIM,  Food  Allergy 
Independent Measure. EO1, Chance of accidental exposure. EO2, Chance of severe reaction when accidentally 
exposed. EO3, Chance of dying when accidentally exposed. EO4, Chance of not acting effectively when accidentally 
exposed. IM1, Number of foods one needs to avoid. IM2, Impact of food allergy on social life.  Based on face validity, 
the expert panel allocated *item from EI to AA, **item from AA to RAE, and ***item from RAE to EI. 50
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Reliability
The FAQLQ-CF and the domains had excellent internal consistency with Cronbach’s 
α  exceeding  0.70  (Table  3). The  total  FAQLQ-CF  score  intraclass  correlation 
coefficient was 0.91 (95% confidence interval, 0.81-0.96), indicating excellent 
test-retest reliability.
Discriminative ability 
The HRQL of children who reported more than two food allergies was clinically (i.e. 
>0.5 which is the minimal importance difference 30) and statistically significantly 
more impacted than the HRQL of children who reported two or less food allergies 
(total FAQLQ-CF score 4.3 vs. 3.6; p=0.036). There was no difference in total 
FAQLQ-CF score between children who reported anaphylaxis (i.e. cardiovascular 
symptoms) and children who did not report anaphylaxis (4.2 vs. 3.9; p=0.315). 
If children with respiratory symptoms were added to the group of children with 
cardiovascular symptoms, the difference in total FAQLQ-CF score was still not 
significant (p=0.267). In addition, no difference in total FAQLQ-CF score was 
found between boys and girls (3.8 vs. 4.1; p=0.397) and between children who 
were recruited from our clinic and children who were recruited by advertisement 
(3.7 vs. 4.3; p=0.057). 
Convergent and discriminant validity
The FAQLQ-CF correlated weakly with 8 of the 11 CHQ-CF87 sub-scales. The 
highest correlation was found with the CHQ-CF87 sub-scale “Family activities”.   
Table 4. Spearman’s correlation coefficient for the total FAQLQ-CF score and domains of the FAQLQ-CF with 
the CHQ-CF87 sub-scales. 
Total FAQLQ-CF Domains of the FAQLQ-CF
CHQ-CF87 sub-scales AA RAE EI DR
Physical functioning  -0.13 -0.03 -0.10 -0.14 -0.14
Role functioning- Emotional  -0.29 -0.21 -0.24 -0.17 -0.32
Role functioning-Behaviour  -0.15 -0.12 -0.13 -0.05 -0.17
Role functioning-Physical  -0.26 -0.18 -0.21 -0.26 -0.24
Bodily pain  -0.23 -0.13 -0.21 -0.27 -0.19
General behaviour  -0.31 -0.34 -0.12 -0.22 -0.29
Mental health -0.29 -0.22 -0.09 -0.25 -0.32
Self esteem -0.29 -0.24 -0.14 -0.24 -0.31
General health perceptions -0.36 -0.27 -0.35 -0.44 -0.15
Family activities -0.45 -0.39 -0.35 -0.41 -0.32
Family cohesion -0.19 -0.12 -0.04 -0.18 -0.25
Bold  indicates  p<0.05.  FAQLQ-CF,  Food  Allergy  Quality  of  Life  Questionnaire-Child  Form.  AA,  Allergen 
Avoidance. RAE, Risk of Accidental Exposure. EI, Emotional Impact. DR, Dietary Restrictions. Correlation 
coefficients are negative because a high score on the FAQLQ-CF indicates maximal impairment of quality of 
life, whereas a high score on the CHQ-CF87 indicates better health status.Food Allergy Quality of Life Questionnaire - Child Form
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In addition, the FAQLQ-CF domains AA, RAE, EI and DR correlated with four, 
three, six and seven CHQ-CF87 sub-scales, respectively (Table 4). The presence 
of some correlation, albeit low, indicates that both questionnaires are measuring 
constructs partly related (i.e. convergent validity). On the other hand, these low 
correlations indicate that the generic CHQ-CF87 is not as sensitive as the disease- 
specific FAQLQ-CF and therefore justifies the need of a disease-specific quality of 
life instrument in food allergic children (i.e. discriminant validity). 
Discussion
This report describes the development and cross-sectional validation of the first self-
administered disease-specific HRQL questionnaire for food allergic children: the 
FAQLQ-CF. The content of this questionnaire measures the most important issues 
that food allergic children have to deal with in their daily life and consequently 
impairs their quality of life. By using the clinical impact method for selection of 
the items for the FAQLQ-CF, this questionnaire consists exclusively of items that are 
regarded as important by children. 
In addition, the items of the FAQLQ-CF point to important issues for health 
care providers, catering industries, food manufacturers and governments to develop 
and implement regulations that may improve the quality of life of food allergic 
children 12. The impact on quality of life of items such as ‘Must always watch what 
you eat’ and ‘Having to explain to people around you that you have a food allergy’ 
may be reduced if awareness of food allergy is enhanced in the general public. 
Although recently the labelling legislation has been improved for food allergic 
patients in Europe and USA 31, the use of precautionary labelling has also increased. 
The impact of this phenomenon on quality of life is shown by the item ‘The label 
states; “May contain traces of …” Items such as ‘Able to eat fewer things’ and 
‘Limited in buying things you like’ indicates the desirability of developing new 
therapeutic interventions which may allow food allergic children to eat the food to 
which they are allergic and consequently improve quality of life. 
In order to validate the FAQLQ-CF, we developed the FAIM, which includes 
four EO questions and two IM questions.  The FAIM measures the child’s perception of 
the severity of his/her condition. The FAIM is based on the  approach of expectation 
of outcome questions that has already been successfully implemented to validate 
disease-specific HRQL questionnaires 11;18 and these HRQL questionnaires were able 
to measure relevant and plausible changes over time (i.e. longitudinal validity) 32. 
The method of expectation of outcome questions as independent measure is of 
special use in anaphylactic disorders where no objective measurement of the extent 
or severity of disease exists 13. Moreover, purely symptom-based clinical measures 
would be less applicable to food allergic patients who only experience symptoms 
when they are exposed to a food to which they are allergic while their HRQL 
is continuously affected by their condition 4. The EO questions are based on the 52
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perceived expectation of patients of what will happen following exposure which is 
likely to be a driving force of quality of life 13. The IM questions are based on the 
same principle and ask about the perceived number of foods one needs to avoid 
and perceived impact on social life. The correlation coefficient we found between 
the FAQLQ-CF and FAIM (0.60), is in accordance with other studies using solely 
EO questions to validate the disease-specific HRQL questionnaires, which found 
correlation coefficients of 0.69  18 and 0.41  11, respectively. Finally, validation of 
the FAQLQ-CF was carried out in the Dutch language and carefully translated into 
English using the guidelines of the World Health Organization. The validity of the 
questionnaire in English and eight other European languages is currently being 
investigated. 
The items for the FAQLQ-CF were selected by using the clinical impact 
method which reveals items that are clinically most important as perceived by 
food allergic children. This is in contrast to the method of selecting items based 
on mathematical linkage between items by performing factor analyses. The latter 
method has the potential drawback that it may result in excluding items with a 
high clinical impact   29. However, because we included items based on clinical 
importance rather than mathematical linkage between the items, the allocation of 
items into domains revealed by the factor analysis did not always make intuitive 
sense. Therefore, the allocation of items into domains was based on factor analysis 
supplemented by allocation based on face validity determined by an expert panel. 
Calculation  of  Cronbach’s  alpha  showed  that  these  domains  were  internally 
consistent because they all had a Cronbach alpha exceeding 0.70. 
In  the  current  study,  the  clinical  impact  method  may  also  have  some 
limitations. The number of children included in the item reduction was relatively 
small compared to the number of items of the extended item questionnaires. If the 
sample size was larger, it may be that other items gained more impact and would 
possibly be included in the questionnaire. However, although the sample size was 
relatively small, it was a representative sample, and therefore we think that the 
extended item questionnaire was reduced to the correct items. Another limitation 
of the clinical impact method may be that the selected items cover a relatively 
narrow range of items, resulting in a very high overall Cronbach’s alpha. 
Typically, HRQL questionnaires inquire about events during a specific period, 
e.g. one week or one month. However, such a restricted reporting period may result 
in missing important issues outside the reporting period. Moreover, many patients 
verbalized discontent with the short and framed reporting period of one week of the 
Food Allergy Quality of Life – Parental Burden (FAQL-PB) questionnaire 11. Therefore, 
we used a less restricted reporting period. Patients were asked to complete the 
questionnaire according to their current state. This method will allow for before-
after comparison in intervention studies and analysing changes over time without 
loss of important information by a restricted reporting period.
The FAQLQ-CF discriminates well between children who reported more than 
two food allergies and children who reported two or fewer food allergies, but there 
was no difference in total FAQLQ-CF score in children who reported anaphylaxis Food Allergy Quality of Life Questionnaire - Child Form
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(i.e. cardiovascular symptoms) and children who did not report anaphylaxis. There 
may be two possible explanations for this finding. The first possibility is that many 
children may not remember an anaphylactic reaction well 33. Indeed, in our patient 
group with a mean age of 10.2 (SD 1.3) years, we found that the most severe 
reaction occurred a mean of 4.2 (SD 3.4) years ago. However, we could not find any 
relation between the time since the most severe reaction and the total FAQLQ-CF 
score (rho -0.08, p=0.490) making this explanation unlikely. We thus speculate that 
children may be too young to realize the potentially life-threatening consequences 
of severe anaphylactic reactions to food. This suggests that in children, the day-to-
day consequences of the food allergy itself, including the avoidance requirements 
and the possibility of an allergic reaction, impairs quality of life irrespective of the 
severity of symptoms in the past. 
It is known from the literature that the minimal importance difference (MID) 
of HRQL questionnaires with a seven-point scale is approximately 0.5. The MID is 
the smallest difference in score which patients perceive as beneficial and which 
would mandate, in absence of troublesome side effects and excessive cost, a change 
in the patient’s management 30. Therefore, the difference in total FAQLQ-CF score 
between children who reported more than two food allergies and children who 
reported two or less food allergies was not only a statistically significant difference 
but also a clinically significant difference. Although the MID of 0.5 is a robust 
estimate for HRQL questionnaires with a seven-point scale, the specific MID of the 
FAQLQ-CF remains to be estimated in a longitudinal survey.
The FAQLQ-CF is the first disease-specific HRQL questionnaire for food 
allergic children that asks children to assess their own quality of life. It is important 
to  ask  children  themselves  about  their  quality  of  life,  because  children  and 
parents differ in their views and judgments about quality of life  34. In general, 
parents are less able to make judgments regarding the experience of symptoms, 
relationships with peers or worries about the future 35. On the other hand, it is 
obvious that in very young children one can only make use of the proxy ratings of 
the parents. A parent administered instrument has been developed in the context 
of the EuroPrevall project (FAQLQ-PF) 36 and studies are in progress to determine 
in which age groups one or both of these questionnaires may be used to obtain 
optimal measurements of HRQL in food allergic children. Possible drawbacks of a 
self-administered questionnaire for children are that the result may be affected by 
reading limitations of children or that parents may interfere with the completion 
of the questionnaire. However, it has been reported that children aged 8 to 12 years 
can self-report reliably on their health-status 37. In addition, children are likely to 
express a level of concern regarding their food allergy that is in keeping with their 
usual level of concern in the home environment, and we therefore asked them to 
complete questionnaires at home. This also made the study less burdensome for 
these children and thus more feasible. To reduce unwanted parental influence as 
much as possible, we emphatically instructed parents and children that the children 
should fill out the questionnaire by themselves. 54
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In summary, we have described for the first time a disease-specific HRQL 
questionnaire for food allergic children. The FAQLQ-CF is valid, reliable and short 
and it measures the most important issues that food allergic children have to face. 
In  addition,  it  discriminates  between  children  who  differ  in  number  of  food 
allergies and it was easy to use in the population studied. Therefore, the FAQLQ-CF 
is a suitable questionnaire for studies of food allergic children in which HRQL is 
the outcome of interest. Examples include investigation of the effect of emerging 
treatments such as oral immunotherapy and anti-IgE therapy on quality of life. 
The instrument may be accessed directly from this publication and it is available in 
numerous European language translations from the author.
Acknowledgements
This  work  was  funded  by  the  EU  through  the  EuroPrevall  project  (FOOD-
CT-2005-514000). We  would  like  to  thank Arnaud  Boom,  consultant/teacher 
for sick children, and Karel Verbeek, linguist, for reviewing the extended item 
questionnaire and the FAQLQ-CF and Tina van der Velde for performing the test-
retest of the FAQLQ-CF. 
Reference list
  1.   Sicherer SH. Food allergy. Lancet 2002;360:701-710.
  2.   Munoz-Furlong A. Daily coping strategies for patients and their families. Pediatrics 
2003;111:1654-1661.
  3.   Ostblom E, Egmar AC, Gardulf A, Lilja G, Wickman M. The impact of food hypersensitivity 
reported in 9-year-old children by their parents on health-related quality of life. Allergy 
2008;63:211-218.
  4.   Marklund B, Ahlstedt S, Nordstrom G. Health-related quality of life in food hypersensitive 
schoolchildren and their families: parents’ perceptions. Health Qual.Life Outcomes. 2006;4:48.
  5.   Sicherer SH, Noone SA, Munoz-Furlong A. The impact of childhood food allergy on quality of 
life. Ann.Allergy Asthma Immunol. 2001;87:461-464.
  6.   Primeau MN, Kagan R, Joseph L et al. The psychological burden of peanut allergy as perceived 
by adults with peanut allergy and the parents of peanut-allergic children. Clin.Exp.Allergy 
2000;30:1135-1143.
  7.   Lebovidge JS, Stone KD, Twarog FJ et al. Development of a preliminary questionnaire to assess 
parental response to children’s food allergies. Ann.Allergy Asthma Immunol. 2006;96:472-477.
  8.   Bollinger ME, Dahlquist LM, Mudd K et al. The impact of food allergy on the daily activities of 
children and their families. Ann.Allergy Asthma Immunol. 2006;96:415-421.
  9.   Avery NJ, King RM, Knight S, Hourihane JO. Assessment of quality of life in children with peanut 
allergy. Pediatr.Allergy Immunol. 2003;14:378-382.
  10.   Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement 
properties? J.Clin.Epidemiol. 1992;45:1341-1345.
  11.   Cohen BL, Noone S, Munoz-Furlong A, Sicherer SH. Development of a questionnaire to measure 
quality of life in families with a child with food allergy. J.Allergy Clin.Immunol. 2004;114:1159-
1163.
  12.   de Blok BM, Vlieg-Boerstra BJ, Oude Elberink JN et al. A framework for measuring the social impact 
of food allergy across Europe: a EuroPrevall state of the art paper. Allergy 2007;62:733-737.
  13.   Oude Elberink JN. Significance and rationale of studies of health-related quality of life in 
anaphylactic disorders. Curr.Opin.Allergy Clin.Immunol. 2006;6:298-302.Food Allergy Quality of Life Questionnaire - Child Form
3
55
  14.   Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and 
specific quality-of-life instruments. J.Clin.Epidemiol. 2003;56:52-60.
  15.   Jaeschke R, Guyatt G. How to develop and validate a new quality of life instrument. In: Spilker B, 
ed. Quality of life assessments in clinical trials. New York: Raven Press; 1990:47-57.
  16.   Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality 
of life instrument. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 
Philadelphia: Lippincott-Raven Publishers; 1996:49-56.
  17.   Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with 
nocturnal allergic rhinoconjunctivitis. J.Allergy Clin.Immunol. 2003;111:484-490.
  18.   Oude Elberink JN, de Monchy JG, Golden DB et al. Development and validation of a health-
related quality-of-life questionnaire in patients with yellow jacket allergy. J.Allergy Clin.Immunol. 
2002;109:162-170.
  19.   Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. 
CMAJ. 1986;134:889-895.
  20.   Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-
334.
  21.   Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: 
which coefficient should be used? Qual.Life Res. 2004;13:571-586.
  22.   Bullinger M, Anderson R, Cella D, Aaronson N. Developing and evaluating cross-cultural 
instruments from minimum requirements to optimal models. Qual.Life Res. 1993;2:451-459.
  23.   Dunngalvin A, Hourihane JO, Frewer L et al. Incorporating a gender dimension in food allergy 
research: a review. Allergy 2006;61:1336-1343.
  24.   Landgraf JM, Abetz L, Ware JE. Child Health Questionnaire (CHQ): a user’s manual. Boston: 
HealthAct; 1999.
  25.   Raat H, Landgraf JM, Bonsel GJ, Gemke RJ, Essink-Bot ML. Reliability and validity of the child 
health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual.Life Res. 
2002;11:575-581.
  26.   World Health Organization. Process of translation and adaptation of instruments [Cited 2008 
February 12] Available from. http://www.who.int/substance_abuse/research_tools/translation/
en/ . 2008. 
  27.   Kline P. An easy guide to factor analysis. London: Routledge; 1994.
  28.   Rutishauser C, Sawyer SM, Bond L, Coffey C, Bowes G. Development and validation of the 
Adolescent Asthma Quality of Life Questionnaire (AAQOL). Eur.Respir.J. 2001;17:52-58.
  29.   Juniper EF, Guyatt GH, Streiner DL, King DR. Clinical impact versus factor analysis for quality of 
life questionnaire construction. J.Clin.Epidemiol. 1997;50:233-238.
  30.   Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically 
important difference. Control Clin.Trials 1989;10:407-415.
  31.   Taylor SL, Hefle SL. Food allergen labeling in the USA and Europe. Curr.Opin.Allergy Clin.
Immunol. 2006;6:186-190.
  32.   Oude Elberink JN, de Monchy JG, Van Der Heide S, Guyatt GH, Dubois AE. Venom immunotherapy 
improves health-related quality of life in patients allergic to yellow jacket venom. J.Allergy Clin.
Immunol. 2002;110:174-182.
  33.   Akeson N, Worth A, Sheikh A. The psychosocial impact of anaphylaxis on young people and their 
parents. Clin.Exp.Allergy 2007;37:1213-1220.
  34.   Connolly MA, Johnson JA. Measuring quality of life in paediatric patients. Pharmacoeconomics. 
1999;16:605-625.
  35.   Eiser C. Children’s quality of life measures. Arch.Dis.Child 1997;77:350-354.
  36.   DunnGalvin A, de BlokFlokstra BM, Burks AW, Dubois AE, Hourihane JO. Food allergy QoL 
questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity. Clin.
Exp.Allergy 2008;38:977-986.
  37.   Riley AW. Evidence that school-age children can self-report on their health. Ambul.Pediatr.
   2004;4:371-376.56
|Chapter 3
Appendix 1: Food Allergy Quality of Life Questionnaire 
– Child Form (8-12 years)
Instructions
The questions are about the influence of your food allergy on your quality of life. It is important that you 
fill out the answers yourself. You may ask your parents for help, but they are not allowed to tell you which 
answer to give. Answer every question by putting an ‘x’ in the proper box. You may choose from the 
following answers.
not                       barely                    a little bit                  fairly                       quite                        very                   extremely 
How troublesome do you find it, because of your food 
allergy, that you … 
                 
1  must always watch what you eat? 
2  can eat fewer things? 
3  are limited in buying things you like? 
4  have to read labels? 
5  have to refuse food when you do things with others? 
6  can less easily stay for a meal with someone? 
7  can taste or try fewer things when eating out? 
8  have to tell beforehand about  what you are not allowed to 
eat when eating out? 
9  have to check yourself whether you can eat something 
when eating out? 
10  hesitate eating certain foods when you don’t know if it is 
safe? 
11  must watch out when touching certain foods? 
12  don’t get anything when someone is giving treats at 
school? Food Allergy Quality of Life Questionnaire - Child Form
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How troublesome is it, because of your food allergy, … 
                 
13  that the ingredients of a food change? 
14  that the label states: “May contain traces of….”? 
15  that you have to explain to people around you that you 
have a food allergy? 
16  that people around you forget that you have a food 
allergy? 
17  that others can eat the food you are allergic to when you 
do things with other people? 
18  that you don’t know how things taste which you can’t eat?
How frightened are you because of your food allergy … 
                 
19  of an allergic reaction? 
20  of eating the wrong food by accident? 
21  to eat something you have never eaten before? 
Answer the following questions: 
                 
22  How concerned are you that you will never get rid of your 
food allergy? 
23  How disappointed are you when people don’t take your 
food allergy into account? 
24  How disappointed do you feel because you have a food 
allergy? 
not                       barely                    a little bit                  fairly                       quite                        very                   extremely 58
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Appendix 2: Food Allergy Independent Measure – Child 
Form (8-12 years)
The following four questions are about the chance that you think you have of something
happening to you because of your food allergy. Choose one of the answers. This is followed
by two more questions about your food allergy. Answer every question by putting an ‘x’ in
the box next to the proper answer. 
0  1  2  3  4  5  6 
never  
(0% chance)
very small 
chance
small 
chance
fair 
chance  
big
chance
very big 
chance
always
(100% chance) 
How big do you think the chance is that you …                                  0     1      2     3     4     5    6 
                 
a.  will accidentally eat something to which you are allergic? 
b.  will have a severe reaction if you accidentally eat 
something to which you are allergic?  
c.  will die if you accidentally eat something to which you 
are allergic? 
d.  can not do the right things for your allergic reaction 
should you accidentally eat something to which you are 
allergic? 
e. How many foods are you 
unable to eat because of 
your food allergy? 
f.   Everyone does things with other people, such as; 
playing with friends, going to a birthday party, 
visiting, staying over with someone for a meal or 
eating out.  How much does your food allergy 
affect things you do with others?
 almost none     so little I don’t actually notice it 
 very few     very little 
 a few     a little 
 some     moderately 
 many     a good deal 
 very many     a great deal 
 almost all     a very great deal Chapter
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Abstract
Background: 
Food allergy may affect health-related quality of life (HRQL). Currently no validated, 
self-administered, disease-specific HRQL questionnaire for adolescents with food 
allergy exists. 
Objective: 
To develop and validate the Food Allergy Quality of Life Questionnaire-Teenager 
Form (FAQLQ-TF) in the Dutch language.
Methods: 
Ten  food  allergic  adolescents  (13-17  years)  were  interviewed  and  generated 
166 HRQL items. The most important items were identified by 51 food allergic 
adolescents  using  the  clinical  impact  method,  resulting  in  the  FAQLQ-TF 
containing 28 items (score range 1 ‘no impairment’ to 7 ‘maximal impairment’). 
The  FAQLQ-TF,  the  Food Allergy  Independent  Measure  (FAIM)  and  a  generic 
HRQL questionnaire (CHQ-CF87) were sent to 98 food allergic adolescents for 
cross-sectional validation of the FAQLQ-TF. 
Results: 
Construct validity was assessed by the correlation between the FAQLQ-TF and 
the FAIM (rho 0.57, p<0.001). The FAQLQ-TF had excellent internal consistency 
(Cronbach α 0.92) and discriminated between adolescents who differed in number 
of food allergies (1 food allergy vs. >2 food allergies, total FAQLQ-TF score, 4.3 vs. 
3.5; p=0.037), but did not discriminate between reported anaphylaxis or not. The 
FAQLQ-TF correlated weakly with 6 of the 11 CHQ-CF87 scales, demonstrating 
convergent/discriminant validity.
Conclusion: 
The FAQLQ-TF is the first self-administered, disease-specific HRQL questionnaire 
for food allergic adolescents. It has good construct validity and excellent internal 
consistency and discriminates between adolescents who differ in number of food 
allergies. The FAQLQ-TF is short and easy to use and may therefore be a useful tool 
in clinical research. Food Allergy Quality of Life Questionnaire - Teenager Form
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Introduction
 
Having a food allergy can be fatal and adolescents are at the highest risk of death 
from food allergy 1-3. It is estimated that 2.3% of adolescents are food allergic 4. The 
only effective form of treatment of food allergy is strict avoidance of the implicated 
food(s) and provision of medications for emergency treatment 5. In spite of the 
high risk of death, food allergic adolescents actually reported social isolation as the 
most disturbing aspect of their disease 6. In addition, some adolescents reported 
depression as a result of food allergy and this may lead to difficulties in school 
performance and leisure activities  7. Thus, food allergic adolescents need to be 
continuously alert as to what they are eating in numerous situations and settings 
and, along with the fear of allergic reactions, this may have a negative impact on 
quality of life.
At  present,  no  validated  self-administered,  food-allergy-specific  health-
related  quality  of  life  (HRQL)  questionnaire  exists  for  use  in  adolescents. A 
few studies have reported that food allergy has a negative impact on HRQL in 
adolescents.  However,  three  limitations  arise  when  interpreting  these  studies. 
First, no distinction was made between adolescents and younger children  8-13, 
whereas HRQL in adolescents needs to be addressed separately, because HRQL may 
be influenced by the stage of neurocognitive and emotional development of an 
individual 14;15. Second, HRQL questionnaires were administered to parents thus 
measuring parents’ perceptions 8-13. However, children and parents differ in their 
views and judgments about quality of life 16. Finally, studies used generic HRQL 
questionnaires  11-13;17  or  disease-specific  questionnaires  which  have  not  been 
validated 8;10, whereas generic HRQL questionnaires are not as sensitive as disease-
specific HRQL questionnaires 18 and validation is extremely important in order 
to determine whether the questionnaire is measuring that part of quality of life 
which is determined by the target disorder 19.
Therefore, we have developed and cross-sectionally validated the first self-
administered,  food-allergy-specific  HRQL  questionnaire  for  adolescents,  the 
Food Allergy  Quality  of  Life  Questionnaire-Teenager  Form  (FAQLQ-TF). This 
questionnaire has been developed as part of the EuroPrevall project, a European 
multi-center research project on food allergy. The FAQLQ-TF complements the 
recently developed self-administered Food Allergy Quality of Life Questionnaire-
Child Form (FAQLQ-CF) for children aged 8 to 12 years (B.M.J. Flokstra-de Blok 
et al., unpublished data, June 2008) and the parent-administered Food Allergy 
Quality of Life Questionnaire-Parent Form (FAQLQ-PF) for parents of food allergic 
children aged 0 to 12 years 20. 64
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Methods 
Participants and procedure
During item generation, participants were recruited only from our outpatient 
pediatric allergy clinic. Two adolescents were approached during a double-blind 
placebo-controlled food challenge (DBPCFC) and, based on patient records, eight 
adolescents were approached by phone. All approached adolescents (n=10) agreed 
to participate in an interview on the impact of food allergy on their daily life.
During  item  reduction  and  cross-sectional  validation,  participants  were 
recruited from our outpatient pediatric allergy clinic (based on patient records 
or appointments for DBPCFC) or were recruited by advertisement in local news 
papers and through food allergy support organizations (the Dutch Foundation 
for Food Allergy and the Dutch Anaphylaxis Network). A letter of invitation, the 
questionnaire  and  a  pre-paid  return  envelop  was  sent  to  suitable  adolescents 
from  our  clinic  and  to  adolescents  who  responded  to  the  advertisement. The 
letter of invitation stressed that participation was completely voluntary. When the 
questionnaire was not returned within a month, the adolescent was contacted by 
phone as a reminder. Adolescents were not paid for their participation in any stage 
of questionnaire development or validation.
Before cross-sectional validation, the questionnaire was pretested in three 
adolescents (aged 13, 15 and 17 years). No major problems emerged during this 
pretest. Thereafter, the FAQLQ-TF, the Food Allergy Independent Measure (FAIM) 
and the CHQ-CF87, a generic quality of life questionnaire, were sent by mail to 
98 food allergic adolescents. Some of them had participated in the item generation 
(10%) or item reduction (49%). Descriptive characteristics were asked regarding 
age, sex, type and number of food allergies, type of symptoms and diagnosis. For 
the adolescents recruited from our clinic, we checked patient records to determine 
whether food allergy had been diagnosed by a DBPCFC.
During all stages of questionnaire development and validation, all common 
food allergies and different types and severities of symptoms were represented. 
The study was approved by the local medical ethics review commission (METc 
2005/051) who deemed that permission from the commission was not required. 
Development
Item generation
For the development and validation of the FAQLQ-TF, the same methodology was 
used as for the development and validation of the FAQLQ-CF, which is described in 
more detail elsewhere (B.M.J. Flokstra-de Blok et al., unpublished data, June 2008). 
Briefly, potential items for the new questionnaire were generated by interviewing 
10 food allergic adolescents (aged 13-17 years). In addition, literature review and 
expert opinion were consulted. This resulted in an extended item questionnaire of 
166 items. Food Allergy Quality of Life Questionnaire - Teenager Form
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Item reduction
The extended item questionnaire was sent to a different group of 51 food allergic 
adolescents to identify the most important items by using the clinical impact 
method 21;22. The adolescents were asked to indicate the importance of applicable 
items using a five-point scale. Frequency (percentage) was multiplied by mean 
importance  (MI),  resulting  in  the  overall  importance  (OI)  of  each  item. The 
maximal possible OI was 5.0  23;24. Items with the greatest OI were selected for 
the FAQLQ-TF, except one of any pair of items with an inter-item correlation 
>0.85 and/or overlapping content (face validity). The selected items were worded 
as questions having a seven-point response scale ranging from ‘not troubled’ to 
‘extremely troubled’22;24. A psychologist and a linguist reviewed the FAQLQ-TF for 
clarity and ease of use. 
Cross-sectional validation
Construct validity
Construct validity was investigated by calculation of correlation coefficients for 
the FAQLQ-TF with the Food Allergy Independent Measure (FAIM). This approach 
has  already  been  successfully  implemented  to  validate  disease-specific  HRQL 
questionnaires  9;20;24 and it is especially useful in anaphylactic disorders where 
no objective measurement of the extent or severity of disease exists 25. The FAIM 
includes  four  Expectation  of  Outcome  (EO)  questions  and  two  Independent 
Measure (IM) questions. The EO questions are based on the perceived expectation 
of patients of what will happen following exposure which is likely to be a driving 
force of quality of life 25. The IM questions are based on the same principle and 
ask about the perceived number of foods one needs to avoid and perceived impact 
on social life. We expected moderate correlation coefficients (0.40-0.60) for the 
FAQLQ-TF with the FAIM. The validation of the FAQLQ-TF was carried out in the 
Dutch language. The English version of the FAQLQ-TF and the FAIM may be found 
as Appendix 1 and 2. The Dutch FAQLQ-TF and the FAIM were translated into 
English by a native English speaker and back translated by a native Dutch speaker, 
according to the guidelines of the World Health Organization  26. The original 
Dutch version was compared with the back translated Dutch version. No important 
differences in content or meaning of questions emerged.
Discriminative ability
To establish the discriminative ability of the FAQLQ-TF, we compared the total 
FAQLQ-TF score for adolescents who reported anaphylaxis (i.e. adolescents who 
reported two or more of the following cardiovascular symptoms; dizziness, feeling 
your heart beat fast, loss of vision, inability to stand, light headedness, collapse, loss 
of consciousness/passing out) versus adolescents who did not, for adolescents who 
reported many food allergies versus adolescents who reported few food allergies, 
for boys versus girls 27 and for adolescents who were recruited from our clinic 
versus adolescents who were recruited by advertisement.66
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Reliability
The reliability of the FAQLQ-TF was assessed by administering the questionnaire to 
34 adolescents on 2 occasions 10-14 days apart. 
Convergent and discriminant validity
To investigate convergent and discriminant validity, a generic HRQL questionnaire 
was administered: the Child Health Questionnaire-Child Form (CHQ-CF87)   28;29. 
This questionnaire is self-administered by adolescents and contains 87 items di-
vided into twelve scales. We expected weak correlation coefficients (0.20-0.40) for 
the FAQLQ-TF with the CHQ-CF87. 
Statistical analyses
The raw FAQLQ-TF and FAIM scores 0 to 6 were recoded as 1 to 7. The total 
FAQLQ-TF score is the mean score of all items with a range of 1 ‘no impairment’ 
to 7 ‘maximal impairment’. To assess construct validity, Spearman’s correlation 
coefficients were calculated between the FAQLQ-TF and the FAIM. The allocation 
of the items of FAQLQ-TF into domains was based on factor analysis (principal 
component analysis with Varimax rotation) 30 and face validity determined by a 
clinical expert panel (BMJFdB, JNGOE and AEJD) 14;31. To investigate the internal 
consistency of the FAQLQ-TF and the domains, Cronbach’s α were calculated. An 
α greater than 0.70 indicates good internal consistency 32. The Mann-Whitney test 
was used for measuring the discriminative ability of the FAQLQ-TF. The reliability 
of the FAQLQ-TF was assessed by calculating the intraclass correlation coefficient 
of the repeated FAQLQ-TF measurement 33. Finally, convergent and discriminant 
validity were assessed by calculating Spearman’s correlation coefficients between 
the FAQLQ-TF and the CHQ-CF87 scales. Statistical analyses were performed with 
SPSS for Windows 14.0 (SPSS Inc., Chicago, IL, USA).
Results
Development
Descriptive  characteristics  of  the  adolescents  involved  in  the  item  generation 
and item reduction are shown in Table 1. The extended item questionnaire was 
returned by 46 adolescents (response rate 90%). The OI scores of all 166 items 
of the extended item questionnaire ranged from 0.00 to 2.89. The item reduction 
resulted in the selection of 28 items (OI>1.37) for the FAQLQ-TF (Table 2).
Cross-sectional validation
Participants
The  questionnaire  package  including  the  FAQLQ-TF,  the  FAIM  and  the  CHQ-
CF87  were  returned  by  75  adolescents  (response  rate  77%).  One  adolescent Food Allergy Quality of Life Questionnaire - Teenager Form
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was  excluded  because  the  descriptive  characteristics  were  missing  from  the 
questionnaire,  resulting  in  74  assessable  questionnaires  for  the  cross-sectional 
validation. Forty-three adolescents (58%) were recruited from our clinic, of which 
19 (26%) had a food allergy confirmed by a DBPCFC. The other adolescents from 
our clinic had a physician-diagnosed food allergy (skin prick and/or blood test) 
and the majority was awaiting DBPCFC. All adolescents recruited by advertisement 
(42%) reported physician-diagnosed food allergies. Descriptive characteristics of 
the adolescents involved in the cross-sectional validation are shown in Table 1. 
There were no significant differences in descriptive characteristics between boys 
and girls, between adolescents recruited from our clinic and adolescents recruited 
by advertisement or between adolescents with a physician-diagnosed food allergy 
and adolescents with a food allergy diagnosed by DBPCFC.
Table 1. Descriptive characteristics of the adolescents involved in the item generation, item reduction and 
cross-sectional validation.
Item generation Item reduction Cross-sectional validation
Participants (n) 10 46 74
Sex (m/f) 4/6 23/23 34/40
Age, mean in years (SD) 14.2 (1.5) 14.9 (1.4) 14.7 (1.3)
Food allergy, n (%)
   Peanut 7 (70) 36 (78) 57 (77)
   Tree nuts 8 (80) 33 (72) 56 (76)
   Egg 3 (30) 17 (37) 26 (35)
   Milk 5 (50) 15 (33) 29 (39)
   Fish 2 (20) 8 (17) 13 (18)
   Shell fish 1 (1) 10 (22) 12 (16)
   Wheat 0 4 (9) 5 (7)
   Sesame 0 7 (15) 8 (11)
   Soy 3 (30) 11 (26) 17 (23)
   Celery 0 4 (9) 3 (4)
Number of food allergies, n (%)
   1 food 3 (30) 10 (22) 12 (16)
   2 foods 0 16 (35) 31 (42)
   3 foods 1 (10) 2 (4) 8 (11)
   >3 foods 6 (60) 17 (33) 23 (31)
Type of symptoms, n (%)
   Cardiovascular1 4 (40) 9 (20) 17 (23)
   Respiratory tract2 3 (30) 26 (58) 39 (53)
   Gastrointestinal tract3 2 (20) 4 (9) 11 (15)
   Skin4  1 (10) 4 (9) 4 (5)
   Other5 0 2 (4) 3 (4)
1 dizziness, feeling your heart beat fast, loss of vision, inability to stand, light headedness, collapse, loss of 
consciousness / passing out. 2 tightening throat, difficulty swallowing, hoarseness / hoarse voice, difficulty 
breathing in, shortness of breath, wheezing, cough. 3 sick to your stomach, stomach cramps, vomiting, 
diarrhea. 4 itchy skin, red rash, hives, worsening eczema, swelling of the skin. 5 oral allergy, swollen tongue 
or lips, symptoms of the nose or eyes.68
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Construct validity
Most items of the FAQLQ-TF correlated significantly with at least one of the FAIM 
questions and with the mean of the FAIM questions. Five items did not correlate 
with any of the FAIM questions and were therefore excluded from the questionnaire. 
The validated FAQLQ-TF therefore consists of 23 questions. As expected, we found 
moderate correlation coefficients between the FAQLQ-TF and the FAIM. The total 
FAQLQ-TF score correlated significantly with the mean FAIM (rho 0.57, p<0.001) 
and with the individual FAIM questions (Table 3). This significant correlation 
coefficient was found for adolescents with a food allergy diagnosed by DBPCFC 
and for adolescents with a physician-diagnosed food allergy (total FAQLQ-TF score 
Table 2. Selected items for the FAQLQ-TF.
Item % MI OI
Always be alert as to what you are eating 91 3.17 2.89
Change of ingredients of a product 87 3.30 2.87
Able to eat fewer products 91 3.12 2.85
Having to read labels 93 2.98 2.78
Troublesome for those with whom you are eating if you have an allergic 
reaction 80 3.41 2.74
Hesitate eating a product when you have doubts about it 96 2.77 2.65
Label states: “May contain traces of….” 76 3.29 2.50
Refusing treats at school or work 85 2.82 2.39
Limited as to the products you can buy 96 2.45 2.35
Less able to taste or try various products when eating out 83 2.61 2.15
Frightened of an allergic reaction 54 3.68 2.00
Checking personally whether you can eat something when eating out 85 2.31 1.96
Refusing many things during social activities 65 2.93 1.91
Being careful about touching certain foods 67 2.81 1.89
Disappoint people when they are making an effort to accommodate your food 
allergy 57 3.35 1.89
Frightened of accidentally eating something wrong 61 2.96 1.80
Frightened of eating something you have never eaten before 59 2.85 1.67
The labeling of the bulk packaging (for example box or bag) is different than 
the individual packages 57 2.92 1.65
The feeling that you have less control of what you eat when eating out 65 2.53 1.65
Disappointed when people do not take your food allergy into account 57 2.77 1.57
Less able to spontaneously accept an invitation to stay for a meal 52 2.92 1.52
Carrying an Epipen 63 2.41 1.52
People must accommodate you when you visit them 54 2.68 1.46
Having to explain to people around you that you have a food allergy 87 1.68 1.46
During social activities your food allergy is not taken into account 39 3.67 1.43
During social activities others can eat the food to which you are allergic 91 1.57 1.43
Not knowing how things taste which you can’t eat 48 2.95 1.41
Feel discouraged during an allergic reaction 39 3.50 1.37
MI, mean importance. OI, overall importance.Food Allergy Quality of Life Questionnaire - Teenager Form
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Table 3. Spearman correlation coefficients for the FAQLQ-TF with the FAIM and internal consistency 
(Cronbach’sα) of the FAQLQ-TF.
FAIM α
EO1 EO2 EO3 EO4 IM1 IM2 Mean
Total FAQLQ-TF 0.44 0.29 0.15 0.50 0.41 0.54 0.57 0.92
Allergen Avoidance & Dietary Restrictions (AADR) 0.89
Refuse treats at school or work 0.29 0.22 -0.12 0.46 0.13 0.16 0.27
Able to eat fewer products 0.37 0.12 0.08 0.46 0.27 0.28 0.35
Limited as to the products you can buy 0.28 0.09 0.01 0.34 0.34 0.41 0.34
Less able to taste or try various products when eating out 0.38 0.33 0.14 0.46 0.25 0.38 0.49
Hesitate eating a product when you have doubts about it 0.30 0.15 -0.03 0.32 0.14 0.26 0.27
Less able to spontaneously accept an invitation to stay 
for a meal 0.21 0.26 0.00 0.21 0.25 0.17 0.30
Always be alert as to what you are eating 0.44 0.19 0.19 0.32 0.11 0.19 0.33
Checking personally whether you can eat something 
when eating out 0.24 0.29 0.18 0.33 0.18 0.44 0.39
Having to read labels* 0.29 0.06 0.10 0.37 0.18 0.35 0.27
Having to explain to people around you that you have a 
food allergy* 0.16 0.14 0.20 0.43 0.07 0.45 0.27
Emotional Impact (EI) 0.81
Frightened of eating something you have never eaten 
before 0.30 0.23 0.19 0.45 0.45 0.41 0.48
Frightened of an allergic reaction 0.33 0.31 0.15 0.40 0.20 0.27 0.42
Frightened of accidentally eating something wrong 0.37 0.28 0.20 0.46 0.41 0.45 0.53
Feel discouraged during an allergic reaction 0.36 0.10 0.21 0.34 0.03 0.14 0.18
The feeling that you have less control of what you eat 
when eating out 0.32 0.05 0.09 0.36 0.40 0.38 0.38
Disappointed when people do not take your food allergy 
into account 0.17 0.29 0.12 0.51 0.34 0.38 0.43
Carrying an Epipen 0.14 0.41 0.30 0.33 -0.20 -0.12 0.15
Risk of Accidental Exposure (RAE) 0.81
Change of ingredients of a product 0.33 -0.08 0.02 0.33 0.43 0.30 0.27
The labeling of the bulk packaging (for example box or 
bag) is different than the individual packages 0.16 0.01 0.15 0.11 0.30 0.14 0.20
Label states: “May contain traces of….” 0.40 0.10 0.14 0.28 0.33 0.42 0.40
Being careful about touching certain foods 0.20 0.08 -0.07 0.46 0.27 0.49 0.29
During social activities your food allergy is not taken 
into account 0.21 0.10 -0.11 0.58 0.34 0.46 0.34
During social activities others can eat the food to which 
you are allergic** 0.38 0.18 0.06 0.40 0.31 0.39 0.42
p<0.05 is shown in bold. EO1, Chance of accidental exposure. EO2, Chance of severe reaction when accidentally 
exposed.  EO3,  Chance  of  dying  when  accidentally  exposed.  EO4,  Chance  of  not  acting  effectively  when 
accidentally exposed. IM1, Number of foods one needs to avoid. IM2, Impact of food allergy on social life. Based 
on face validity, the expert panel allocated *items from EI to AADR and **item from AADR to RAE.70
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with the mean FAIM, rho 0.76, p<0.001 and rho 0.52, p<0.001, respectively). 
These results support the construct validity of the FAQLQ-TF. That is, the FAQLQ-
TF measures that part of quality of life that is affected by food allergy. Expectation 
of Outcome question 3 (EO3) did not correlate with any of the individual HRQL 
items and is thus unlikely to be an appropriate independent measure for food 
allergy in adolescents. Therefore, we excluded this question from further analyses.
Domain structure and internal consistency
The  23  items  of  the  FAQLQ-TF  were  subjected  to  factor  analysis  (principal 
component analysis), which revealed 5 factors with eigenvalues >1. To aid in 
the interpretation of these factors, Varimax rotation was performed for 5, 4 and 
3 factors. These groupings were reviewed by an expert panel, and based on face 
validity the grouping of 3 factors made the most sense. This grouping revealed 
the following domains: Allergen Avoidance and Dietary Restrictions, Emotional 
Impact and Risk of Accidental Exposure. These three factors showed a number of 
strong loadings; all exceed 0.300, which is regarded as an acceptable criterion 30. 
The expert panel allocated 3 items to a more appropriate domain based on face 
validity. The FAQLQ-TF and the domains had excellent internal consistency with 
Cronbach’s α exceeding 0.70 (Table 3).
Discriminative ability
Adolescents  who  reported  2  or  more  food  allergies  reported  a  significantly 
more impaired HRQL than adolescents who reported only 1 food allergy (total 
FAQLQ-TF score 4.3 vs. 3.5; p=0.037). There was no significant difference in total 
FAQLQ-TF score between adolescents who reported anaphylaxis (cardiovascular 
symptoms) and adolescents who did not report anaphylaxis (4.5 vs. 4.0; p=0.184) 
or between boys and girls (4.0 vs. 4.3; p=0.324). Adolescents who were recruited 
by advertisement reported a significantly more impaired HRQL than adolescents 
recruited from our clinic (total FAQLQ-TF score 4.6 vs. 3.9; p=0.015). 
Reliability
The  total  FAQLQ-TF  score  intraclass  correlation  coefficient  was  0.98  (95% 
confidence interval, 0.95-0.99), indicating excellent test-retest reliability.
Convergent and discriminant validity
The total FAQLQ-TF score correlated weakly with 6 of the 11 CHQ-CF87 scales. In 
addition, the domains of the FAQLQ-TF correlated weakly with several CHQ-CF87 
scales (Table 4). This indicates that both questionnaires measure constructs that are 
partly related (i.e. convergent validity). However, as expected the correlations are 
weak and sometimes even absent because the CHQ-CF87 is a generic quality of life 
questionnaires and therefore not as sensitive as the disease-specific FAQLQ-TF (i.e. 
discriminant validity). Food Allergy Quality of Life Questionnaire - Teenager Form
4
71
Discussion
We have developed and validated the first health-related quality of life (HRQL) 
questionnaire specific for adolescents with food allergy, the Food Allergy Quality of 
Life Questionnaire-Teenager Form (FAQLQ-TF). We found that the FAQLQ-TF has 
good construct validity and excellent internal consistency (Table 3). In addition, 
the FAQLQ-TF discriminates between adolescents who differ in number of food 
allergies. Finally, the FAQLQ-TF showed convergent/discriminant validity (Table 
4), which supports the need for a disease-specific quality of life questionnaire for 
food allergic adolescents.
It is known that HRQL may be influenced by the current stage of cognitive, 
social and emotional development of an individual. Therefore, it has been argued that 
HRQL in adolescents should be measured by means of a specific instrument 14;15. The 
FAQLQ-TF was specifically designed for food allergic adolescents aged 13 to 17 
years. Age appropriateness was ensured by generating and including only items that 
were regarded as important by food allergic adolescents (clinical impact method). 
The FAQLQ-TF focuses on the perceptions of the adolescents themselves, because 
the questionnaire is self-administered. 
Many of the items in this instrument are specific to adolescents. An example 
is ‘Carrying an Epipen’. The Epipen issue in food allergic adolescents is in con-
cordance with the literature. It has been reported that adolescents raise concerns 
about its size and portability 34, and sometimes adolescents do not carry it based on 
social circumstances and perceived risks 35. Despite our age specific approach and 
the separate development of child and adolescent questionnaires, it is striking that 
Table 4. Spearman’s correlation coefficients for the total FAQLQ-TF score and domains of the FAQLQ-TF with 
the CHQ-CF87 scales. 
Total FAQLQ-TF Domains of the FAQLQ-TF
CHQ-CF87 scales AADR EI RAE
Physical functioning -0.29 -0.18 -0.22 -0.37
Role functioning- Emotional  -0.15 -0.23 0.04 -0.07
Role functioning-Behavior -0.16 -0.18 -0.12 -0.10
Role functioning-Physical -0.20 -0.15 -0.25 -0.11
Bodily pain -0.29 -0.27 -0.28 -0.18
General behavior -0.23 -0.19 -0.32 -0.09
Mental health -0.33 -0.33 -0.37 -0.15
Self esteem -0.27 -0.27 -0.30 -0.20
General health perceptions -0.31 -0.27 -0.36 -0.16
Family activities -0.43 -0.37 -0.39 -0.35
Family cohesion -0.19 -0.27 -0.19 0.05
p<0.05 is shown in bold. AADR, Allergen Avoidance and Dietary Restrictions. EI, Emotional Impact. RAE, Risk 
of Accidental Exposure. Correlation coefficients are negative because a high score on the FAQLQ-TF indicates 
maximal impairment of quality of life, whereas a high score on the CHQ-CF87 indicates better health status. 72
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approximately two thirds of the adolescent questions in the FAQLQ-TF correspond 
to the child questions in the FAQLQ-CF (B.M.J. Flokstra-de Blok et al., unpublished 
data, June 2008). Thus, although we generated many age specific items, there are 
apparently ‘general’ food allergy items that are important in children and adoles-
cents. Furthermore, we found that the three most important items that impair qual-
ity of life were the same in children and teenagers (‘Always be alert as to what you 
are eating’, ‘The ingredients of a product change’, ‘Able to eat fewer products’). 
An unexpected finding was that EO3 (Chance of dying when accidentally 
exposed) was not correlated with any of the items of the FAQLQ-TF. This may 
indicate that fear of dying of food allergy is not a driving force of quality of life in 
adolescents, which may be characteristic and specific for adolescents. It has been 
reported that adolescents perceived their anaphylaxis as ‘no big deal’ 34. In addition, 
adolescents are at the highest risk of death from food allergy 1-3. This high risk may 
be the result of underestimation of the severity of food allergy and the belief of 
adolescents that they will not die from any cause, including their food allergy. In 
fact, there were no adolescents in this study who reported ‘always (100% chance)’ 
of dying when accidentally exposed, whereas this was reported by 5% of children 
and 4% of adults in other FAQLQ validation studies (not shown). Although not 
statistically significant, this is a noteworthy observation. The incorrect belief of 
immortality of adolescents may result in risk-taking behavior that may increase 
the risk of dying from a food allergy. Therefore, physicians and other health-care 
providers should be aware that underestimation of food allergic symptoms may be 
important when counseling adolescents with food allergy.
When  comparing  the  discriminative  results  of  the  FAQLQ-TF  with  the 
FAQLQ-CF  (B.M.J.  Flokstra-de  Blok  et  al.,  unpublished  data,  June  2008),  2 
interesting observations emerged. First, there was no significant difference in total 
FAQLQ-TF score between adolescents who reported anaphylaxis (cardiovascular 
symptoms) and adolescents who did not. The same result was found in children. 
Secondly, adolescents who were recruited by advertisement reported a significantly 
more impaired HRQL than adolescents recruited from our clinic. This difference 
was  not  significant  in  children,  although  a  trend  was  seen.  It  may  be  that 
adolescents experience safety and security by being looked after in the clinic, 
whereas adolescents outside the clinic experience more uncertainty and insecurity 
about their food allergy 36. Most adolescents recruited from our clinic were known 
to us for many years (mean number of years since first visit 12.5 (SD 5.4)). In 
addition, it has recently been shown that parental trait anxiety is higher in parents 
of children with a suspected food allergy who refused to participate in a DBPCFC 
than parents who did participate (W.T. Zijlstra et al., unpublished data, June 2008). 
Since it is known that parental anxiety is related to child anxiety 37, it may be that 
the adolescents in our study recruited by advertisement have higher levels of trait 
anxiety than adolescents recruited from our clinic and may therefore have more 
impairment in quality of life.  
This study may have some limitations. Firstly, the validation of the FAQLQ-
TF was carried out in the Dutch language. The FAQLQ-TF was carefully translated Food Allergy Quality of Life Questionnaire - Teenager Form
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into English using the guidelines of the World Health Organization. The validity of 
the English language version of this questionnaire is currently being investigated 
as well as versions in several other European languages. Our experience with the 
Dutch Vespid Allergy Quality of Life Questionnaire was that the English translation 
validated well 24. It is possible, however, that cultural differences may influence the 
ability of our questionnaire to identify the most important items for food allergic 
patients in different cultural or linguistic settings. 
Secondly, patients were recruited at our clinic and by advertisement. These 
patients may differ from each other, for example in terms of level of information 
about their food allergy. However, we did not find significant differences in the 
descriptive characteristics between these groups and other possible differences 
would not have adversely influenced the validation procedure, where a spectrum 
of severity is beneficial to obtain optimal correlations. 
Thirdly, some of the items in this questionnaire are likely to be time sensitive 
in the long run. For example, new labelling laws could make the labelling items 
included in this questionnaire obsolete. It is likely that in time, this questionnaire 
will require some updating and adaptation. 
Finally, this report describes only the cross-sectional validation of the FAQLQ-
TF. Currently, the longitudinal validation of the questionnaire is being investigated 
(i.e. the capacity of the FAQLQ-TF to measure differences in HRQL over time). 
In summary, we have developed and validated the first HRQL questionnaire 
specific for food allergic adolescents, the Food Allergy Quality of Life Questionnaire-
Teenager Form (FAQLQ-TF). We found that this questionnaire is valid and reliable 
and it is short and easy to use. The FAQLQ-TF will be thus a suitable questionnaire 
for clinical research in food allergic adolescents in which HRQL is the outcome of 
interest. 
Acknowledgements
This  work  was  funded  by  the  EU  through  the  EuroPrevall  project  (FOOD-
CT-2005-514000). We would like to thank Dr. GFEC van Linden van den Heuvell, 
medical psychologist, and Karel Verbeek, linguist, for reviewing the extended item 
questionnaire and the FAQLQ-TF and Tina van der Velde for performing the test-
retest of the FAQLQ-TF. 74
|Chapter 4
Reference list
  1.   Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to 
food, 2001-2006. J.Allergy Clin.Immunol. 2007;119:1016-1018.
  2.   Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. 
J.Allergy Clin.Immunol. 2001;107:191-193.
  3.   Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in chil-
dren and adolescents. N.Engl.J.Med. 1992;327:380-384.
  4.   Pereira B, Venter C, Grundy J et al. Prevalence of sensitization to food allergens, reported adverse 
reaction to foods, food avoidance, and food hypersensitivity among teenagers. J.Allergy Clin.Im-
munol. 2005;116:884-892.
  5.   Sicherer SH. Food allergy. Lancet 2002;360:701-710.
  6.   Noone SA, Munoz-Furlong A, Sicherer SH. Parent and adolescent perceptions on food allergy 
[abstract]. J.Allergy Clin.Immunol. 2003;111(suppl):S133.
  7.   Calsbeek H, Rijken M, Dekker J, van Berge Henegouwen GP. Disease characteristics as deter- 7.   Calsbeek H, Rijken M, Dekker J, van Berge Henegouwen GP. Disease characteristics as deter- Disease characteristics as deter-
minants of the labour market position of adolescents and young adults with chronic digestive 
disorders. Eur.J.Gastroenterol.Hepatol. 2006;18:203-209.
  8.   Bollinger ME, Dahlquist LM, Mudd K et al. The impact of food allergy on the daily activities of 
children and their families. Ann.Allergy Asthma Immunol. 2006;96:415-421.
  9.   Cohen BL, Noone S, Munoz-Furlong A, Sicherer SH. Development of a questionnaire to measure 
quality of life in families with a child with food allergy. J.Allergy Clin.Immunol. 2004;114:1159-
1163.
  10.   Lebovidge JS, Stone KD, Twarog FJ et al. Development of a preliminary questionnaire to assess 
parental response to children’s food allergies. Ann.Allergy Asthma Immunol. 2006;96:472-477.
  11.   Marklund B, Ahlstedt S, Nordstrom G. Health-related quality of life in food hypersensitive school-
children and their families: parents’ perceptions. Health Qual.Life Outcomes. 2006;4:48.
  12.   Primeau MN, Kagan R, Joseph L et al. The psychological burden of peanut allergy as perceived 
by adults with peanut allergy and the parents of peanut-allergic children. Clin.Exp.Allergy 
2000;30:1135-1143.
  13.   Sicherer SH, Noone SA, Munoz-Furlong A. The impact of childhood food allergy on quality of 
life. Ann.Allergy Asthma Immunol. 2001;87:461-464.
  14.   Rutishauser C, Sawyer SM, Bond L, Coffey C, Bowes G. Development and validation of the Adoles-
cent Asthma Quality of Life Questionnaire (AAQOL). Eur.Respir.J. 2001;17:52-58.
  15.   Ravens-Sieberer U, Erhart M, Wille N et al. Generic health-related quality-of-life assessment in 
children and adolescents: methodological considerations. Pharmacoeconomics. 2006;24:1199-
1220.
  16.   Connolly MA, Johnson JA. Measuring quality of life in paediatric patients. Pharmacoeconomics. 
1999;16:605-625.
  17.   Marklund B, Ahlstedt S, Nordstrom G. Health-related quality of life among adolescents with 
allergy-like conditions - with emphasis on food hypersensitivity. Health Qual.Life Outcomes. 
2004;2:65.
  18.   Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and 
specific quality-of-life instruments. J.Clin.Epidemiol. 2003;56:52-60.
  19.   Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement 
properties? J.Clin.Epidemiol. 1992;45:1341-1345.
  20.   DunnGalvin A, de BlokFlokstra BM, Burks AW, Dubois AE, Hourihane JO. Food allergy QoL ques-
tionnaire for children aged 0-12 years: content, construct, and cross-cultural validity. Clin.Exp.
Allergy 2008;38:977-986.
  21.   Jaeschke R, Guyatt G. How to develop and validate a new quality of life instrument. In: Spilker B, 
ed. Quality of life assessments in clinical trials. New York: Raven Press; 1990:47-57.
  22.   Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of 
life instrument. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. Phila-
delphia: Lippincott-Raven Publishers; 1996:49-56.Food Allergy Quality of Life Questionnaire - Teenager Form
4
75
  23.   Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with 
nocturnal allergic rhinoconjunctivitis. J.Allergy Clin.Immunol. 2003;111:484-490.
  24.   Oude Elberink JN, de Monchy JG, Golden DB et al. Development and validation of a health-
related quality-of-life questionnaire in patients with yellow jacket allergy. J.Allergy Clin.Immunol. 
2002;109:162-170.
  25.   Oude Elberink JN. Significance and rationale of studies of health-related quality of life in anaphy-
lactic disorders. Curr.Opin.Allergy Clin.Immunol. 2006;6:298-302.
  26.   World Health Organization. Process of translation and adaptation of instruments [Cited 2008 
February 12] Available from http://www.who.int/substance_abuse/research_tools/translation/
en/, 2008. 
  27.   Dunngalvin A, Hourihane JO, Frewer L et al. Incorporating a gender dimension in food allergy 
research: a review. Allergy 2006;61:1336-1343.
  28.   Landgraf JM, Abetz L, Ware JE. Child Health Questionnaire (CHQ): a user’s manual. Boston: Heal- Boston: Heal-
thAct; 1999.
  29.   Raat H, Landgraf JM, Bonsel GJ, Gemke RJ, Essink-Bot ML. Reliability and validity of the child 
health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual.Life Res. 
2002;11:575-581.
  30.   Kline P. An easy guide to factor analysis. London: Routledge; 1994.
  31.   Juniper EF, Guyatt GH, Streiner DL, King DR. Clinical impact versus factor analysis for quality of 
life questionnaire construction. J.Clin.Epidemiol. 1997;50:233-238.
  32.   Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-
334.
  33.   Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: 
which coefficient should be used? Qual.Life Res. 2004;13:571-586.
  34.   Akeson N, Worth A, Sheikh A. The psychosocial impact of anaphylaxis on young people and their 
parents. Clin.Exp.Allergy 2007;37:1213-1220.
  35.   Sampson MA, Munoz-Furlong A, Sicherer SH. Risk-taking and coping strategies of adolescents 
and young adults with food allergy. J.Allergy Clin.Immunol. 2006;117:1440-1445.
  36.   Teufel M, Biedermann T, Rapps N et al. Psychological burden of food allergy. World 
J.Gastroenterol. 2007;13:3456-3465.
  37.   Muris P, Steerneman P, Merckelbach H, Meesters C. The role of parental fearfulness and modeling 
in children’s fear. Behav.Res.Ther. 1996;34:265-268.76
|Chapter 4
Food Allergy Quality of Life Questionnaire – Teenager Form (13-17 years) 
The following questions concern the influence your food allergy has on your quality of life.
Answer every question by marking the appropriate box with an ‘x’. You may choose from
one of the following answers. 
0  1  2  3  4  5  6 
not  barely  slightly  moderately quite  very  extremely 
How troublesome  do you find it, because of your food 
allergy, that you …  0   1   2   3   4   5   6    
                 
1  must always be alert as to what you are eating? 
2  are able to eat fewer products? 
3  are limited as to the products you can buy? 
4  must read labels? 
5  have the feeling that you have less control of what you eat 
when eating out? 
6  are less able to spontaneously  accept an invitation to stay 
for a meal? 
7  are less able to taste or try various products when eating 
out? 
8  must check yourself whether you can eat something when 
eating out? 
9  hesitate eating a product when you have doubts about it? 
10    must refuse treats at school or work? 
11    must be careful about touching certain foods? 
12    must carry an Epipen? (If you don’t have a Epipen mark 
an ‘x’ here   ) 
Appendix 1: Food Allergy Quality of Life Questionnaire – 
Teenager Form (13-17 years)Food Allergy Quality of Life Questionnaire - Teenager Form
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0  1  2  3  4  5  6 
not  barely  slightly  moderately quite  very  extremely 
How  troublesome is it, because of your food allergy, ...                        0 1  2  3  4  5 6  
                 
13  that the ingredients of a product change? 
14  that the label states: “May contain traces of….”? 
15  that the labeling of the bulk packaging (for example box 
or bag) is different than the individual packages?  
16  that you have to explain to people around you that you 
have a food allergy? 
17  that during social activities others can eat the food to 
which you are allergic? 
18  that during social activities your food allergy is not taken 
into account enough? 
How frightened are you because of your food allergy …      0 1  2  3  4  5 6  
                 
19  of an allergic reaction? 
20  of accidentally eating something wrong? 
21  to eat something you have never eaten before? 
    6   5     4     3     2     1   0   : s n o i t s e u q   g n i w o l l o f   e h t   r e w s n A
                 
22  How discouraged  do you feel during an allergic reaction? 
23  How disappointed are you when people do not take your 
food allergy into account? 78
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Food Allergy Independent Measure – Teenager Form (13-17 years) 
The following four questions are about the chance that you think you have of something
happening to you because of your food allergy. Choose one of the answers provided. This is
followed by two more questions about your food allergy. Answer every question by putting
an ‘x’ in the box next to the appropriate answer.    
0  1  2  3  4  5  6 
never  
(0% chance)
very small 
chance
small 
chance
fair 
chance
great
chance
very great 
chance
always
(100% chance) 
How great do you think the chance is that you …      
                 
a.  will accidentally eat something to which you are allergic? 
b.  will have a severe reaction if you accidentally eat 
something to which you are allergic?  
c.  will die if you accidentally eat something to which you 
are allergic?* 
d.  can not effectively deal with an allergic reaction should 
you accidentally eat something to which you are allergic? 
e. How many products must you avoid 
because of your food allergy?
f. How great is the impact of your food 
allergy on your social life? 
 almost none    negligibly small 
    w e f   y r e v     very small
    w e f   a     small 
    e m o s     moderate 
    y n a m     great 
    y n a m   y r e v     very great 
    l l a   t s o m l a     extremely great 
* This Expectation of Outcome question was not correlated with any of the items of the FAQLQ-TF and is thus 
unlikely to be an appropriate independent measure for food allergy in adolescents. Therefore, this question was 
excluded from further analyses. 
0   1   2   3   4   5   6    
Appendix 2: Food Allergy Independent Measure – Teenager 
Form (13-17 years)Chapter
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Abstract
Background: 
Health-Related Quality of Life (HRQL) may be affected by food allergy. Presently 
no disease-specific HRQL questionnaire exists for food allergic adults. Therefore we 
developed and validated the Food Allergy Quality of Life Questionnaire-Adult Form 
(FAQLQ-AF) in the Dutch language.
Methods: 
Twenty-two food allergic patients (>18 years) were interviewed and generated 180 
HRQL items. The most important items were identified by 54 food allergic patients 
using the clinical impact method resulting in the FAQLQ-AF containing 29 items 
(score range 1 ‘not troubled’ to 7 ‘extremely troubled’). The FAQLQ-AF, the Food 
Allergy Independent Measure (FAIM) and a generic HRQL questionnaire (RAND-
36) were sent to 100 other food allergic adults for cross-sectional validation of the 
FAQLQ-AF. 
Results: 
Cross-sectional validity was assessed by the correlation between FAQLQ-AF and 
FAIM  (rho  0.76,  p<0.001). The  FAQLQ-AF  had  excellent  internal  consistency 
(Cronbach’s α 0.97). The FAQLQ-AF discriminated between patients who differ 
in severity of symptoms (anaphylaxis vs. no anaphylaxis, total FAQLQ-AF score 
4.9 vs 4.1; p=0.041) and number of food allergies (>3 food allergies vs. <3 food 
allergies, total FAQLQ-AF score 5.2 vs 4.2; p=0.008). The total FAQLQ-AF score 
was correlated with one RAND-36 scale (convergent/discriminant validity).
Conclusions: 
The FAQLQ-AF is the first disease-specific HRQL questionnaire for food allergic 
adults and reflects the most important issues that food allergic patients have to 
face. The questionnaire is valid, reliable and discriminates between patients with 
different  disease  characteristics. The  FAQLQ-AF  is  short  and  easy  to  use  may 
therefore be a useful tool in clinical research. Food Allergy Quality of Life Questionnaire - Adult Form 
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Introduction
 
Food plays an important role in our social and cultural life. In patients with food 
allergy the ingestion of a particular food may provoke an allergic reaction, which may 
be fatal for some patients 1-3. The only proven form of treatment is strict avoidance of 
the food(s) involved and medications for emergency treatment 4. Food allergic patients 
thus need to be continuously alert as to what they are eating in numerous situations 
and settings. Consequently, daily life of these patients may be seriously disrupted by 
the required continuous vigilance, the threat of accidental exposure and fear of an 
allergic reaction and this may have a negative impact on their quality of life.
A few studies have investigated the impact of food allergy on Health-Related 
Quality of Life (HRQL) 5-11, but all these studies investigated children or adolescents 
with food allergy or parents with a food allergic child. Only one study investigated 
HRQL in adults with food allergy and reported that daily life was significantly more 
disrupted in peanut allergic adults than in adults with a rheumatologic disease 12. 
However, in that study a generic HRQL questionnaire was used, which may be not 
as sensitive as a disease-specific HRQL questionnaire 13. At present, no validated 
food-allergy-specific HRQL questionnaire exists for use in adults. 
Therefore, we here report the development and cross-sectional validation of 
the first disease-specific HRQL questionnaire for adults with food allergy, the Food 
Allergy Quality of Life Questionnaire-Adult Form (FAQLQ-AF). This questionnaire 
is the last HRQL questionnaire in a series of questionnaires developed in the 
EuroPrevall project, a European multi-centre research project on food allergy, to 
cover all age groups of patients with food allergy. It complements the recently 
developed FAQLQ-PF for parents of food allergic children aged 0 to 12 years and 
the two self-administered questionnaires; the FAQLQ-CF for children aged 8 to 12 
years and the FAQLQ-TF for adolescents aged 13 to 17 years 14-16. 
Methods
Participants and Procedure
During all stages of questionnaire development, only patients 18 years or older 
with a physician-diagnosed food allergy were included.  All common food allergies 
and different types and severities of symptoms were represented. Patients with only 
oral allergy syndrome were excluded. During the item generation, patients were 
recruited only from our outpatient allergy clinic. During the item reduction and 
cross-sectional validation, patients were recruited when attending our outpatient 
allergy  clinic  or  recruited  through  food  allergy  support  organizations  (the 
Dutch Foundation for Food Allergy and the Dutch Anaphylaxis Network) and by 
advertisement in local news papers. 
Before the cross-sectional validation, the questionnaire was pretested in three 
patients. No major problems emerged during this pretest. Thereafter, the FAQLQ-84
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AF, the Food Allergy Independent Measure (FAIM) and the RAND-36, a generic 
quality of life questionnaire, were sent to 100 food allergic patients by post. These 
questionnaires are described in more detail later on. A subset of these patients were 
previously asked to participate in the item generation (n=20) or item reduction 
phase (n=59), but were eligible to participate in the validation process since it is 
independent of the development phase. Descriptive characteristics were elicited 
regarding age, gender, type and number of food allergies, type of symptoms and 
diagnosis. For the patients recruited from our clinic, we checked the patient records 
to determine whether or not the food allergy was diagnosed by a double-blind 
placebo-controlled food challenge (DBPCFC). 
The study was approved by the local medical ethics review commission 
(METc 2005/051) who deemed that permission from the commission was not 
required,  since  this  study  does  not  fall  under  the  Medical  Research  Involving 
Human Subjects Act.
Development
Item generation
The development and validation of the FAQLQ-AF was based on the methodology 
used for the development and validation of the FAQLQ-CF and FAQLQ-TF  15;16. 
Potential items for the new adult questionnaire were generated by interviewing 
22 food allergic patients, reviewing literature and consulting expert opinion. This 
procedure resulted in an ‘extended item questionnaire’ of 180 items.
Item reduction
The clinical impact method was used for identifying the most important items of 
the extended item list 17;18. The ‘extended item questionnaire’ was sent to a different 
group of 63 food allergic patients, who were asked to indicate the importance to 
them of each applicable item, rated on a 5-point scale. The overall importance (OI) 
of each item was calculated by multiplying the frequency with which an item was 
identified as being important (%) with the mean importance using the 5-point 
scale. The maximal possible OI was 5.0 19;20. The items with the greatest OI were 
selected for the FAQLQ-AF, except one of any pair of items with overlapping content 
(face validity) and/or an inter-item correlation >0.85. The selected items were 
worded as questions with a 7-point response scale (ranging from ‘not troubled’ to 
‘extremely troubled’) 18;20. A psychologist and a linguist reviewed the FAQLQ-AF 
for clarity and ease of use. 
Cross-sectional validation
Construct validity
Construct  validity  is  usually  evaluated  by  comparing  the  HRQL  questionnaire 
with an objective measurement of the extent or severity of the disease. However, 
in disorders not characterized by chronic symptoms, as in food allergy, such an Food Allergy Quality of Life Questionnaire - Adult Form 
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independent measure is not available. It is has been shown that the perceived 
expectation of what will happen following exposure can be used as independent 
measure to evaluate construct validity and instruments developed in this way have 
proved to be useful and consistent in measuring HRQL  8;14-16;20;21. Therefore, in 
order to investigate construct validity of the FAQLQ-AF, correlation coefficients 
were calculated for the FAQLQ-AF with the Food Allergy Independent Measure 
(FAIM). The FAIM, which has previously been used to validate the FAQLQ-PF, -CF 
and -TF 14-16, contains four Expectation of Outcome (EO) questions 8;20;21 and two 
additional Independent Measure (IM) questions 15;16. The EO questions are based 
on the perceived expectation of patients of what will happen following exposure, 
which is likely to be a driving force of quality of life 21. The IM questions are based 
on the same principle and query about the perceived number of foods one needs 
to avoid and perceived impact on social life. We expected moderate correlation 
coefficients (0.40-0.60) 22 for the FAQLQ-AF with the FAIM. The validation of the 
FAQLQ-AF was carried out in the Dutch language. The Dutch FAQLQ-AF and the 
FAIM were translated into English following the guidelines of the World Health 
Organization 23. The English version of the FAQLQ-AF and the FAIM may be found 
as Appendices 1 and 2. 
Convergent and discriminant validity
Additionally,  construct  validity  was  further  investigated  by  convergent  and 
discriminant validity. To investigate convergent and discriminant validity, a generic 
HRQL questionnaire was administered, the RAND-36 24. This health profile measure 
is the Dutch version of the MOS 36-item Short-Form Health Survey (SF-36) 25 and 
consists of 36 items divided into nine scales: physical functioning, social functioning, 
role  functioning-physical,  role  functioning-emotional,  mental  health,  vitality, 
bodily pain, general health and change in health (single item). Because the FAQLQ-
AF is a disease-specific questionnaire and the RAND-36 a generic questionnaire, we 
expected no to weak correlations (0.20-0.40) for the total FAQLQ-AF score with 
the RAND-36 scales (i.e. discriminant validity). When looking at the FAQLQ-AF 
domains we expected that Food Allergy related Health (FAH) would correlate better 
with the RAND-36 scales than the other FAQLQ-AF domains, since this is the most 
‘generic’ FAQLQ-AF domain (i.e convergent validity).
Discriminative ability
To investigate the discriminative ability of the FAQLQ-AF, we compared the total 
FAQLQ-AF score of patients who reported anaphylaxis (i.e. two or more of the 
following cardiovascular symptoms: dizziness, palpitations, loss of vision, inability 
to stand, light headedness, collapse, loss of consciousness) vs patients who did 
not, for men vs women, for patients who were recruited from our clinic vs patients 
who were recruited by advertisement and for patients who reported many food 
allergies vs patients who reported few food allergies. We investigated which cut off 
in number of reported food allergies revealed a significant difference in the total 
FAQLQ-AF score. 86
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Reliability
The  test-retest  reliability  of  the  FAQLQ-AF  was  assessed  by  administering  the 
questionnaire to 36 patients on two occasions 10-14 days apart.
Statistical analyses
The raw FAQLQ-AF and FAIM scores 0 to 6 were recoded as 1 to 7. The total 
FAQLQ-AF score is the mean score of all items with a range of 1 ‘no impairment’ 
to 7 ‘maximal impairment’. Cross-sectional validity was assessed by calculating 
Spearman’s  correlation  coefficients  between  the  FAQLQ-AF  and  the  FAIM 
(individual FAQLQ-AF items with individual FAIM items, individual FAQLQ-AF 
items with mean FAIM, total FAQLQ-AF score with mean FAIM, and total FAQLQ-
AF score with individual FAIM items). Domains were created by performing factor 
analysis (principal component analysis with Varimax rotation) 26 and face validity 
determined by a clinical expert panel (BMJFdB, JNGOE and AEJD) 27. The internal 
consistency was measured by calculating Cronbach’s α. An α > 0.70 indicates 
good internal consistency  28. Convergent and discriminant validity was assessed 
by  calculating  Spearman’s  correlation  coefficients  between  the  FAQLQ-AF  and 
the RAND-36 scales. The discriminative ability was measured by using the Mann-
Whitney test. The test-retest reliability was assessed by calculating the intraclass 
correlation coefficient of the repeated FAQLQ-AF measurement 29. Statistical analyses 
were performed with SPSS for Windows 14.0 (SPSS Inc., Chicago, IL, USA).
Results
Development
Descriptive characteristics of the patients involved in the item generation and item 
reduction are shown in Table 1. The ‘extended item questionnaire’ was returned 
by 54 of the 63 adults (response rate 86%). The OI scores of all 180 items of the 
extended item list ranged from 0.00 to 3.19. The item reduction resulted in the 
selection of 29 items (OI >1.61) for the FAQLQ-AF (Table 2).
Cross-sectional validation
Participants
The FAQLQ-AF with the FAIM and the RAND-36 were returned by 80 of the 100 
adults (response rate 80%). The questionnaire of one patient was excluded from 
the analysis because no current food allergies were reported and the questionnaires 
of seven patients were excluded because no physician-diagnosed food allergy was 
reported. Thus, 72 questionnaires were assessable for the cross-sectional validation. 
Forty-two patients (58%) were recruited from our clinic, of which 11 (15%) 
had a food allergy confirmed by a DBPCFC and three (4%) with an open food 
challenge (OFC). The other patients from our clinic had a physician-diagnosed Food Allergy Quality of Life Questionnaire - Adult Form 
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food allergy with a positive history and positive skin prick and/or blood test. All 
patients  recruited  by  advertisement  (42%)  reported  physician-diagnosed  food 
allergies. Descriptive characteristics of the patients involved in the cross-sectional 
validation are shown in Table 1. There were no significant differences in descriptive 
characteristics between men and women (not shown). Patients who were recruited 
by advertisement reported significantly more food allergies than patients who were 
recruited from our clinic (p=0.001). Patients with a DBPCFC or OFC diagnosis 
reported significantly fewer food allergies (p=0.046) and reported significantly 
more severe symptoms (p=0.046) than patients with a physician-diagnosed food 
allergy.
Table 1. Descriptive characteristics of the patients involved in the item generation, item reduction and cross-
sectional validation.
Item generation Item reduction Cross-sectional validation
Patients (n) 22  54 72
Gender (m/f) 6/16 20/34 18/54
Age, mean in years (SD) 36.4 (16.5) 39.1 (16.4) 37.2 (14.3)
Food allergy, n (%)
   Peanut 10 (45) 32 (59) 42 (58)
   Tree nuts 6 (27) 36 (67) 42 (58)
   Egg 4 (18) 13 (24) 16 (22)
   Milk 6 (27) 17 (32) 19 (26)
   Fish 3 (14) 9 (17) 11 (15)
   Shell fish 2 (9) 16 (30) 12 (17)
   Wheat 4 (18) 14 (26) 12 (17)
   Sesame 3 (14) 12 (22) 13 (18)
   Soy 2 (9) 14 (26) 13 (18)
   Celery 3 (14) 10 (19) 11 (15)
Number of food allergies, n (%)
   1 food 7 (32) 11 (20) 21 (29)
   2 foods 4 (18) 10 (19) 19 (26)
   3 foods 5 (23) 15 (28) 14 (19)
   >3 foods 6 (27) 18 (33) 18 (25)
Type of symptoms, n (%)
   Cardiovascular1 6 (27) 20 (37) 32 (44)
   Respiratory tract2 7 (32) 21 (39) 29 (40)
   Gastrointestinal tract3 7 (32) 5 (9) 4 (6)
   Skin4  2 (9) 8 (15) 4 (6)
   Other5 0 0 3 (4)
1 dizziness, feeling your heart beat fast, loss of vision, inability to stand, light headedness, collapse, loss of 
consciousness / passing out, 2 tightening throat, difficulty swallowing, hoarseness / hoarse voice, difficulty 
breathing in, shortness of breath, wheezing, cough,  3 sick to your stomach, stomach cramps, vomiting, 
diarrhoea , 4 itchy skin, red rash, hives, worsening eczema, swelling of the skin, 5 oral allergy, swollen tongue 
or lips, symptoms of the nose or eyes.88
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Construct validity
All items of the FAQLQ-AF correlated significantly with at least one of the FAIM 
questions  and  all  items  correlated  significantly  with  the  mean  of  the  FAIM 
questions. Therefore, all 29 selected items were included in the final version of the 
validated FAQLQ-AF. The total FAQLQ-AF score correlated significantly with the 
mean FAIM (rho 0.76, p<0.001) and with the individual FAIM questions (Table 
3). The correlation coefficients for the FAQLQ-AF with the FAIM were the same 
for patients with a food allergy diagnosed by DBPCFC or OFC and patients with 
a physician-diagnosed food allergy (total FAQLQ-AF score with the mean FAIM, 
Table 2. Selected items for Food Allergy Quality of Life Questionnaire–Adult Form (FAQLQ-AF).
Item % MI OI
Always be alert as to what you are eating 89 3.58 3.19
Change of ingredients of a product 80 3.91 3.11
Able to eat fewer products 96 3.21 3.09
Limited as to the products you can buy 87 3.36 2.93
Frightened of an allergic reaction 81 3.48 2.83
Labels are incomplete 65 3.94 2.56
Feel discouraged during an allergic reaction 69 3.70 2.54
Having to read labels 94 2.65 2.50
Frightened of accidentally eating the wrong food 69 3.62 2.48
Hesitate eating a product when you have doubts about it 91 2.73 2.48
Troublesome for your host or hostess should you have an allergic reaction 67 3.64 2.43
Have the feeling that you have less control of what you eat when eating out 72 3.31 2.39
Apprehensive about eating something you have never eaten before 69 3.38 2.31
Refuse many things during social activities 69 3.24 2.22
The lettering on labels is too small 61 3.61 2.20
Less able to spontaneously accept an invitation to stay for a meal 57 3.77 2.17
Worried that the allergic reactions to foods will become increasingly severe 57 3.65 2.09
Less able to taste or try various products when eating out 72 2.79 2.02
Sometimes frustrate people when they are making an effort to accommodate 
your food allergy
54 3.72 2.00
People underestimate your problems caused by food allergy 72 2.72 1.96
Label states: “May contain (traces of)….” 48 3.96 1.91
Unclear to which foods you are allergic 46 4.00 1.85
Frightened of an allergic reaction when eating out despite the fact that your 
dietary restrictions have been discussed beforehand
59 3.09 1.83
Worried about your health 54 3.21 1.72
Ingredients are different in other countries (for example during vacation) 50 3.41 1.70
Eating out less often 44 3.79 1.69
Have to explain to those around you that you have a food allergy 91 1.86 1.69
Check personally whether you can eat something when eating out 67 2.42 1.61
Feel you are being a nuisance because you have a food allergy when eating out 48 3.35 1.61
MI, mean importance. OI, overall importance.Food Allergy Quality of Life Questionnaire - Adult Form 
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rho 0.78, p=0.001 and rho 0.78, p<0.001, respectively). These results support the 
construct validity of the FAQLQ-AF, i.e. the FAQLQ-AF is measuring quality of life 
that is affected by food allergy.
Domain structure and internal consistency
Factor analysis (principal component analysis) was performed on the 29 items 
of the FAQLQ-AF and revealed five components with eigenvalues >1. To aid in 
the interpretation of these components, Varimax rotation was performed for 5, 
4 and 3 factors. An expert panel reviewed these groupings and based on face 
validity the grouping of four domains made the most sense. This grouping revealed 
the  following  domains: Allergen Avoidance  and  Dietary  Restrictions  (AADR), 
Emotional Impact (EI), Risk of Accidental Exposure (RAE) and Food Allergy related 
Health (FAH). All factors showed a number of strong loadings and were >0.300 
which is regarded as an acceptable criterion 26. Based on face validity, the expert 
panel allocated a few items to a more appropriate domain. The FAQLQ-AF and the 
domains had excellent internal consistency which is shown by the Cronbach’s α 
that are all exceeding 0.70 (Table 3).  
Convergent and discriminant validity
The total FAQLQ-AF score was weakly correlated with one RAND-36 scale (mental 
health) and the correlations with the other RAND-36 scales were not significant 
(Table 4). Given the fact that the FAQLQ-AF is a disease-specific questionnaire, 
whereas the RAND-36 is a generic questionnaire, these results were expected 
(discriminant validity). The domains of the FAQLQ-AF showed weak correlation 
with a few RAND-36 scales. As expected, most correlations with the RAND-36 
scales were found for the domain FAH, as this is the most general domain of the 
disease-specific FAQLQ-AF (convergent validity). 
Discriminative ability
Patients  who  reported  anaphylaxis  (i.e.  cardiovascular  symptoms)  reported  a 
significantly more impaired HRQL than patients who did not report anaphylaxis 
(total FAQLQ-AF score 4.9 vs 4.1; p=0.041). In addition, the total FAQLQ-AF 
score of patients who reported more than three food allergies was significantly 
higher, indicating more impairment in HRQL, than patients who reported three 
or less food allergies (5.2 vs 4.2; p=0.008). The impairment of HRQL did not 
differ significantly between men and women (total FAQLQ-AF score 4.1 vs 4.6; 
p=0.060) and did not differ significantly between patients who were recruited 
by advertisement and patients who were recruited from our clinic (4.8 vs 4.2; 
p=0.054). 
Reliability
The  total  FAQLQ-AF  score  intraclass  correlation  coefficient  was  0.95  (95% 
confidence interval, 0.91-0.98), indicating excellent test-retest reliability.90
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Discussion
We here report the development and cross-sectional validation of the first disease-
specific HRQL questionnaire for adults with food allergy, the Food Allergy Quality 
of  Life  Questionnaire-Adult  Form  (FAQLQ-AF).  Our  analysis  showed  that  the 
FAQLQ-AF has good construct validity (Table 3) and excellent internal consistency. 
In  addition,  the  FAQLQ-AF  discriminates  between  patients  with  and  without 
anaphylaxis and between patients who differ in the number of food allergies. Finally, 
the FAQLQ-AF showed convergent/discriminant validity (Table 4). This supports 
the need for a disease-specific quality of life questionnaire in food allergic adults.
The content of the FAQLQ-AF reflects the most important issues that food 
allergic patients have to deal with in their daily life and impairs their quality of 
life. Consequently, these issues are likely to be important targets for interventions 
by health care providers, catering industries, food manufacturers and governments 
aimed at improving quality of life in food allergic patients 30. An example is the 
item ‘Change of ingredients of a product’. In the item reduction phase it turned 
out that this was one of the most important items (Table 2). This item indicates 
that food allergic patients find it very frustrating when a product that was safe to 
eat, which in some cases are very few, turned out to be unsafe. The impact of this 
item may be reduced to some extent if, for example, manufacturers would place a 
warning on the product indicating changed ingredients. 
Another notable item of the FAQLQ-AF is ‘Unclear to which foods you 
are allergic’. The inclusion and validation of this item emphasizes the fact that if 
Table 4. Spearman’s correlation coefficient of the total FAQLQ-AF score and domains of the FAQLQ-AF with 
the RAND-36 (SF-36) scales.
Total FAQLQ-AF Domains of the FAQLQ-AF
RAND-36 scales AADR EI RAE FAH
Physical functioning 0.10 0.04 0.22 0.03 0.02
Social functioning -0.22 -0.26 -0.09 -0.18 -0.35
Role functioning-physical -0.10 -0.14 -0.02 -0.15 -0.21
Role functioning-emotional -0.20 -0.18 -0.12 -0.19 -0.25
Mental health -0.27 -0.25 -0.18 -0.21 -0.35
Vitality -0.18 -0.19 -0.07 -0.14 -0.27
Bodily pain 0.01 -0.05 0.16 -0.09 -0.09
General health -0.06 -0.06 0.12 -0.16 -0.27
Change in health 0.10 0.16 0.06 0.01 0.07
The values given in bold are p<0.05. FAQLQ-AF, Food allergy Quality of life Questionnaire-Adult Form. AADR, 
Allergen Avoidance and Dietary Restrictions. EI, Emotional Impact. RAE, Risk of Accidental Exposure. FAH, 
Food Allergy related Health. Correlation coefficients are negative because a high score on the FAQLQ-AF 
indicates maximal impairment of quality of life, whereas a high score on the RAND-36 indicates better health 
status.Food Allergy Quality of Life Questionnaire - Adult Form 
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uncertainty is left about foods that may cause allergic reactions, this consequently 
impairs  quality  of  life. Therefore,  this  item  demonstrates  the  need  for  proper 
diagnosis for all suspected food allergies and it stresses the need for education on 
proper management of food allergy in order to prevent unnecessary impairment 
of quality of life.
In  the  discriminative  analysis  it  turned  out  that  patients  who  reported 
anaphylaxis had a significantly more impaired quality of life than patients who 
did not report anaphylaxis. The difference in total FAQLQ-AF score between these 
two groups was 0.8. It is known from the literature that the minimal importance 
difference (MID) of HRQL questionnaires with a 7-point scale is approximately 
0.5. The MID is the smallest difference in score which patients perceive as beneficial 
and which would mandate, in absence of troublesome side effects and excessive 
cost, a change in the patient’s management  31. Therefore, the difference in total 
FAQLQ-AF score between patients who reported anaphylaxis and patients who did 
not was not only a statistically significant difference but also a clinically significant 
difference. The same was true for the difference in total FAQLQ-AF score of patients 
who reported more than three food allergies versus patients who reported three 
or less food allergies. Although the MID of 0.5 is a robust estimate for HRQL 
questionnaires with a 7-point scale, the specific MID of the FAQLQ-AF remains to 
be estimated in a longitudinal survey.
When  looking  at  the  discriminative  ability  of  the  previously  developed 
questionnaires for children (FAQLQ-CF) and adolescents (FAQLQ-TF), it turned 
out  that  there  was  no  significant  difference  in  quality  of  life  between  young 
patients who reported anaphylaxis and those who did not 15;16. At that time we 
speculated that these patients may be too young to realize the potentially life-
threatening consequences of severe anaphylactic reactions to food. This hypothesis 
is confirmed when considering the present results in adults. The difference in total 
FAQLQ score between patients who reported anaphylaxis and patients who did not 
increases with age (0.3 in children, 0.5 in teenagers and 0.8 in adults, respectively) 
and this difference was significant in adults. This suggests that, as individuals age, 
they become more aware of the severity of symptoms in the past and the possibly 
life-threatening effect of food allergy. Consequently, these patients may judge their 
quality of life to be more impaired than patients with less severe food allergic 
reactions. 
Finally, this study may have some limitations. The validation of the FAQLQ-
AF was carried out in the Dutch language. The FAQLQ-AF was carefully translated 
into English using the guidelines of the World Health Organization. The validity of 
the English language version of this questionnaire is currently being investigated 
as well as versions in several other European languages. Our experience with the 
Dutch Vespid Allergy Quality of Life Questionnaire was that the English translation 
validated well 20. It is possible, however, that cultural differences may influence the 
ability of our questionnaire to identify the most important items for food allergic 
patients in different cultural or linguistic settings. Another limitation may be that 
we did not independently verify the food allergy diagnosis of patients recruited 94
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through advertisement who reported a physician-diagnosed food allergy. However, 
all  these  patients  reported  an  allergy  to  a  common/know  food  allergen,  they 
reported symptoms that are common/known in food allergy, and they reported 
strict avoidance of the food to which they think they were allergic. Additionally, this 
report describes only the cross-sectional validation of the FAQLQ-AF. Currently, the 
longitudinal validation of the questionnaire is being investigated (i.e. the capacity 
of the FAQLQ-AF to measure differences in HRQL over time). 
In summary, we presented here the first disease-specific HRQL questionnaire 
for food allergic adults, the Food Allergy Quality of Life Questionnaire-Adult Form 
(FAQLQ-AF)  with  very  good  to  excellent  measurement  properties.  Moreover, 
the questionnaire is short and easy to use. The FAQLQ-AF is thus suitable for 
studies of adult food allergic patients in which HRQL is the outcome of interest. 
Examples include investigation of the effect of emerging treatments such as oral 
immunotherapy and anti-IgE therapy on quality of life.  The FAQLQ-AF complements 
the  recently  developed  FAQLQ-TF  (for  adolescents  aged  13  to  17  years),  the 
FAQLQ-CF (for children aged 8 to 12 years) and the FAQLQ-PF (for parents of food 
allergic children aged 0 to 12 years) 14-16. Hence, validated disease-specific HRQL 
questionnaires are now available for food allergic patients of all age groups.
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Appendix 1: Food Allergy Quality of Life Questionnaire – Adult Form (  18 years) 
The following questions concern the influence your food allergy has on your quality of life.
Answer every question by marking the appropriate box with an ‘x’. You may choose from
one of the following answers.    
0  1  2  3  4  5  6 
not  barely  slightly  moderately quite  very  extremely 
How troublesome do you find it, because of your food 
allergy, that you … 
                 
1  must always be alert as to what you are eating? 
2  are able to eat fewer products? 
3  are limited as to the products you can buy? 
4  must read labels? 
5  have the feeling that you have less control of what you eat 
when eating out? 
6  must refuse many things during social activities? 
7  sometimes frustrate people when they are making an 
effort to accommodate your food allergy? 
8  are less able to spontaneously accept an invitation to stay 
for a meal? 
9  are less able to taste or try various products when eating 
out? 
10      can eat out less? 
11       must personally check whether you can eat something 
when eating out? 
12  hesitate eating a product when you have doubts about it? 
0   1   2   3   4   5   6    
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0  1  2  3  4  5  6 
not  barely  slightly  moderately quite  very  extremely 
How troublesome is it, because of your food allergy, …
                 
13  that the ingredients of a product change? 
14  that labels are incomplete? 
15  that the lettering on labels is too small? 
16  that the label states: “May contain (traces of)….”? 
17  that ingredients are different in other countries (for 
example during vacation)? 
18  that people underestimate your problems caused by food 
allergy? 
19  that it is unclear to which foods you are allergic? 
20     that you must explain to those around you that you have a 
food allergy? 
21  for your host or hostess should you have an allergic 
reaction? 
How worried are you because of your food allergy … 
                 
22  about your health? 
23  that the allergic reactions to foods will become 
increasingly severe? 
How frightened are you because of your food allergy …   
                 
24  of an allergic reaction? 
25  of accidentally eating the wrong food? 
26  of an allergic reaction when eating out despite the fact 
that your dietary restrictions have been discussed 
beforehand?
0   1   2   3   4   5   6    
0   1   2   3   4   5   6    
0   1   2   3   4   5   6    98
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0  1  2  3  4  5  6 
not  barely  slightly  moderately quite  very  extremely 
  6   5     4     3     2     1   0   : s n o i t s e u q   g n i w o l l o f   e h t   r e w s n A
                 
27  To what degree do you feel you are being a nuisance
because you have a food allergy when eating out? 
28  How discouraged do you feel during an allergic reaction? 
29  How  apprehensive are you about eating something you 
have never eaten before?Food Allergy Quality of Life Questionnaire - Adult Form 
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Appendix 2: Food Allergy Independent Measure – Adult Form (   18 years) 
The following four questions are about the chance that you think you have of something
happening to you because of your food allergy. Choose one of the answers provided. This is
followed by two more questions about your food allergy. Answer every question by putting
an ‘x’ in the box next to the appropriate answer.   
0  1  2  3  4  5  6 
never 
(0% chance) 
very small 
chance
small 
chance
fair 
chance
great
chance
very great 
chance
always
(100% chance) 
How great do you think the chance is that you … 
                 
a.  will accidentally eat something to which you are allergic? 
b.  will have a severe reaction if you accidentally eat 
something to which you are allergic?  
c.  will die if you accidentally eat something to which you 
are allergic? 
d.  can not effectively deal with an allergic reaction should 
you accidentally eat something to which you are allergic? 
e. How many products must you avoid 
because of your food allergy?
f. How great is the impact of your food 
allergy on your social life? 
 almost none    negligibly small 
    w e f   y r e v     very small
    w e f   a     small 
    e m o s     moderate 
    y n a m     great 
    y n a m   y r e v     very great 
    l l a   t s o m l a     extremely great 
0   1   2   3   4   5   6    
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Abstract
Objective: 
The  self-administered  Food Allergy  Quality  of  Life  Questionnaire-Child  Form 
(FAQLQ-CF), -Teenager Form (FAQLQ-TF) and -Adult Form (FAQLQ-AF) were 
recently developed within EuroPrevall, a multi-centred study of food allergy in 
Europe. The primary aim of this study was to evaluate the test-retest reliability of 
the FAQLQ-CF, -TF and -AF. 
Methods: 
One-hundred-and-one Dutch patients (31 children, 34 adolescents and 36 adults) 
completed the FAQLQ twice with a 10-14 day interval. The intraclass correlation 
coefficient  (ICC),  Lin’s  concordance  correlation  coefficient  (CCC)  and  Bland-
Altman plots were used to assess test-retest reliability.
Results: 
Test-retest reliability was excellent with ICCs and CCCs above 0.907, 0.975 and 
0.951 for the FAQLQ-CF, -TF and -AF, respectively. Bland-Altman plots showed that 
the mean differences of the test and retest were all close to zero for the FAQLQs. 
Conclusions: 
The FAQLQs are reliable over a short time interval. The FAQLQs are not only 
excellent tools for group comparison studies, but also for monitoring individual 
patients. Test-retest reliability of the FAQLQs
6
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Introduction
Food allergy affects almost 4% of the general population in westernized countries 1 
and it is the primary cause of anaphylaxis presenting to emergency departments 2. 
The only proven therapy is careful avoidance of the causal food(s) and provision of 
medication for emergency treatment 3. Consequently, patients often fear an allergic 
reaction and are continuously faced with dietary and social restrictions in their 
daily lives, which can have a negative impact on quality of life 4-11. 
To measure Health-Related Quality of Life (HRQL), disease-specific ques-
tionnaires are significantly more sensitive than generic ones and they are important 
for estimating the general burden of food allergy as well as measuring the response 
to interventions or future treatments. However, generic HRQL instruments allow 
comparison of the burden of disease between patient populations with different 
diseases 12. Recently, as part of the EuroPrevall project, the first self-administered 
HRQL questionnaires specific for food allergy have been developed and validated; 
the Food Allergy Quality of Life Questionnaire-Child Form, -Teenager Form and 
-Adult Form (FAQLQ-CF, -TF, -AF). The FAQLQs showed good validity, internal 
consistency and discriminative abilities 13-16, but test-retest reliability was not ex-
tensively investigated.
Reliability measures are important to ensure that what the questionnaire is 
measuring is dependable and repeatable 12 and allow sample sizes to be determined 
for clinical trials 17. The aim of this study was therefore to assess the test-retest reli-
ability of the self-administered FAQLQ-CF, -TF and -AF. 
Methods
Patients
We  contacted  Dutch  children  (8-12  years),  adolescents  (13-17  years)  and 
adults (>18 years) with food allergy, who were recruited from our clinic or by 
advertisement. We included patients with the most prevalent food allergies.
Questionnaires
The FAQLQ-CF contains 24 items and 4 domains, the FAQLQ-TF contains 23 items 
and 3 domains and the FAQLQ-AF contains 29 items and 4 domains 13-15. The total 
FAQLQ score is the sum of all the items divided by the number of items and ranges 
from 1 (minimal impairment in HRQL) to 7 (maximal impairment in HRQL) 18;19. 
     
Procedures
We sent the FAQLQs by mail to be completed at home. Regarding the FAQLQ-CF, 
parents were instructed that they were allowed to explain a question when needed, 
but they were not allowed to tell the child which answer to give. All patients who 
completed the first questionnaires (test) received the second questionnaires (re-104
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test) 10-14 days after completion of the first. Patients who did not respond in time 
were excluded from the study  20;21 as well as patients who reported a clinically 
important change in disease between the measurements or within two months 
before  the  study. We  defined  a  clinically  important  change  in  disease  which 
may influence HRQL as a food allergic reaction of grade 3 or 4 according to the 
Mueller classification 22. The study was approved by the local medical ethics review 
commission (METc 2005/051). 
  
Statistical Analysis
Data were analysed using SPSS software for Windows (Version 14.0). To investigate 
test-retest reliability of the FAQLQs we used the intraclass correlation coefficient 
(ICC), using a one-way ANOVA 20;21;23. Values should be above 0.70 for group com-
parison studies and above 0.90-0.95 for individual measurements over time 24.  
As a second measure of test-retest reliability we calculated the Lin’s concor-
dance correlation coefficient (CCC). The different components of the CCC (Pearson 
correlation coefficient (measure of precision), location shift and scale shift (measures 
of accuracy)), were calculated. We plotted the first measurement against the second 
measurement and we used major axis analyses to calculate the best fitting line 25. 
Visual assessment of test-retest agreement was obtained by use of Bland-
Altman plots 26. Differences between the first and the second measurement were 
plotted against the mean of the first and the second measurement. Limits of agree-
ment (mean difference +/- 1.96*SD of the difference) were calculated, which 
reflect the interval within which about 95% of the differences between the two 
measurements should lie 27;28. A regression coefficient (r) was calculated to estimate 
a relationship between the difference and the mean 26. 
Results
Patients
We contacted 148 patients, of which 131 patients completed and returned the 
first questionnaire and 114 responded to the second questionnaire. This resulted 
in an overall response rate of 77%. A few patients were excluded, resulting in 
101 patients that were eligible for analysing test-retest reliability (Table 1). The 
descriptive characteristics are shown in table 2. Mean duration between the first 
and second measurement was 11 days for all three age groups.
Analysis of FAQLQs
ICCs were > 0.900 for the FAQLQs and CCCs were comparably high. Location shift 
and scale shift, should all be considered minimal according to Lin’s examples 29. 
Pearson correlation should be considered moderate in the FAQLQ-CF and good in 
the FAQLQ-TF and -AF (Table 3). Comparable results were found for the individual 
domains of the FAQLQs (data not shown). Test-retest reliability of the FAQLQs
6
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Table 1. Patient recruitment.  
Patients   Children            Adolescents        Adults Total
Contacted (n)        48                       51                        49 148
Returned 1st questionnaire (n) . 41                       47                        43  131 
Returned 2nd questionnaire (n) 38                       38                         38 114 
Excluded  (n) 7                         4                           2 13*
Analysed  (n) 31                       34                         36 101
* Seven patients (3 children, 3 adolescents, 1 adult) were excluded, because they completed the second 
questionnaire more than 14 days after completion of the first. One child and 1 adult were excluded because of 
a grade 3 or 4 allergic reaction between the first and second measurement. One child was excluded because 
she was aged under 8 years. Two children and 1 adolescent were excluded because they experienced their 
most severe reaction ever within 2 months before the first measurement.
Figure 1 illustrates the correlation between the first and second measurement. 
Major axis analysis revealed no significant differences of the slope and intercept of 
the best fitting line from the concordance line for the FAQLQ-CF and -TF. For 
the FAQLQ-AF there were significant but modest differences of the slope (1.10, 
p=0.046) and the intercept (-0.612, p=0.019) of the best fitting line from the 
concordance line. The slope and intercept of the best fitting line of the FAQLQ-CF, 
-TF and -AF did not differ significantly from each other.   
The Bland-Altman plots are shown in figure 2. About 95% of the differences 
lie within the 1.96 SD limits of agreement. There was no significant correlation 
between the mean of both scores and the differences of both scores for the FAQLQ-
CF and -TF. There was a significant but modest correlation between the mean 
of both scores and the differences of both scores for the FAQLQ-AF (r=-0.334; 
p=0.046). No significant systematic bias was observed, which means that mean 
differences of both scores were all close to zero. The limits of agreement are most 
narrow for FAQLQ-TF and wider for FAQLQ-CF and -AF.
Discussion
This article describes the evaluation of the test-retest reliability of the recently 
developed  self-administered  FAQLQ-CF,  -TF  and  -AF.  Overall,  reliability  was 
considered to be excellent for the FAQLQs as measured with the ICC and CCC. 
Additionally, Bland-Altman plots showed that mean differences were all close to 
zero, supporting the high reliability of the FAQLQs.
In this study we used ICCs calculated by a one-way ANOVA, CCCs and Bland-
Altman plots to assess test-retest reliability. However, different methods can be used 
to assess test-retest reliability and there is much discussion in literature on the 
best way to do this 20. A disadvantage of the ICC is that if patient groups are very 106
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Table 2. Demographics and clinical characteristics.
Children (n=31) Adolescents (n=34) Adults (n=36)
Mean age, years (SD) 10.6 (1.5) 15.0 (1.5) 37.3 (14.5)
Gender, n (%)
Male
Female
17 (55)
14 (45)
18 (53)
16 (47)
7 (19)
29 (81)
Type food allergy, n (%)
Peanut
Tree nuts
Milk
Egg
Wheat
Soy
Sesame
Fish
Shell fish
Celery
Fruit
Vegetables
Others
25 (71)
17 (49)
15 (43)
14 (40)  
5 (14)
9 (26)
7 (20)   
2 (6)   
6 (17)
0 (0)  
14 (40)  
6 (17)  
25 (71% )
30 (88)
28 (82)
15 (44)
16 (47)
4 (12)
13 (38)
9 (26)
5 (15)
8 (24)
4 (12)
13 (38)
6 (18)
24 (71)
25 (69)
25 (69)
15 (42)
7 (19)
7 (19)
8 (22)
6 (17)
9 (25)
12 (33)
8 (22)
26 (72)
10 (28)
13 (36)
Number of food allergies, n (%)
1 food
2 foods
3 foods
> 3 foods
6 (19)
4 (13)
4 (13)
17 (55)
3 (9)
4 (12)
8 (24)
19 (56)
1 (3)
3 (8)
10 (28)
22 (61)
Severity of Symptoms
Mueller Classification, n (%)
Grade 1
Grade 2
Grade 3
Grade 4
Other1
6 (19)
2 (6)
17 (55)
6 (19)
0 (0)
2 (6)
3 (9)
18 (53)
9 (26)
2 (6)
3 (8)
3 (8)
13 (36)
17 (47)
0 (0)
Most severe reaction,
years ago (SD)
4.6 (3.6) 7.1 (5.4) 5.2 (7.5)
Diagnosed by, n (%)
Specialist2      
Dietician
General Practitioner
Alternative Physician
Patient
Parents
26 (83)
0 (0)
4 (13)
1 (3)
0 (0)
0 (0)
25 (74)
1 (3) 
6 (18)
0 (0)
0 (0)
2 (6)
25 (69)
0 (0)
3 (8)
3 (8)
4 (11)
1 (3)
1 Other food allergy types not specified in the Mueller Classification, for example the Oral Allergy Syndrome.
2 Allergist, Dermatologist or PaediatricianTest-retest reliability of the FAQLQs
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homogeneous, the ICC tends to be low, because the ICC compares variance among 
patients to total variance. If patient groups are very heterogeneous, the ICC tends to 
be high. Thus, the ICC would only generalize to similar populations. Additionally, 
the one-way ICC does not take into account the order in which observations were 
taken  29. Therefore, the CCC is a useful additional measure. The CCC takes into 
account not only mean differences between the first and second measurement, 
such as ICCs calculated by a one-way ANOVA, but also takes into account variance 
differences between the first and second measurement by reducing the magnitude 
of the resulting test-retest reliability estimate. In addition, the CCC is a better tool 
to distinguish between bias and imprecision 20;29. There can be large differences in 
ICC and CCC scores, especially in studies with heterogeneous groups. The similar 
scores we found in our study reflect that both coefficients worked very well in 
this population and that results can be generalized to other groups. Bland-Altman 
plots are very illustrative in assessing test-retest agreement. They were useful to 
identify some extreme and outlying differences, to analyse the magnitude of the 
measurement  error,  which  was  small,  and  to  visualize  a  possible  relationship 
between the difference and the mean of both scores 26.  
Table 3. Reliability and agreement measures of the FAQLQs. 
                              FAQLQ-CF FAQLQ-TF FAQLQ-AF 
M1 (SD) 4.13 (1.15) 4.37 (1.20) 4.49 (1.44)
M2 (SD) 4.08 (1.34) 4.42 (1.29) 4.34 (1.59)
MB (SD) 4.11 (1.22) 4.40 (1.24) 4.41 (1.50)
MD (SD) 0.045 (0.537) -0.051 (0.274) 0.147 (0.451)
Limits of agreement (1.96*SD) -1.008  to  1.097  -0.588  to  0.486 -0.737  to  1.031  
ICC one-way (95% CI) 0.910 (0.823-0.955) 0.976 (0.952-0.988) 0.952 (0.909-0.975)
    Error variance 0.147 0.038  0.102
CCC (95% CI) 0.907 (0.847-0.967) 0.975 (0.959-0.991) 0.951 (0.921-0.981)
    Scale shift 1.162  1.077  1.104 
    Location shift 0.036 -0.041 0.097
    Pearson  0.918  0.978  0.960 
Kendall’s tau-b 0.759 0.888 0.780
M 1 = Total FAQLQ score measurement 1 
M 2 = Total FAQLQ score measurement 2     
MB = Mean FAQLQ score of both measurements
MD = Mean difference between measurement 1 and 2 (M1-M2)
SD = Standard deviation 
CI = Confidence interval
Limits of agreement: MD +/- 1.96*SD of the MD
ICC = Intraclass correlation coefficient
CCC = Concordance correlation coefficient
Scale shift (SD2/SD1)
Location shift: 
2 * 1 SD SD
(Μ1−Μ2)108
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Figure 1. FAQLQ score of the first 
measurement against FAQLQ score 
of the second measurement with 
45º line through the origin in A 
children, B adolescents and C 
adults.
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Mean FAQLQ-CF score
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Figure 2. Bland-Altman plots 
for the FAQLQs in A children, B 
adolescents and C adults. The 
mean of both measurements are 
plotted against the difference of 
both measurements (calculated as 
first measurement minus second 
measurement).
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This study may also have some limitations. Firstly, the sample sizes were 
relatively small. However, we found that the reliability of the questionnaires was 
very high, which indicates that the sample sizes were adequate and that a greater 
number of patients would probably not have influenced the outcomes. Another 
limitation may be that the majority of adults in this study was female. However, we 
did not find significant differences in the test-retest reliably outcomes between men 
and women (data not shown). Therefore, we think that the imbalance between men 
and women did not influence the generalisability of the results of the FAQLQ-AF. 
Finally, the significant correlation between the first and second measurement of the 
FAQLQ-AF (figure 1C) and between the mean of both scores and the differences 
of both scores of the FAQLQ-AF (figure 2C) was an unexpected finding. We think 
this correlation might be due to an outlier. This assumption was supported by a 
re-analysis excluding this outlier, which showed that the correlation was no longer 
significant.
In summary, the FAQLQs clearly showed excellent reliability and are thus 
promising measures in evaluative studies in patients with food allergy, but also in 
monitoring individual patients. The high test-retest reliability supports the value of 
the FAQLQs for clinical trials with relatively small sample sizes. We recommend the 
use of the FAQLQs in clinical trials of current management strategies of food allergy 
and they may also be useful when new treatments become available. Currently, the 
longitudinal validity of the FAQLQs and the validity of several other European 
language versions of the FAQLQs are being investigated.
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Abstract
Background: 
Health-Related Quality of Life (HRQL) has never been measured with generic and 
disease-specific questionnaires in the same group of food allergic (FA) patients. 
Objective: 
The aims of this study were to compare generic HRQL of FA patients with the 
general population and other diseases and to compare HRQL of FA patients as 
measured with generic and disease-specific questionnaires.
Methods:
Generic HRQL questionnaires (CHQ-CF87 and RAND-36) and disease-specific 
HRQL questionnaires (FAQLQ-CF, -TF and -AF) were completed by 79 children, 74 
adolescents and 72 adults with FA. The generic HRQL scores were compared with 
scores from published studies on the general population and patients with asthma, 
irritable bowel syndrome (IBS), diabetes mellitus type I (DM) and rheumatoid 
arthritis (RA).
Results:
FA children and adolescents reported fewer limitations in school work due to 
behavioural problems (p<0.013), but FA adolescents and adults reported more 
pain  (p=0.020),  poorer  overall  health  (p<0.001),  more  limitations  in  social 
activities (p<0.001) and less vitality (p=0.002) than individuals from the general 
population. FA patients reported poorer HRQL than patients with DM, but better 
HRQL than patients with asthma, IBS and RA. In contrast to the disease-specific 
questionnaires, high ceiling effects were found for some generic HRQL scales.
Conclusion:
HRQL is impaired in FA adolescents and adults compared to the general population 
and is intermediate in magnitude between DM and asthma, IBS and RA. Children 
show the least impact on HRQL from FA. Because of high ceiling effects, generic 
HRQL  questionnaires  are  less  suitable  to  measure  disease-specific,  clinically 
important impairments in food allergy. Generic quality of life of food allergic patients
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Introduction
Currently, there is still no cure available for patients with food allergy. Food allergic 
patients must carefully avoid the causal foods every day, which may be a great 
burden to themselves and their families  1;2. Despite taking precautions, there is 
always a chance of accidental exposure and for some patients such exposure may 
be fatal 3 which in turn may provoke even more anxiety.  Thus, while food allergic 
patients may experience symptoms only intermittently, they continuously need 
to undertake extensive measures in order to prevent exposure to foods to which 
they are allergic. This has a negative impact on their health-related quality of life 
(HRQL) 4.
 HRQL may be defined as ‘the effects of an illness and its consequent therapy 
upon a patient, as perceived by the patient’ 5. The measurement of HRQL offers 
the opportunity to study the impact of a disease or the effect of a treatment from 
the patient’s unique perspective. More importantly, HRQL is the only available 
measure reflecting the ongoing severity of food allergy, since no objective disease 
parameters are available 6. 
There are two major types of questionnaires to measure HRQL: generic and 
disease-specific questionnaires. Generic questionnaires can be used to evaluate and 
compare different diseases. The disadvantages of generic questionnaires are that 
they may not focus adequately on problems specific to a particular disease and 
that they simultaneously measure the impact of comorbid diseases. Disease-specific 
instruments are targeted to a specific disease. These disease-specific questionnaires 
are more likely to detect clinically important changes in patients’ HRQL. However, 
disease-specific questionnaires do not allow comparison between different diseases 7. 
In food allergy research, there are only a few studies that have investigated 
the impact of food allergy on HRQL 8-20. However, there are no studies that have 
compared generic HRQL of food allergic patients from childhood to adulthood 
with generic HRQL of the general population and patients with other chronic 
diseases. To our knowledge, there are two previous studies that have compared 
HRQL of food allergic patients with one other chronic disease (rheumathological 
disease and diabetes mellitus, respectively)  8;10. However, the later study  10 used 
non validated disease-specific questionnaires, which makes a comparison between 
different diseases problematic. The former study 8 used a single Visual Analogue 
Scale and the Impact on Family Scale, which only covers a single domain of generic 
HRQL. This study is the only study in the field of food allergy that investigated the 
HRQL of food allergic adults 8. All other studies investigated food allergic children. 
Of these pediatric studies, there was only one study in which adolescents aged 
13-21 years completed a self-administered HRQL questionnaire, while in all other 
pediatric studies, the HRQL questionnaires were completed by the parents. Finally, 
since  self-administered  disease-specific  HRQL  questionnaires  for  food  allergic 
patients have become available only recently 18-20, the administration of both generic 
and disease-specific instruments to the same population of food allergic patients 
has not been possible until now.116
|Chapter 7
The aims of this study were to investigate the impact of food allergy on 
HRQL measured with self-administered generic HRQL questionnaires in children 
from the age of 8 years, adolescents and adults and to compare the generic HRQL 
of these food allergic patients with the generic HRQL of the general population 
and patients with other diseases. Additionally, we compared HRQL of food allergic 
patients as measured with generic and disease-specific questionnaires.
Methods
Participants 
The current study is part of a larger study on the development and validation of 
food allergy specific HRQL questionnaires and the measurement of the impact of 
food allergy on HRQL. This larger study was reviewed by the local medical ethics 
review commission (METc 2005/051) who deemed that the study did not fall 
under the range of the Medical Research Involving Human Subjects Act and that 
therefore approval was not needed. Participants in the present study were part of 
the studies on the cross-sectional validation of the Food Allergy Quality of Life 
Questionnaire-Child Form, -Teenager Form and -Adult Form (FAQLQ-CF, -TF and 
-AF)18-20.  These participants, aged 8 years and older with a physician-diagnosed 
food allergy for at least one food, were recruited from our outpatient (paediatric) 
allergy clinic or were recruited through food allergy support organisations (the 
Dutch Foundation for Food Allergy and the Dutch Anaphylaxis Network) and by 
advertisement in local newspapers. All common food allergies and different types 
and severities of symptoms were represented 18-20. 
Procedure
A letter of invitation, the questionnaires (the age appropriate generic and disease-
specific HRQL questionnaire) and descriptive questions on age, sex, type and 
number of food allergies, type of symptoms and diagnosis were sent by mail to be 
completed at home.   The letter of invitation stressed that participation was completely 
voluntary. Participants were not paid for their participation. The children and their 
parents were instructed that the children should fill out the questionnaires by 
themselves. Parents were allowed to explain a question when needed, but they were 
not allowed to tell the child which answer to give. For completing the descriptive 
questions parents were allowed to help their child when needed.  
Questionnaires
Generic HRQL questionnaires 
In children and adolescents, the Child Health Questionnaire-Child Form (CHQ-
CF87) was administered 21;22. This questionnaire is self-administered by the child 
and contains 87 items divided into twelve scales (Table 1). After recoding the raw Generic quality of life of food allergic patients
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Table 1. CHQ-CF87 and RAND-36 scales, items per scale and definition of the scales. 
Generic HRQL scales No. of 
items
  Definition of the scales
CHQ-CF87
Physical functioning (PF) 9 Limitations in physical activities
Role functioning-emotional (RE) 3
Limitations in school work or activities with friends due to 
emotional problems
Role functioning-behaviour (RB) 3
Limitations in school work or activities with friends due to 
behavioural problems
Role functioning-physical (RP) 3
Limitations in school work or activities with friends due to 
physical problems
Bodily pain (BP) 2 Severity, frequency of pain and limitations due to pain
General behaviour (BE) 17
The degree to which the child exhibits aggressive, immature or 
delinquent behaviour
Mental health (MH) 16
The degree of positive and negative feelings, including 
anxiety, depression, peacefulness and happiness.
Self-esteem (SE) 14
The degree of satisfaction with abilities, looks, family/peer 
relationship and life overall
General health (GH) 12 Perceptions of overall health
Change in health* 1 Change in health compared to 1 year ago
Family activities (FA) 6
The degree to which the child’s health limits or interrupts 
family activities or is a source of family tension
Family cohesion  (FC) 1 The ability of the family to get along with each other
RAND-36
Physical functioning (PF) 10 Limitations in physical activities
Social functioning (SF) 2 Limitations in social activities
Role functioning-physical (RP) 4 Limitations in work or daily activities due to physical problems
Role functioning-emotional (RE) 3
Limitations in work or daily activities due to emotional 
problems
Mental health (MH) 5
The degree of positive and negative feelings, including 
anxiety, depression, peacefulness and happiness.
Vitality (VT) 4 The degree of vitality and liveliness
Bodily pain (BP) 2 Severity, frequency of pain and limitations due to pain
General health (GH) 5 Perceptions of overall health
Change in health (CH) 1 Change in health compared to 1 year ago
* This single-item scale was not used in this study.
scores, scale scores are computed and transformed into a 100-point scale. Higher 
scores indicate better HRQL. 
In adults we administered the RAND-36, which is the Dutch translation of 
the MOS 36-item Short-Form Health Survey  23;24. The RAND-36 consists of 36 
items divided into nine scales (Table 1). After recoding the raw scores, scale scores 
are computed and transformed into a 100-point scale. Higher scores indicate better 
HRQL.118
|Chapter 7
Disease-specific HRQL questionnaires
The  disease-specific  HRQL  questionnaires  used  in  this  study  were  the  Food 
Allergy  Quality  of  Life  Questionnaire-Child  Form  (FAQLQ-CF)  for  children 
aged 8-12 years, the Food Allergy Quality of Life Questionnaire-Teenager Form 
(FAQLQ-TF) for adolescents aged 13-17 years and the Food Allergy Quality of Life 
Questionnaire-Adult Form (FAQLQ-AF) for adults aged 18 years and older18-20.  All 3 
questionnaires were validated in the Netherlands and showed excellent reliability25. 
These questionnaires consist of 24, 23 and 29 items, respectively. The raw FAQLQ 
scores 0 to 6 were recoded as 1 to 7. The total score is the mean of all items of each 
questionnaire and ranges from 1 (minimal impairment of HRQL) to 7 (maximal 
impairment of HRQL). Thus higher scores indicate poorer HRQL.
Comparative studies 
Norm values of the Dutch population were obtained from the validation studies 
of the generic questionnaires in the Netherlands 22;23. The original database of the 
Dutch school population was obtained 22 and used to calculate CHQ-CF87 scores 
for children and adolescents separately. As comparative diseases we chose asthma, 
irritable bowel syndrome (IBS), diabetes mellitus type I (DM) and rheumatoid 
arthritis (RA). These diseases were chosen because they are chronic with  sufficient 
parallels with food allergy and  were used as comparative disease in previous studies 
on HRQL in food allergy 8;10.
Selection of comparative studies
To compare the impact of food allergy on HRQL with the general population and 
patients with other diseases, we searched PubMed for comparative studies on 
generic HRQL. Comparative studies were identified through a search from 1998 
to 2008 using the search terms ‘Child Health Questionnaire Child Form 87’ or 
‘CHQ-CF87’ for the children and adolescents and ‘RAND-36’, ‘SF-36’ or ‘Medical 
Outcomes Study Short Form 36’ for the adults, together with disease-specific 
terms. Only studies in Dutch populations were included, since the current study 
of food allergic patients was carried out in the Netherlands. For inclusion in the 
comparison, the studies had to report the mean (SD) scores for each of the CHQ-
CF87 subscales or RAND-36 subscales. Because the focus of the comparison was 
the effect of disease on HRQL, baseline or pre-treatment scores were required. If 
multiple studies met the selection criteria, the study with the largest sample size 
was chosen.
Statistical analysis
One-sample t-tests were used to compare the scores of the food allergic patients 
on the CHQ-CF87 and RAND-36 with Dutch populations and specific disease 
populations previously studied. Because we obtained the original database of the 
Dutch child and adolescent populations  22, we used the Mann-Whitney test to 
compare the scores of the food allergic children and adolescents on the CHQ-
CF87 with the scores of the Dutch child and adolescent populations (not normally Generic quality of life of food allergic patients
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distributed). Additionally, floor and ceiling effects (percentage of patients with 
minimal  or  maximal  score,  respectively)  of  the  generic  and  disease-specific 
questionnaires were investigated. The floor and ceiling of the generic CHQ-CF87 
and RAND-36 were score 0 and score 100. The floor and ceiling of the disease-
specific FAQLQ-CF, -TF and -AF were score 1 and score 7. Statistical analyses were 
performed with SPSS for Windows 14.0 (SPSS Inc., Chicago, IL, USA).
Results
Participants 
The  questionnaire  packages  including  the  FAQLQ-CF,  -TF  or  -AF  and  the  age 
appropriate generic HRQL questionnaires were sent to 312 participants divided 
over the three age groups. Response rates were high: children 84/111 (73%), 
adolescents 75/98 (77%) and adults 80/100 (80%).  A few returned questionnaires 
were excluded from the analysis because a) no current food allergies were reported 
(three children and one adult) or b) no physician-diagnosed food allergy was 
reported (seven adults) or c) the descriptive characteristics were missing (one 
child and one adolescent) or d) the generic questionnaire was not completed (one 
child). Therefore, 225 participants were included in the final analysis. Table 2 shows 
the descriptive characteristics of these participants.
Comparative studies
The following numbers of articles were reviewed for each generic questionnaire 
and each disease: 
-  CHQ-CF87, children and adolescents: asthma, 3; IBS, 0; DM, 5; RA, 11; 
-  RAND-36, adults: asthma, 7; IBS, 1; DM, 19; RA, 16; 
A summary of the selected articles (population based and disease based) is shown 
in Table 3.
CHQ-CF87: food allergy versus population
Food allergic children scored significantly higher on the scale RB (p=0.005) than 
children from the general  population 22, indicating better HRQL for the food allergic 
children on this scale (Figure 1). Also food allergic adolescents scored significantly 
higher on the scale RB (p=0.013), but lower on the scales BP (p=0.020) and 
GH (p<0.001) than adolescents from  the general population 22, indicating better 
HRQL on one scale for the food allergic adolescents and poorer HRQL on the other 
two scales (Figure 2a). 
CHQ-CF87: food allergy versus other diseases
No studies in asthma, IBS, DM or RA were found that examined the CHQ-CF87 
in children aged 8 to 12 years. Only two studies examined the CHQ-CF87 in 
adolescents with asthma 26 and DM 27. Asthmatic adolescents scored significantly 120
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Table 2. Descriptive characteristics of the food allergic participants (n=225). 
Children Adolescents Adults
Patients (n) 79 74 72
Sex (m/f) 45/34 34/40 18/54
Age, mean (years) 10.2 (1.3) 14.7 (1.3) 37.2 (14.3)
Age, range (years) 8-12 13-17 18-72
Type of food allergies, n (%)
   Peanut 59 (74) 57 (77) 42 (58)
   Tree nut 57 (72) 56 (76) 42 (58)
   Egg  29 (37) 26 (35) 16 (22)
   Milk 22 (28) 29 (39) 19 (26)
   Fish  2 (3) 13 (18) 11 (15)
   Shell fish  7 (9) 12 (16) 12 (17)
   Wheat  10 (13) 5 (7) 12 (17)
   Sesame 14 (18) 8 (11) 13 (18)
   Soy 12 (15) 17 (23) 13 (18)
   Celery 1 (1) 3 (4) 11 (15)
   Fruits 29 (37) 38 (51) 35 (49)
   Vegetables 14 (18) 22 (30) 27 (38)
   Other* 15 (19) 20 (27) 30 (42)
Number of food allergies, n (%)
   1 food 15 (19) 9 (16) 12 (17)
   2 foods 15 (20) 12 (41) 14 (19)
   3 foods 16 (20) 15 (11) 8 (11)
   >3 foods 32 (41) 38 (51) 38 (53)
Type of symptoms, n (%)
   Cardiovascular symptoms1  28 (35) 31 (58) 44 (61)
   Respiratory symptoms2 56 (71) 61 (82) 60 (83)
   Gastrointestinal symptoms3 49 (62) 47 (64) 48 (67)
   Skin symptoms4 69 (87) 60 (81) 55 (76)
   Other5 66 (84) 66 (89) 62 (86)
* E.g. lupine, kernels and seeds, herbs and spices, meat.
1 dizziness, feeling your heart beat fast, loss of vision, inability to stand, light headedness, collapse, loss of 
consciousness / passing out
2 tightening throat, difficulty swallowing, hoarseness / hoarse voice, difficulty breathing in, shortness of 
breath, wheezing, cough
3 nausea, stomach cramps, vomiting, diarrhea 
4 itchy skin, red rash, urticaria, worsening eczema, swelling of the skin
5 oral allergy, swollen tongue or lips, symptoms of the nose or eyesGeneric quality of life of food allergic patients
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lower on the scales PF (p=0.049), BE, MH, FA and FC (all p<0.001) than those with 
food allergy, indicating better HRQL for food allergic adolescents than asthmatic 
adolescents. Adolescents with DM scored significantly higher on to the scales PF 
(p=0.039), BP (p=0.012), MH (p=0.034) and SE (p=0.014) than those with 
food allergy, indicating poorer HRQL for food allergic adolescents than diabetic 
adolescents (Figure 2b). 
RAND-36: food allergy versus population 
Food  allergic  adults  scored  significantly  lower  on  the  scales  SF  (p<0.001), 
VT (p=0.002) and GH (p<0.001) than adults from the general population  23, 
indicating poorer HRQL for food allergic adults (Figure 3a). 
RAND-36: food allergy versus other diseases
Adults with DM 28 scored significantly higher on five scales than those with food 
allergy (SF, p<0.001; RP, p=0.014; VT, p=0.002; BP, p=0.001; GH, p<0.001), 
indicating poorer HRQL for food allergic adults than diabetic adults. Adults with 
asthma 29 scored significantly lower on all scales, except one (MH), than those with 
food allergy (all p<0.01), indicating better HRQL for food allergic adults than 
asthmatic adults. Also adults with RA 30 scored significantly lower on six scales than 
those with food allergy (PF, p<0.001; RP, p<0.001; RE, p=0.008; VT, p=0.031; 
BP, p<0.001; GH, p=0.048), indicating better HRQL for food allergic adults than 
adults with RA. Finally, adults with IBS 31 scored significantly lower on all scales 
than those with food allergy (all p<0.01), indicating better HRQL for food allergic 
adults than adults with IBS (Figure 3b).
Table 3. Description of studies included in the comparison.
Reference Disease Patients,
 n*
Age, 
mean (SD) 
Age, 
range
Male,
 %
Sample source
CHQ-CF87
Raat et al. 22 Population 444 12.8 (1.7) 9-17 50.5 School children
Mohangoo et al. 26  Asthma 72 15 (0.7) 14-17 27.8 School children
De Wit et al. 27 DM 91 14.9 (1.1) 13-16.5 47 Outpatient clinic
RAND-36
Van de Zee et al. 23 Population 1063 44.1 (17.5) 18-89 35 Dutch population
Willems et al. 29 Asthma 27  45.9 (15.9) NA 33.3 Outpatient clinic
Ten Berg et al. 31 IBS 169 55.0 (17.1) NA 22.8 Medical database 
Hart et al. 28 DM 274 38.2 ( 12.4) NA 54.4 Outpatient clinic
Rupp et al. 30 RA 679 59.6 (13.8) NA 29 Diagnostic register
DM=diabetes mellitus type I 
RA=rheumatoid arthritis
IBS= irritable bowel syndrome 
NA=not available 
*represents the number of patients included in the analysis of the generic HRQL questionnaire122
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Figure 1  C HQ-CF87 scores of children with food allergy and a sample of children from 
the general population 
22. *p<0.01. Higher scores indicate better HRQL. FA, not available for 
the sample of children from the general population. See table 1 for the definition of the scales. 
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* Figure 1. CHQ-CF87 
scores of children 
with food allergy and 
a sample of children 
from the general 
population 22. *p<0.01. 
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Figure 2a  C HQ-CF87  scores  of  adolescents  with  food  allergy  and  a  sample  of 
adolescents from the general population 
22. *p<0.05;**p<0.001. Higher scores indicate better 
HRQL. FA, not available for the sample of adolescents from the general population. See table 
1 for the definition of the scales. 
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Figure 2a. CHQ-CF87 
scores of adolescents 
with food allergy 
and a sample of 
adolescents from the 
general population22. 
*p<0.05;**p<0.001. 
Higher scores indicate 
better HRQL. FA, not 
available for the sample 
of adolescents from the 
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Figure 2b   CHQ-CF87 scores of adolescen ts with food allergy, asthma 
26 and diabetes 
mellitus type 1 (DM) 
27. *p<0.05; **p<0.01. Higher scores in dicate better HRQL. RE and RB 
not available for asthma, FA not available for DM . See table 1 for the definition of the scales.
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Generic versus disease-specific HRQL questionnaires: Floor and ceiling 
effects
The FAQLQ-CF, -TF and -AF showed minimal if any floor or ceiling effects (Table 
4), indicating that almost no food allergic patients reported the minimal score 
(best HRQL) or maximal score (worst HRQL) on the FAQLQ. In children, the CHQ-
CF87 showed almost no floor effects because the minimal score (worst HRQL) was 
seldom reported. However, remarkable ceiling effects were seen for the scales RE, 
RB, RP, where more than 80% of the children reported the maximal score (best 
HRQL). A similar pattern was seen in adolescents. In adults, the RAND-36 showed 
some floor effects (adults with the minimal score, thus worst HRQL), but more 
pronounced were the ceiling effects (adults with the maximal score, thus best 
HRQL), especially for the scale RE (79%).
Figure 3a   RAND-36 scales scores of  food allergic adults and a sample of adults from the 
general population 
23. *p<0.01; **p<0.001. Higher scores i ndicate better HRQL. See table 1 
for the definition of the scales. 
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Discussion
In this study we found that food allergic children and adolescents reported less 
impairment on the scale role functioning-behaviour (RB) than general pediatric 
and  adolescent  populations.  However,  food  allergic  adolescents  reported  more 
impairment on the scales bodily pain (BP) and general health (GH) than a general 
adolescent population and food allergic adults reported more impairment on the 
scales self-esteem (SE), vitality (VT) and general health (GH). Compared with other 
chronic diseases, food allergic patients reported poorer generic HRQL than patients 
with DM, but better generic HRQL than patients with asthma, IBS and RA. Finally, 
we found very high ceiling effects for some scales of the generic questionnaires. 
No significant floor or ceiling effects were found for the disease-specific FAQLQs.
One of the advantages of generic HRQL questionnaires is that they can be used 
to compare healthy individuals with patients with a chronic disease. We compared 
food allergic patients with individuals from the general population and found that 
food allergic children and adolescents reported fewer limitations in school work 
or activities with friends due to behavioural problems (RB). This may be explained 
by the fact that having a food allergy demands that the child be conscious of his or 
her behaviour, especially regarding to situations involving food, with an emphasis 
on avoidance of impulsive behaviour. These disease managing demands may result 
Table 4. Percentage of floor and ceiling effects of FAQLQ-CF, -TF and -AF, CHQ-CF87 and RAND-36. 
Children Adolescents Adults
Floor
%
Ceiling
%
Floor
%
Ceiling
%
Floor
%
Ceiling
%
FAQLQ 1.3 0 0 1.4 1.4 0
CHQ-CF87 RAND-36
PF 0 64.8 0 58.1 PF 0 26.0
RE 1.3 81.0 1.4 73.0 SF 1.4 23.0
RB 0 82.3 0 81.1 RP 19.4 58.3
RP 0 86.1 2.7 85.1 RE 11.1 79.2
BP 0 41.8 1.4 20.3 MH 0 2.8
BE 0 5.1 0 0 VT 0 1.4
MH 0 2.6 0 0 BP 0 37.5
SE 0 6.3 0 0 GH 0 2.8
GH 0 3.8 0 0 CH 1.4 8.3
FA 0 31.6 0 24.3
FC 0 25.3 0 23.0
See table 1 for the definition of the scales. 
Floor effect = percentage of patients with minimal score. 
Ceiling effect = percentage of patients with maximal score. 
Floor and ceiling of the FAQLQ-CF, -TF and -AF are score 1 (best HRQL) and 7 (worst HRQL), respectively. 
Floor and ceiling of CHQ-CF87 and RAND-36 are score 0 (worst HRQL) and 100 (best HRQL), respectively. Generic quality of life of food allergic patients
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in more consciousness about behaviour in other situations as well, resulting in less 
behavioural problems than in children of the general population. In addition to RB, 
trends were seen for food allergic children to report better HRQL scores on RE and 
FC and also in food allergic adolescents and adults to report better HRQL scores 
on the scales RB and PF, respectively. However, the overall trend was that food 
allergic patients reported poorer HRQL on most scales than the general population. 
Compared to the older age groups, food allergic children reported the least impact 
of food allergy on generic HRQL and their scores were comparable to the scores of 
the children in the general population. As in this age group parents are responsible 
for the management of the food allergy, children probably do not experience 
much impact of their food allergy on their generic HRQL. Alternatively, the generic 
questionnaire used in children may be less responsive than the corresponding 
questionnaires in adolescents and adults.
Food allergic adolescents reported significantly more pain and limitations 
due to pain (BP) and poorer perceptions of overall health (GH) than adolescents 
from the general population. It is remarkable that food allergic adolescent reported 
significantly lower scores on BP than those from the general population, since pain 
is not a feature of food allergy. However, the questions included in BP ask about 
bodily pain or symptoms. While symptoms are generally not a feature of food 
allergy outside of accidental exposures, they are a feature of frequent comorbid 
conditions such as asthma  32. Since generic questionnaires do not separate the 
impact on HRQL of the disease in question from the impact of comorbid diseases, 
this may have influenced the responses to questions in this domain. Food allergic 
adults reported significantly more limitations in social activities (SF), less vitality 
and liveliness (VT) and poorer perceptions of overall health (GH) than adults from 
the general population. Overall, food allergic patients tend to report poorer HRQL 
than individuals from the general population, apart from the exceptions indicated 
above. 
A further advantage of generic HRQL questionnaires is that they can be used 
to compare different diseases. We compared food allergy with four other chronic 
diseases and found that food allergic patients reported poorer HRQL than patients 
with DM, but better HRQL than patients with asthma, IBS and RA. While this may 
indicate that these diseases differ in their impact on HRQL, other factors may have 
played a role as well. Firstly, HRQL in adults is age-dependent and it has been found 
that HRQL as measured with the scales PF, RB, BP and GH decreases with age 23. On 
average, the food allergic adults in our study were younger than the adult patients 
with asthma, IBS and RA, which may have led to diminished HRQL being reported 
by these patient groups. The adults with DM had approximately the same age as 
the food allergic adults, and thus this comparison is probably not influenced by 
the described age effect. Another possibility is that generic questionnaires may be 
biased to being responsive in diseases characterised by daily chronic symptoms 
such as asthma, IBS and RA. Conversely, generic HRQL questionnaires tend to 
ignore limitations of lifestyle and psychological burden caused by disease managing 
activities more characteristic for diseases such as food allergy and DM. This may 126
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also have influenced the HRQL reported by these patient groups and could have led 
to an underestimation of the impact on generic HRQL in DM and food allergy. 
The  disadvantages  of  generic  questionnaires  are  that  they  are  by  design 
comprehensive,  so  they  may  not  focus  adequately  on  problems  specific  to  a 
particular disease and that they do not separate the impact on HRQL of the disease 
in question from the impact of comorbid diseases. In previous studies on the 
development and validation of the FAQLQ-CF, -TF and -AF we already showed 
that the correlations between the generic and disease-specific questionnaires were 
only low to moderate  18-20. This indicates that the generic and disease-specific 
questionnaires are not measuring exactly the same thing. Additionally, we found 
very high ceiling effects for some scales of the generic questionnaires in this 
study, which means that a substantial part of the food allergic patients reported 
no problems in these areas. This indicates that, as expected, some areas measured 
by generic questionnaires are irrelevant to food allergy. In contrast, no floor or 
ceiling effects were observed for the disease-specific FAQLQ-CF, -TF and -AF.  This 
indicates that these questionnaires are responsive to the specific concerns of food 
allergic patients and it underscores the internal validity of these questionnaires. 
In addition, it illustrates the general desirability of using disease-specific HRQL 
questionnaires when studying specific diseases.
This study may also have some limitations. We decided to only include 
comparative studies that were performed in the Netherlands, since the HRQL 
measurement in food allergic patients was done in the Netherlands. This may 
decrease the generalisability of the results to other countries and cultures. However, 
for the comparisons within this study, it was important to include only Dutch 
studies to prevent bias caused by different languages or cultures. The FAQLQs used 
in this study will be validated in other countries as well, so they can be used for 
international disease-specific studies of food allergy. Further comparative studies in 
other counties and cultures will show if the same patterns are seen as in our study. 
In addition, it should be mentioned that the comparison between the different 
diseases is restricted to the patients included in the selected studies. Patients within 
these different studies could not be perfectly matched on demographic variables 
which might influence the impact of these diseases on HRQL.
In conclusion, this study showed that food allergic children reported the least 
impact of food allergy on generic HRQL, which was even better than in children in 
the general population in some respects.  In contrast, food allergic adolescents and 
adults reported overall poorer generic HRQL than the general population.  The HRQL 
impact of food allergy is intermediate in magnitude between DM and asthma, IBS 
and RA. Generic HRQL questionnaires may thus be useful to compare the impact 
of food allergy on HRQL with the general population and other chronic diseases. 
However, the very high ceiling effects that were found for some generic scales 
may indicate that generic HRQL questionnaires are not sufficiently responsive to 
measure disease-specific but potentially clinically important impairments in food 
allergy. For measuring these disease-specific effects in food allergic patients, it is 
preferable to use disease-specific questionnaires.Generic quality of life of food allergic patients
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Abstract
Purpose:
The purpose of this review is to give an overview of how health-related quality of 
life (HRQL) can be measured in food allergy and to explore recent findings on how 
food allergy might impact HRQL. 
Recent findings: 
In addition to the more familiar burdens of having a food allergy, the psychosocial 
impact of food allergy and information gaps concerning food allergy have received 
much attention in the recent literature. Recently, reliable and valid disease-specific 
HRQL questionnaires have become available to measure the impact of food allergy 
on HRQL in food allergic patients of all ages.
Summary: 
Assessment of HRQL could be used by clinicians to get insight in the specific 
problems patients have to face. In addition, HRQL measurements may be used to 
measure the effects of an intervention on the patient’s quality of life. Finally, HRQL 
is the only available measure reflecting the ongoing severity of food allergy, since 
no objective disease parameters are available.  Quality of life in food allergy: valid scales
8
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Introduction 
Living with a food allergy is increasingly being recognised as being more difficult 
than is generally appreciated 1. Management of food allergy includes avoidance of the 
culprit food in numerous situations which may interfere with daily life 2. In addition, 
there is always a chance of accidental exposure which may lead to a (severe) allergic 
reaction. This may in turn be a source of anxiety 3. When a severe allergic reaction 
occurs, prompt and accurate administration of epinephrine may be required which 
by itself may provoke anxiety about being able to respond adequately 4. Therefore, 
food allergy may have a considerable impact on quality of life 5.
What is quality of life?
Although there is no consensus on the definition of quality of life 6, a constructive 
definition has been drawn up by the World Health Organisation (WHO): “the 
individual’s perception of their position in life in the context of the culture and 
value  systems  in  which  they  live  and  in  relation  to  their  goals,  expectations, 
standards and concerns” 7. The component of overall quality of life that concerns 
an individuals’ health is called health-related quality of life (HRQL) and may be 
defined as “the effects of an illness and its consequent therapies upon a patient as 
perceived by the patient” 8. HRQL is a multidimensional concept that consists of 
bio-psycho-social domains such as physical and psychological status and social 
interaction 6. 
How might food allergy influence HRQL?
Since there is no cure available for food allergy, the only form of treatment is 
strict avoidance of foods causing allergic reactions and provision of emergency 
treatment. The difficulty of this treatment is that it may take considerable effort in 
daily life and that success is not guaranteed. There is always a chance of accidental 
exposure. Consequently, this might influence HRQL 9. 
Allergen avoidance and allergic reactions
Allergen avoidance, aiming to prevent allergic reactions, may include numerous 
actions in different settings in daily life in which food allergic patients have to 
relay on external factors for their safety. It has been reported that ingredients lists 
were insufficient for the needs of food allergic patients and that ingredients of pre-
packed products were frequently changed which was perceived as frustrating 10. In 
addition, it was shown that a considerable percentage of restaurant personnel have 
insufficient knowledge about food allergy. Despite this, they expressed relatively 134
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high comfort levels in providing safe meals to food allergic patients 11. The premise 
that accidental exposure may occur in any situation is underlined by a study that 
showed that 9% of food allergic patients who had been on board of an airplane 
reported experiencing an allergic reaction there. Even more alarming was the 
finding that the information about flying with food allergies was in some cases 
incomplete or inaccurate  12. Therefore, in addition to the need of food allergic 
patients to be vigilant in various situations involving food, they are often reliant on 
external information which may very well be unreliable.  
Anxiety and psychological impact
Food allergy may be a psychological burden with high levels of stress and anxiety 
for the food allergic patient and, in the case of children, also for their parents 13;14. 
Mothers with a food allergic child reported that they experienced parenting such a 
child as “living with risk” 15. The pervading theme expressed by adolescents with 
food allergy was “striving to normalise the experience of being food allergic”. 
These adolescents experienced deprivation, insecurity and fear of severe allergic 
reactions, but most of them ultimately felt competent in dealing with their food 
allergy  16. Lastly, it has been reported that adolescents perceived anaphylaxis as 
“no big deal” whereas their parents described a large impact on their own day-
to-day life  17. Thus, food allergy may have a considerable psychological impact 
and may provoke anxiety in food allergic patients and in parents of food allergic 
children. The lower levels of anxiety sometimes reported by adolescents may not 
be justified.
Uncertainty and information gaps
Having a food allergy implies being “at risk” for an allergic reaction and this 
inevitably invokes uncertainty 18. Moreover, no biological markers are available to 
predict who will or who will not have an anaphylactic reaction in the future  19. 
Uncertainties concerning food allergy may arise from a lack of information 20. 
One way to deal with uncertainties caused by lack of information is to join 
a patient organisation21;22. Recently, it was shown that parents themselves had a 
solid foundation of food allergy knowledge, but that they had concerns about the 
food allergy knowledge of primary care physicians 23. The general public had a 
wide variation in knowledge of food allergy with many misconceptions 24. Such 
knowledge gaps, especially among physicians and the general public, may have a 
negative impact on the HRQL of food allergic patients and parents of food allergic 
children.
Why is HRQL measurement important?
The importance of measuring HRQL may be addressed from different points of 
view. First of all, measurement of HRQL gives insight in the impact of disease Quality of life in food allergy: valid scales
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from the patient’s perspective. It is, for example, possible that two patients with the 
same objective clinical impairment may have very different degrees of impairment 
in their HRQL 25. HRQL assessment could be used by clinicians to get insight in 
the specific problems patients have to face and to help them coping with those 
issues  26. HRQL questionnaires can usually be completed by the patient in less 
than 15 minutes and are thus suitable for administration just before the clinical 
interview (e.g. in the waiting room). During the clinical interview, the clinician 
could discuss areas most affecting HRQL with the patient and help them to manage 
the mentioned problems. Follow-up measurement over time gives the clinician and 
patient insight in the effect on HRQL of the chosen management.
In research, HRQL measurements may be used to measure the effects of 
interventions generally on patients’ quality of life, which could help improve the 
quality of patients’ treatment and outcome. HRQL measurements may also be used 
to compare the effect of different interventions and to compare the impact of 
different diseases on HRQL 6. Such HRQL studies may be used by policy makers to 
improve the allocation of health care resources. Ultimately, combining HRQL data 
with epidemiologic data on prevalence may give insight in the societal impact of 
a disease 27.
Finally, with regard of food allergy, it is important to note that there are 
no objective disease parameters available to measure the ongoing severity of food 
allergy, such as FEV1 in asthma. One could measure the severity of a food allergic 
reaction, but allergic reactions occur only when a patient is exposed to a culprit 
food. Despite the absence of actual symptoms, food allergy has an ongoing severity 
due to the allergen avoidance requirements and resulting psychosocial burden. 
HRQL  is  the  only  available  measure  reflecting  this  ongoing  severity  of  food 
allergy.  
How to measure HRQL?
HRQL can be measured with questionnaires, also called as instruments or scales.  There 
are two types of HRQL questionnaires; generic and disease-specific questionnaires. 
The major psychometric properties of questionnaires are reliability and validity. 
Generic and disease-specific questionnaires
Generic questionnaires are developed for use in different diseases and general 
populations.  Thus,  these  questionnaires  allow  comparison  between  different 
diseases. The disadvantage is that they may not focus adequately on problems 
specific to a particular disease and that they also measure the impact of comorbid 
diseases. Disease-specific instruments are developed for use in a specific population. 
These questionnaires are much more likely to detect clinically important changes in 
patients’ impairments. The disadvantage is that do not allow comparison between 
different diseases 25. 136
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Reliability and validity 
Reliability  refers  to  the  extent  to  which  the  questionnaire  is  repeatable  and 
consistently produces the same results. Reliability is most commonly evaluated 
by assessment of internal consistency and test-retest analysis (Table 1). Validity is 
the degree to which the questionnaire measures what it is intended to measure. 
There are two types of validity; internal and external validity. Internal validity refers 
to the internal structure of the questionnaires and is usually evaluated by factor 
analysis, inter-item correlations and floor- and ceiling effects. External validity is 
the relationship between the questionnaire and an external criterion (e.g. other 
measures of the same or different dimensions of health) and the most common 
types are face, content, convergent/discriminant and construct validity 28. 
Table 1. Types of reliability and validity commonly used to evaluate HRQL questionnaires.
Reliability 
Internal consistency Refers to how well the items of a questionnaire relate to each 
other and to the total questionnaire. It is most commonly 
evaluated by Cronbach’s alpha. An alpha > 0.70 indicates good 
internal consistency.
Test-rest reliability It estimates the reproducibility of the questionnaire over time. 
The questionnaire is completed on two occasions by the same 
patients in whom no change in the condition has taken place. 
It is most commonly evaluated by the intraclass correlation 
coefficient (ICC). An ICC > 0.70 indicates good test-rest 
reliability.
Validity
Internal Factor analysis Is used to identify groups of items within the questionnaire that 
relate with each other.
Inter-item correlations Correlation between items. Should not be greater than 0.85 to 
prevent redundancy.
Floor and ceiling effects Percentage of patients with minimal or maximal score on the 
questionnaire, respectively. Floor- and ceiling effects should 
be minimal. 
External Face validity A subjective judgement of whether the questionnaire appears 
to measure what it is supposed to measure.
Content validity The extent to which a questionnaire represents all dimensions 
of a construct. It is also a judgment, but it may be evaluated 
by the correlation between the questionnaire and the symptom 
content of a disease.
Convergent and 
discriminant validity
The extent to which the questionnaire correlates with measures 
designed to measure similar constructs and does not correlate 
with measures designed to measure dissimilar constructs.
Construct validity Refers to whether a questionnaire measures the theorized 
psychological construct (e.g. HRQL). It is evaluated by the 
correlation between the questionnaire and an independent 
measure known to be related with the construct or for which 
there are theoretical grounds for expecting it to be related.Quality of life in food allergy: valid scales
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These types of external validity may be ranked based on the rigor of the method 
of ascertainment. Face validity is determined by expert opinion as to whether the 
questionnaire seems to measure HRQL related to the disease in question. Since 
this assessment is subjective, face validity may be considered the least rigorous 
form of validity. Content validity is also based on subjective assessment of the 
extent to which a questionnaire represents all dimensions of a construct, but more 
systematic assessments may be used as well. Therefore, it may be considered to be 
more rigorous than face validity. Convergent/discriminant validity is assessed by 
calculating the correlation between the questionnaire and measures of similar or 
dissimilar constructs. As this is a systematic assessment, this type of validity may be 
considered as more rigorous than content validity. Finally, since no “gold standard” 
exists to measure HRQL and to compare a new HRQL questionnaire with, the best 
achievable form of validity is construct validity, which is ascertained by calculating 
the correlation between the questionnaire and an independent measure which 
reflects the severity of the disease in question. As this is a systematic assessment 
with measures known to be related with the construct, this type of validity may be 
considered as more rigorous than convergent/discriminant validity (Table 1).
Construct validity is thus usually evaluated by comparing the HRQL ques-
tionnaire with an objective measurement of the extent or severity of the disease, 
and often such an independent measure is directly or indirectly related to the bur-
den of symptoms characterising the disease in question. However, in disorders 
not characterized by chronic symptoms, as in food allergy, such an independent 
measure is not available. Therefore is has been shown that the perceived expecta-
tion of what will happen following exposure can be used as independent measure 
to evaluate construct validity as this will be the driving force determining HRQL, 
and instruments developed in this way have proved to be useful and consistent in 
measuring HRQL 29.
Finally, for a questionnaire to be reliable and valid in a specific population 
(e.g. children), it is very important to include patients of the target population in 
the development of the questionnaire (i.e. item generation and item selection)30. 
This ensures that the questions are of importance for the target population. In 
addition, the wording of the question should be age appropriate. 
Measurement of HRQL in children and adults with food 
allergy
Measurement of HRQL in food allergy is relatively new research area. The first 
study on this topic was published in 2000 31 and the interest in HRQL of food 
allergy has increased ever since. A few studies reported HRQL of food allergic 
patients measured with generic questionnaires. However, reliable and valid disease-
specific questionnaires to measure HRQL in food allergy have become available 
only recently. 138
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Table 2. Generic HRQL questionnaires used in food allergic patients.
Questionnaire No. of 
items
Domains/ Subscales Completed 
by
Used by 
(Authors, 
year, country, 
reference)
Age in years 
of included 
food allergic 
patients
Child Health 
Questionnaire-
Parent Form 
(CHQ-PF28) and 
(CHQ-PF50)
28 / 50 Physical functioning
Role-social/emotional, 
behavioural
Role-social/physical
Bodily pain
General behaviour
Mental health
Self-esteem
General health
Parental impact-emotional
Parental impact-time
Family activities
Family cohesion
Change in health
Parent Primeau et al., 
2000, Canada 31
Sicherer et al., 
2001, US 52
Marklund et al., 
2006, Sweden 53
Östblom et al, 
2008, Sweden 48
< 18
5-18 
8-19 
9 
Child Health 
Questionnaire-
Child Form (CHQ-
CF87)
87 Physical functioning 
Role functioning-emotional
Role functioning-behaviour 
Role functioning-physical 
Bodily pain 
General behaviour 
Mental health
Self-esteem  
General health 
Family activities 
Family cohesion 
Change in health
Child Flokstra-de Blok 
et al., 2009, the 
Netherlands 50
Flokstra-de Blok 
et al., 2008, the 
Netherlands 51
8-12 
13-17 
Medical Outcome 
Trust Short Form 
36 Health Survey 
(SF-36) or (RAND-
36)
36 Physical functioning
Social functioning  
Role functioning-physical 
Role functioning-emotional 
Mental health
Vitality 
Bodily pain 
General health 
Change in health
Patient Primeau et al., 
2000, Canada 31
Marklund et al., 
2004, Sweden 54
Flokstra-de Blok 
et al., 2009, the 
Netherlands 42
18-45
13-21 
18-54 
Impact on Family 
scale (IOF)
24 Familial/social
Personal strain
Financial Burden
Mastery
Patient/
parent
Primeau et al., 
2000, Canada 31
18-45 / 
< 18
Visual Analogue 
Scale (VAS) 
(i.e.thermometer)
1 n.a. Patient/
parent
Primeau et al., 
2000, Canada 31
18-45 / 
< 18
n.a. not applicableQuality of life in food allergy: valid scales
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Generic HRQL questionnaires used in food allergic patients 
Table 2 gives an overview of the generic HRQL questionnaires used in the field of 
food allergy. The Child Health Questionnaires (CHQ-CF28, CHQ-CF50 and CHQ-
CF87) and the Medical Outcome Trust Short Form 36 Health Survey (SF-36 or 
RAND-36) are generic HRQL questionnaires for children and adults, respectively, 
that are reliable and well validated in many languages and that have extensively 
been used in social-medical research 32-37.
The Impact on Family (IOF) scale has been developed to assess the impact of 
chronic childhood conditions on the family.  The original questionnaire has shown 
to be internally consistent with an acceptable factor structure 38. More recently, the 
IOF has been revised and has shown an acceptable level of construct validity 39;40.
The Visual Analogue Scale (VAS) has been adapted from the EQ-5D 41. The VAS 
is a vertical line (i.e. thermometer) with the end-points labelled ‘no disruption’ 
(score 0) and ‘most disruption imaginable’ (score 100) and patients are asked to 
rate how much disruption they experience in their daily activities due to their 
disease 31.  
As can be seen in Table 2, only two studies investigated the generic HRQL of 
food allergic adults 31;42.
Disease-specific HRQL questionnaires available for use in food allergic 
patients
During  the  last  years  a  few  disease-specific  HRQL  questionnaires  have  been 
developed  and  used  in  food  allergy  research.  However,  not  all  questionnaires 
have been extensively validated and therefore sometimes caution is needed when 
interpreting results obtained with these questionnaires. Table 3 summarises disease-
specific HRQL questionnaires for use in food allergic patients that are available in the 
literature. Other disease-specific HRQL questionnaires that were not available from 
the publication are described in the text only. 
The first study of disease-specific HRQL in food allergy was done by Avery 
and colleagues 43. A questionnaire specially developed for this study and an adapted 
version  of  the Vespid Allergy  Quality  of  Life  Questionnaire  (VQLQ)  44  were 
completed by the children aged 7-12 years. However, the first questionnaire was 
not validated. The second questionnaire has been validated in vespid allergy but not 
in food allergy and it was not described how this questionnaire was adapted. 
Thereafter, Arslan and colleagues investigated HRQL in food allergic adults 
(aged 19-80 years) with the Short-Form Nepean Dyspepsia Index (SF-NDI) 28. This 
questionnaire was developed and validated in patients with functional dyspepsia, 
but showed satisfactory test-retest reliability in food allergic patients. Construct 
validity  was  evaluated  by  correlating  the  SF-NDI  with  two  gastrointestinal 
symptom rating scales. Relatively high correlations were found, since all three 
questionnaires are targeted to gastrointestinal problems. However, food allergic 
patients may experience symptoms of other systems as well (e.g. skin, respiratory 
tract, cardiovascular). Moreover, food allergic patients experience symptoms only 
when they are exposed to a culprit food. Otherwise they are symptom free, but the 140
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|Chapter 8
considerable efforts they have to make to avoid the culprit food influences their 
daily life. This impact on daily life is not captured by the SF-NDI. 
The  first  validated  disease-specific  HRQL  questionnaire  for  food  allergy 
became available in 2004: the Food Allergy Quality of Life-Parental Burden (FAQL-
PB)  45. This questionnaire is administered to parents and measures the parental 
burden associated with having a food allergic child. The questionnaire has shown 
to be reliable and valid (Table 3). While being useful and well designed, this 
instrument is not able to measure HRQL of the food allergic children, which may 
be an important outcome measure in clinical research. 
Recently, the Food Allergy Impact Scale (FAIS) and the Food Allergy Parent 
Questionnaire (FAPQ) were developed.  The FAIS measures the impact of food allergy 
on daily activities of food allergic children and their families and is completed by 
the parent 46. It showed acceptable internal consistency and preliminary support for 
the external validity (face and content validity), but internal validity was not tested 
(Table 3). Further study of construct validity and internal validity is desirable to 
investigate the degree to which the FAIS measure what it is intended to measure. 
The FAPQ measures the parental adjustment to and coping with children’s 
food allergy and is completed by the parent  47. The subscales ‘parental anxiety/
stress’ and  ‘psychosocial impact of allergies’ showed good internal consistency, but 
the subscales ‘parental coping/competence’ and ‘family support’ did not. Internal 
validity evaluated by factor analysis was acceptable and preliminary support for 
the external validity (face and content validity) was shown (Table 3). Another 
limitation was that the items of the FAPQ were generated based only on the clinical 
experience of the authors and that no patients/parents were included during the 
development. Also the FAPQ needs further study of the construct validity in order to 
investigate the degree to which the FAIS measure what it is intended to measure. 
More recently, two studies were published on the impact of food allergy on 
quality of life in children and the impact on daily life in food allergic adults. The first 
study used disease-specific questions that were specially developed for this study 
and these questions were completed by the parents 48. However, these questions 
were not tested for reliability or validity (Table 3). The second study investigated 
the impact of food allergy on daily life of adults with two self-designed questions 
(influence on daily life at home and outside the home) 2. Again, these questions 
were not tested for reliability or validity.
Very recently, disease-specific HRQL questionnaires for food allergic patients 
of all ages (i.e. parents, children, adolescents and adults) have been published 42;49-51. 
All four questionnaires have shown to be reliable (internal consistency and test-
retest) with an acceptable level of internal validity (factor analysis, inter-item cor-
relation) and external validity (face, content, convergent/ discriminant and con-
struct validity) (Table 3). During the development of these questionnaires, patients 
of the target age group were the most important source for items generation and 
item selection. Investigation of the ability to measure differences over time (i.e. 
longitudinal validation) and validation in different languages of these question-
naires are underway Quality of life in food allergy: valid scales
8
143
Conclusion
Food allergy may negatively impact HRQL of food allergic patients and families 
with  a  food  allergic  child  in  numerous  ways. To  investigate  this  impact  on 
HRQL, generic or disease-specific questionnaires may be used. Generic HRQL 
questionnaires may be not specific enough to measure disease-specific impairments 
and they also measure the impact of comorbid diseases. Recently, reliable and valid 
disease-specific questionnaires have become available to measure HRQL in patients 
with food allergy of all ages. These questionnaires may be used by clinicians to get 
insight in the specific problems of food allergic patients and in clinical research 
where HRQL is the outcome of interest.
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|Chapter 9
This thesis deals with the development, validation and outcome of disease-specific 
health-related quality of life (HRQL) questionnaires for patients with food allergy. 
In this final chapter we provide a general summary of our findings and we will 
generally discuss these findings. Finally, recommendations for future study will be 
provided.
The impact of food allergy on HRQL 
Since no cure is available, having a food allergy implies being vigilant in numerous 
situations and setting involving food 1;2. This need for allergen avoidance may have 
a considerable impact on daily life. For example, patients have to read labels of 
pre-packaged products, which may be time consuming and which may cause 
frustration when labels are insufficient for the needs of food allergic patients 3. In 
addition, when eating outside the home, patients always need to ask beforehand 
whether the offered food contains the allergen that should be avoided, which may 
be experienced as embarrassing in social situations. However, despite all the effort 
it may cost to avoid allergens in food, success is not guaranteed 4. There is always 
a chance of accidental exposure 5. For example, when ingredients of pre-packaged 
products are changed or when the restaurant personnel or the host is not aware 
of the danger of cross-contamination of allergens in food 6. Finally, when a severe 
allergic reaction occurs, prompt and accurate administration of epinephrine may 
be required which by itself may provoke anxiety about being able to respond 
adequately 7. Therefore, food allergy may have a considerable impact on quality of 
life 8.
Need for valid HRQL questionnaires for food allergic 
patients 
Although food allergy might have a considerable impact on quality of life, no valid 
disease-specific HRQL questionnaires were available to measure the impact of food 
allergy on the patient’s quality of life at the beginning of this study (June 2005) 
(chapter 2). The only well-validated HRQL questionnaire for food allergy available 
at that time, was the Food Allergy Quality of Life – Parental Burden (FAQL-PB) 
questionnaire 9. This questionnaire is completed by parents and measures the pa-
rental burden of having a child with food allergy. Although being useful and well 
designed, this questionnaire is not able to measure the impact of food allergy on 
HRQL as experienced by the patients themselves. Therefore, there was a need for 
valid disease-specific HRQL questionnaires that could be self-administered by food 
allergic patients and in this thesis we describe the development and validation of Summary and discussion 
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these questionnaires. In very young children one can only make use of the proxy 
ratings of parents. Therefore, in addition and concomitantly to the questionnaires 
developed in this thesis, a parent-administered questionnaire has been developed as 
well: the Food Allergy Quality of Life Questionnaire – Parent Form (FAQLQ-PF) 10. 
Development, validation and reliability of HRQL 
questionnaires for food allergic patients
We developed and validated three disease-specific HRQL questionnaires for children 
(8-12 years), adolescents (13-17 years) and adults (18 years and older) with food 
allergy (chapters 3, 4 and 5) and in addition we investigated the reliability of these 
three questionnaires (chapter 6).
The development phase started with the generation of items for the new 
questionnaires. The main sources for items were food allergic patients. In semi-
structured interviews patients were asked about troublesome aspects of having a 
food allergy in daily life. In addition, we searched the literature on food allergy and 
asked clinical experts for additional items. When no important new items emerged, 
the item generation was considered as complete. This item generation phase was 
followed by the item reduction phase, in which the obtained long lists of items 
concerning food allergy were given to other groups of food allergic patients. These 
patients were asked to indicate whether an item was applicable to them and if 
so, to rate on a five-point scale how troublesome that particular item was. By 
following this method, also named as the clinical impact method, we could select 
the most important items for the questionnaires. This resulted in the following 
three questionnaires:
- Food Allergy Quality of Life Questionnaire - Child Form (FAQLQ-CF), 
- Food Allergy Quality of Life Questionnaire - Teenager Form (FAQLQ-TF),
- Food Allergy Quality of Life Questionnaire - Adult Form (FAQLQ-AF). 
The item reduction phase was followed by the cross-sectional validation, in 
which the newly developed questionnaires were investigated as to their validity. The 
FAQLQs, the Food Allergy Independent Measure (FAIM, which will be discussed 
later on) and a generic HRQL questionnaire were sent to other groups of food 
allergic patients. By calculating correlation coefficients between the FAQLQs and the 
FAIM we showed acceptable levels of construct validity for all three questionnaires 
and by calculating correlation coefficients between the FAQLQs and the generic 
HRQL questionnaire we showed acceptable levels of convergent and discriminant 
validity for all three questionnaires. Finally, in chapter 6 we demonstrated, by 
administrating the questionnaires two times to the same patients within a 10 to 
14 day interval, that all three questionnaires showed good test-retest reliability. 
Such reliability measures are important to ensure that what the questionnaire is 
measuring is reproducible.150
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Why three separate questionnaires for three different 
age groups?
Different issues relating to food allergy may have different impacts at different stages 
of life. For example, a food allergic child may face problems when treats are given 
at school, whereas a food allergic adult, for example, may face problems when 
eating in restaurants. In addition to such practical problems, also the psycho-social 
impact of food allergy may differ with age. Think for example of peer pressure 
which may play an important role in adolescence. Therefore, a single questionnaire 
cannot accurately measure quality of life across all age groups. Consequently, we 
have developed three questionnaires; one for children aged 8 to 12 years (primary 
school), one for adolescents aged 13 to 17 years (secondary school) and one for 
adults 18 years and older.
Moreover, when measuring HRQL in children it is important to take age, 
maturity  and  cognitive  development  into  account  in  the  development  of  the 
questionnaire 11. In order to ensure age-appropriateness, we included food allergic 
children in the development process of the questionnaire. In addition, answer 
categories were illustrated by faces (smileys) which is appropriate for the cognitive 
development of the child. Finally, a consultant for sick children reviewed the child 
questionnaire for clarity and ease of use. Another important issue was to decide the 
lower limit of age at which a child is able to report on their own quality of life in 
the form of a self-completed questionnaire. Although the understanding of HRQL 
is determined by the age, maturity and cognitive development of the child, it has 
been reported that children 8 years and older are able to understand questions 
about their HRQL and to give reliable and valid answers 12.  
When looking at the content of the final questionnaires for the different age 
groups, it was striking to see that a considerable part of the items showed overlap. 
Thus, although we separately interviewed food allergic children, adolescents and 
adults and generated many age-specific items, there are apparently general food 
allergy items that are important in all age groups. Moreover, we found that the 
three most important items, determined during the item reduction phase, were the 
same for all the three age groups: ‘Always be alert as to what you are eating’, ‘The 
ingredients of a product change’, ‘Able to eat fewer products’. Although there was 
overlap of items, important age-specific items emerged in each questionnaire as well. 
Examples of items specific for children were: ‘Don’t get anything when someone 
is giving treats at school’, ‘Concerned that you will never get rid of your food 
allergy’, ‘Not knowing how things taste which you can’t eat’ and ‘Feel disappointed 
because you have a food allergy’. Examples of items specific for adolescents were: 
‘Refuse treats at school or work’, ‘Carrying an Epipen’ and ‘During social activities 
your food allergy is not taken into account’. Examples of items specific for adults 
were: ‘Eating out less often’, ‘Feel you are being a nuisance because you have a 
food allergy when eating out’, ‘Sometimes frustrate people when they are making 
an  effort  to  accommodate  your  food  allergy’  and ‘People  underestimate  your 
problems caused by food allergy’. Finally, the layout of the child questionnaires Summary and discussion 
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differs significantly from the other two questionnaires since the answer categories 
in the child questionnaire are illustrated by smileys. Therefore, in conclusion, we 
think it is important to have three separate questionnaires for three different age 
groups.
The importance of including patients in the item 
generation and item reduction
Developing a valid and robust questionnaire is not just putting some questions 
together  13. Usually the development of a questionnaire starts with item generation   14. 
During the item generation all kinds of possible items for the new questionnaire 
are assembled. One source or more different sources may be used such as patients, 
clinicians and the literature 15. Since a disease-specific HRQL questionnaire intends 
to measure the impact of a disease as perceived by the patient, it has been argued 
that patients are the most important source for generating items, because they 
generate the items that are really a problem as perceived by the patients themselves. 
Moreover, it is important to include patients that are representative for the patients 
in whom the final questionnaire will be used 11. 
The item generation is usually followed by the item reduction in which 
the items are reduced to a manageable number for inclusion in the questionnaire. 
Different methods may be used for the reduction of items, of which the clinical 
impact method and the psychometric approach (factor analysis) are the most 
frequently  used  methods  16.  In  the  development  of  the  FAQLQs  we  used  the 
clinical impact method which reveals items that are clinically most important as 
perceived by food allergic patients. This is in contrast to the method of selecting 
items based on mathematical linkage between items by performing factor analyses 
in which items with a low loading on a factor are removed. The latter method has 
the potential drawback that it may result in excluding items with a high clinical 
impact   16. Juniper et al., who also used the clinical impact method for developing 
the Asthma Quality of Life Questionnaire (AQLQ), showed that the three items of 
the greatest importance to patients with asthma would have been excluded from 
the AQLQ if they had used the psychometric approach (factor analysis) 16. A possible 
drawback of selecting items based on their clinical importance may be that, when 
you perform factor analysis on these most important items, the allocation of items 
into domains does not always make intuitive sense. Therefore, in the development 
of the FAQLQs we used the clinical impact method for selecting items. Subsequently, 
the allocation of items into domains was based on factor analysis supplemented by 
face validity determined by an expert panel. 152
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Cross-sectional validation with the Food Allergy 
Independent Measure (FAIM)
Once the items are selected for the new questionnaire, it is important to determine 
whether the individual questions and the total questionnaire measure the things 
that it are intended to measure, also known as validity. As discussed in the chap-
ters 3, 4, 5 and 8, no ‘gold standard’ HRQL measure exists to which a new HRQL 
questionnaire could be compared with to investigate validity, which is known as 
‘criterion’ validity in this context 17. Therefore, construct validity is the best achiev-
able form of validity, which is ascertained by calculating the correlation between 
the HRQL questionnaire and an independent measure. An independent measure is 
usually viewed as an important determinant of HRQL, but it is not itself a HRQL 
item. In addition, it is often an indication of the severity of the disease and it may 
at the same time be a target for intervention, such as FEV1 in asthma. However, 
since symptoms occur only upon exposure in anaphylactic disorders, no objective 
measurement of the extent or ongoing severity of disease exists with which to cor-
relate the new HRQL questionnaire 18. 
Therefore,  we  used  the  Food  Allergy  Independent  Measure  (FAIM)  to 
investigate the construct validity of the FAQLQs, which is based on the concept first 
described by Oude Elberink et al 19. The FAIM was developed for this research and 
includes four Expectation of Outcome (EO) questions and two other independent 
measure questions. Two of these EO questions were adapted from similar questions 
previously developed for the validation of the Vespid Allergy Quality of Life (VQLQ) 
questionnaire (i.e. ‘chance of having a severe reaction when stung’ and ‘chance of 
dying when accidentally stung’) 19 and the validation of the Food Allergy Quality 
of Life-Parental Burden (FAQL-BP) questionnaire (i.e. ‘chance of having a severe 
reaction  when  accidentally  exposed’  and ‘chance  of  dying  when  accidentally 
exposed’) 9. These two EO questions have successfully been implemented to validate 
the VQLQ and the FAQL-PB questionnaire 9;19;20. For the validation of the FAQLQs 
we have developed two additional food allergy specific EO questions (i.e. ‘chance 
of accidental exposure’ and ‘chance of not acting effectively when accidentally 
exposed’) and two additional independent measure questions. The EO questions 
are based on the perceived expectation of patients of what will happen following 
exposure which is likely to be a driving force of quality of life 18. The additional 
independent measure questions are based on the same principle and ask about 
the perceived number of foods one needs to avoid and perceived impact on social 
life.
In addition to the use of the FAIM for the investigation of the validity of 
the FAQLQs and the individual items of the FAQLQs, we also used the correlation 
between the individual FAQLQ items and the FAIM for the selection of items for 
the final questionnaire. That is, if an item of the FAQLQ did not correlate with any 
of the FAIM questions, than it was excluded from the questionnaire. Our starting 
point was to include only items that are perceived as important by the patients Summary and discussion 
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themselves (i.e. high overall importance (OI)) which measure that part of quality of 
life that is affected by food allergy (i.e. correlation with FAIM). If an item does not 
correlate with any of the FAIM questions, then it should not be in the questionnaire 
in the first place, whether or not it fits well in the scale or domains. Therefore we 
investigated the domain structure (factor analysis) and the internal consistency 
after the investigation of the construct validity. This was also the methodology used 
in previous studies which produced the VQLQ 19. 
 
Should we use generic HRQL questionnaires in food 
allergy?
In chapter 7 we presented the results of the study on HRQL of food allergic patients 
measured with generic and disease-specific questionnaires. Measurement of generic 
and disease-specific HRQL in the same group of food allergic patients has never 
been done before. The aims of this study were to compare generic HRQL of food 
allergic patients with the general population and other diseases (asthma, irritable 
bowel syndrome (IBS), diabetes mellitus type I (DM) and rheumatoid arthritis 
(RA)) and to compare HRQL of food allergic patients as measured with generic 
and disease-specific questionnaires. We found that food allergic children reported 
the least impact of food allergy on generic HRQL, which was even better than 
in children in the general population in some respects. Food allergic adolescents 
and adults reported overall poorer generic HRQL than the general population. In 
addition, we found that the generic HRQL impact of food allergy is intermediate 
in magnitude between DM and asthma, IBS and RA. Moreover, we found very high 
ceiling effects for some generic scales, which may indicate that generic HRQL 
questionnaires are not sufficiently sensitive to measure disease-specific clinically 
important impairments in food allergy.  Thus, generic HRQL questionnaires may be 
useful to compare the impact of food allergy on HRQL with the general population 
and other chronic diseases. However, for measuring disease-specific effects in food 
allergic patients, it is preferable to use disease-specific questionnaires. 
Although we found that food allergy has a greater impact on generic HRQL 
than DM, it is remarkable that this is not reflected in the attitudes of governments 
and societies. For example, if you search in ‘Google’ for the word ‘food allergy’, 
then you get 1,960,000 hits within 0.13 seconds. If you search in ‘Google’ for 
the word ‘diabetes mellitus’, then you get 7,080,000 hits within 0.06 seconds. 
Although the prevalence of both diseases differ somewhat, approximately 2% for 
food allergy and approximately 4% for DM 21;22, societal attention for these diseases 
may be out of proportion to each other. Further comparative studies between food 
allergy, DM and other chronic diseases will show if the similar differences in HRQL 
impact are seen as in our study.154
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Availability of valid disease-specific HRQL question-
naires for food allergic patients
In chapter 8, we present a review on how HRQL can be measured in food allergy 
and we reviewed recent findings on how food allergy might impact HRQL. We 
found that in addition to the more familiar burdens of having a food allergy, the 
psycho-social impact of food allergy and information gaps concerning food allergy 
have received much attention in the recent literature. In addition, we described 
that the FAQLQs, which we have developed, have become available recently. These 
are reliable and valid disease-specific HRQL questionnaires to measure the impact 
of food allergy on HRQL in patients of all ages. The assessment of HRQL could be 
used by clinicians to get insight in the specific problems patients have to face and 
HRQL measurements may be used to measure the effects of an intervention on the 
patient’s quality of life. One of the key messages of chapter 8 was that HRQL is the 
only available measure that reflects the ongoing severity of food allergy, since no 
objective disease parameters are available.  
Summary of main findings
The main findings of this thesis were as follows:
At the beginning of this study (June 2005), there was a need for valid HRQL  1) 
questionnaires for food allergic patients
Disease-specific HRQL questionnaires have been developed for children (8- 2) 
12 years), adolescents (13-17 years) and adults (18 years and older) with 
food allergy.
These questionnaires showed good validity and reliability. 3) 
For measuring disease-specific impact of food allergy on HRQL, disease-specific  4) 
questionnaires may be more useful than generic HRQL questionnaires. 
The impact of food allergy on HRQL is greater than the impact of diabetes  5) 
mellitus, but less than the impact of asthma, IBS and rheumatic arthritis as 
measured with generic HRQL questionnaires.
Recommendations for future study
Following the findings discussed in this thesis, there are a number of studies of 
interest for the future:
- Longitudinal validation. In order to investigate if the FAQLQs are able to measure 
differences over time, the longitudinal validity of the questionnaires should be 
investigated. The  longitudinal  validity  could  be  investigated  by  administering Summary and discussion 
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the FAQLQ and the FAIM to food allergic patients in whom HRQL is expected to 
change because of diagnostic and/or therapeutic interventions. The questionnaires 
should be administered before and a few months after the intervention, so that 
patients could become accustomed to their new health state. Preliminary data 
have shown that for some domains HRQL is already significantly improved two 
months after a diagnostic intervention (i.e. double-blind placebo-controlled food 
challenge) (DunnGalvin et al., unpublished data, December 2008). Changes in the 
average score of the FAQLQ are then correlated to changes in the FAIM, comparing 
values before and after the intervention described. Good correlation between the 
FAQLQ and FAIM scores validate the instrument longitudinally and simultaneously 
demonstrate the impact on quality of life of the intervention used. 
- Comparison of the children’s FAQLQ-CF scores with their parents’ FAQLQ-PF scores. As 
discussed earlier, children and parents may differ in their views and judgements 
concerning HRQL 23, and it would thus be interesting to investigate and compare 
the scores of children on the FAQLQ-CF with the scores of their parents on the 
FAQLQ-PF.
- Determination of the Minimal Importance Difference (MID). The MID is the smallest 
difference in score which patients perceive as beneficial and which would mandate, 
in absence of troublesome side effects and excessive cost, a change in the patient’s 
management. The MID of HRQL questionnaires with a 7-point scale is usually 
approximately 0.5 24. It is important to determine the MID of the FAQLQs, because 
it gives clinicians and researchers insight into whether a change in the FAQLQ 
score, for example before and after an intervention, is also a clinically important 
change. 
- Comparison of informed versus blind administration of follow-up questionnaires. It would 
be interesting to investigate if there is a difference in scoring on a follow-up 
questionnaire when the patients are shown their previous answers (i.e. informed) 
with the scores generated when there are not shown their previous answers (i.e. 
blind). It has been suggested that when letting patients see their previous responses, 
the validity of HRQL questionnaires in clinical trials can be improved 25. However, 
when the follow-up measurement was more than three months later, the results 
of the blind and informed questionnaire showed little difference 26. These studies 
were all performed in adults. Therefore, it would be interesting to see if the same is 
true for children and in food allergic patients. 
- Validation of FAQLQ in other countries. Before the FAQLQs can be used in other 
languages and cultures, the questionnaires should be cross-culturally validated in 
the new language or culture 27. Forward and backward translation may be used in 
order to check content comparability. Cross-sectional validation in the new language 
and cultural setting allows for the assessment of the performance of individual 
items in that language and culture. Good cross-sectional correlation coefficients 
indicate validity for that particular language setting. Low correlation coefficients 
may be encountered if the translation is inaccurate or if the item does not appear 
to be a problem in the new cultural context. Following successful cross-sectional 
validation in the new language and cultural setting, the questionnaire could be 156
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incorporation into a longitudinal study in the new language as indicated above.
- Combine HRQL outcomes with economic measurements. It would be interesting to 
combine HRQL outcomes measured with the FAQLQs with economic outcomes 
measured  with  the  economic  questionnaire  for  food  allergy  which  was  also 
developed within EuroPrevall  28;29. Interesting questions such as: “Is the social 
impact of food allergy related to the economic impact of food allergy?” could be 
investigated. In addition, it would be interesting to investigate if the FAQLQs could 
be used to calculate Quality-Adjusted Life Years (QALYs). Lamers et al. 30 showed 
that it is feasible to convert data collected with a disease-specific questionnaire into 
preferences, which can be used to calculate QALYs. A QALY measures the amount 
of healthy years gained by a particular health care intervention. QALYs could be 
used in cost-utility analysis to calculate the ratio of costs to QALYs saved for a 
particular health care intervention.
- Combine HRQL outcomes with epidemiological data. Finally, one of the major aims of 
the EuroPrevall project is to assess the societal impact of food allergies 31. In order 
to realise this, it is important to combine the information from studies on HRQL 
with epidemiological data on prevalence. This will ultimately give some indication 
of the magnitude of the societal impact of food allergy in Europe. 
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Inleiding
Voedselallergie
Voedsel is een essentieel element van ons leven. Het is nodig om in leven te blijven 
en het is een belangrijk onderdeel van onze culturele identiteit. Mensen met een 
voedselallergie  kunnen  ernstig  ziek  worden  na  het  eten  van  bepaald  voedsel. 
Ziekmakende reacties ten gevolge van voeding kunnen het resultaat zijn van een 
voedselallergie, een voedselintolerantie (niet-allergische voedselovergevoeligheid, 
bijvoorbeeld lactose intolerantie) of een intoxicatie. Bij voedselallergie is er sprake 
van een abnormale reactie van het immuunsysteem na het eten of drinken van 
bepaalde voedingsmiddelen. In het lichaam worden specifieke antistoffen (IgE) 
gemaakt tegen bepaalde eiwitten in de voeding (allergenen). Deze antistoffen 
binden zich aan bepaalde cellen in het lichaam zoals mestcellen. Wanneer de antistof 
dan in contact komt met het allergeen kan dit klachten veroorzaken aan de huid, het 
maagdarmkanaal of de luchtwegen. In het ergste geval kan iemand in shock raken 
en overlijden. De voedingsmiddelen die de meeste allergische reacties veroorzaken 
zijn: pinda’s, noten, melk, ei, vis en schaaldieren. Voedselallergie komt voor bij 
ongeveer 2 tot 5% van de kinderen en bij ongeveer 2% van de volwassenen.
Voedselallergie kan helaas nog niet worden genezen. De enige behandeling 
is strikte vermijding van de voedingsmiddelen waar iemand allergisch voor is. Dit 
kan het normale dagelijkse leven behoorlijk verstoren. Daarnaast bestaat er, ondanks 
de strikte vermijding, toch altijd een kans dat men per ongeluk het voedingsmiddel 
binnen  krijgt  met  als  gevolg  een  (ernstige)  allergische  reactie.  Deze  continue 
onzekerheid kan op zijn beurt weer een bron zijn voor angst. Wanneer een ernstige 
allergische reactie optreedt, is onmiddellijke en juiste toediening van adrenaline 
(epinefrine) met een automatische injectiespuit (bijvoorbeeld een Epipen) van 
groot belang. Deze toediening kan als beangstigend worden ervaren. Al met al kan 
het hebben van een voedselallergie een behoorlijke negatieve invloed hebben op 
de kwaliteit van leven.
Kwaliteit van leven
Kwaliteit  van  leven  is  een  breed  begrip.  Hoewel  er  geen  overeenstemming 
bestaat  over  de  definitie  van  het  begrip  kwaliteit  van  leven,  heeft  de  wereld 
gezondheidsorganisatie  (WHO)  een  opbouwende  definitie  opgesteld:  “de 
perceptie van een individu van zijn positie in het leven in de context van de cultuur 
en waardesystemen waarin hij leeft en in relatie tot zijn doelen, verwachtingen, 
normen en belangen”. De component van kwaliteit van leven die betrekking heeft 
op de gezondheid van een individu, wordt gezondheidsgerelateerde kwaliteit van 
leven genoemd. In het Engels wordt hiervoor de afkorting HRQL (Health-Related 
Quality of Life) gebruikt. HRQL wordt gedefinieerd als: “het effect van een ziekte 
en de bijbehorende behandeling op de patiënt, zoals dit door de patiënt wordt 
ervaren”. HRQL is een multi-dimensioneel concept en bestaat uit biologische/
medische, psychologische en sociale aspecten zoals fysieke en mentale status en 
sociale interactie.Nederlandse samenvatting
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HRQL  kan  gemeten  worden  met  vragenlijsten.  Er  bestaan  twee  type 
vragenlijsten: generieke en ziekte specifieke vragenlijsten. Generieke vragenlijsten 
zijn bruikbaar bij verschillende ziekten en bij de algemene populatie. Met deze 
vragenlijsten  is  het  dus  mogelijk  om  de  invloed  op  HRQL  van  verschillende 
ziekten met elkaar te vergelijken. Het nadeel van generieke vragenlijsten is dat 
ze niet ingaan op specifieke problemen van een bepaalde ziekte en dat ze ook 
de invloed meten van andere ziekten wanneer iemand meerdere ziekten heeft. 
Ziekte specifieke vragenlijsten zijn speciaal ontwikkeld voor een bepaalde ziekte 
of aandoening. Deze vragenlijsten zijn gevoeliger dan generieke vragenlijsten en 
hiermee is de kans veel groter dat klinisch belangrijke veranderingen gemeten 
kunnen worden. Het nadeel is dat er met ziekte specifieke vragenlijsten geen direct 
vergelijk tussen verschillende ziekten gemaakt kan worden.
Waarom is het meten van HRQL van belang?
Het belang van het meten van HRQL kan bekeken worden vanuit verschillende 
oogpunten. Ten eerste, geeft het meten van HRQL inzicht in de invloed die een 
bepaalde ziekte of aandoening heeft op de patiënt, vanuit het perspectief van de 
patiënt zelf. Het is bijvoorbeeld mogelijk dat twee patiënten met dezelfde ziekte en 
dezelfde mate van ernst toch verschillende mate van invloed op hun HRQL ervaren 
en rapporteren. Het meten van HRQL kan door artsen gebruikt worden om inzicht 
te krijgen in de specifieke problemen waar een patiënt mee wordt geconfronteerd. 
Zodoende kan de arts de patiënt helpen om beter om te gaan met zijn of haar 
problemen. HRQL vragenlijsten kunnen vaak in minder dan 15 minuten worden 
ingevuld en kunnen dus prima ingevuld worden vóór een bezoek aan de arts 
(bijvoorbeeld in de wachtkamer). Wanneer de HRQL vragenlijst gedurende een 
bepaalde periode vaker wordt ingevuld, geeft dit de arts en de patiënt bijvoorbeeld 
inzicht in het effect van de behandeling op HRQL.
In de wetenschap kunnen HRQL vragenlijsten gebruikt worden om het ef-
fect van (nieuwe) interventies te onderzoeken. Uiteindelijk kan dit helpen om de 
kwaliteit van de behandeling en de uitkomsten voor de patiënt te verbeteren. HRQL 
vragenlijsten kunnen tevens gebruikt worden om de effecten van verschillende 
interventies op HRQL met elkaar te vergelijken. Dit soort onderzoek kan gebruikt 
worden door beleidsmakers bij de besluitvorming over toezegging van gezond-
heidszorggelden.
Ten slotte is het met betrekking tot voedselallergie van belang om stil te staan 
bij het feit dat er geen objectieve ziekte parameters beschikbaar zijn om de voort-
durende ernst van voedselallergie vast te stellen, zoals luchtweggevoeligheid bij 
astma. Natuurlijk kan men de ernst van een allergische reactie vaststellen, maar al-
lergische reacties komen alleen voor wanneer men de voeding eet waar men aller-
gisch voor is. Ondanks het feit dat mensen met voedselallergie de meeste tijd geen 
lichamelijke klachten hebben, is er toch een voortdurende ernst die veroorzaakt 
wordt door de noodzaak om continu bepaalde voedingsmiddelen te vermijden en 
de psychosociale last die dit met zich meebrengt. HRQL is de enige beschikbare 
uitkomstmaat die deze voortdurende ernst van voedselallergie kan meten.162
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Doel van dit proefschrift
Het hoofddoel van dit proefschrift was het ontwikkelen en valideren van ziekte 
specifieke gezondheidsgerelateerde kwaliteit van leven (HRQL) vragenlijsten voor 
kinderen (8-12 jaar), adolescenten (13-17 jaar) en volwassenen (18 jaar en ouder) 
met voedselallergie (hoofdstuk 3, 4 en 5). Dit onderzoek vond plaats in het kader 
van het EuroPrevall project, een grootschalig multi-disciplinair Europees onderzoek 
naar  voedselallergie. Tevens  beschrijft  dit  proefschrift  het  onderzoek  naar  de 
betrouwbaarheid van deze drie vragenlijsten (hoofdstuk 6) en wordt er met behulp 
van generieke vragenlijsten een vergelijk gemaakt met de algemenen populatie en 
andere chronische ziekten (hoofdstuk 7). Tenslotte wordt een overzicht gegeven 
van de huidige kennis op het gebied van voedselallergie en kwaliteit van leven aan 
het begin van het EuroPrevall project (hoofdstuk 2) en tegen het einde van het 
project (hoofdstuk 8).
Samenvatting van de hoofdstukken
Een kader voor het meten van de sociale impact van voedselallergie in 
Europa
In hoofdstuk 2 wordt een kader geschetst voor het meten van de sociale impact van 
voedselallergie in Europa. Voedselallergie (of dit nu door de persoon zelf is vastgesteld of 
door een arts) is een belangrijk medisch en maatschappelijk probleem in de westerse 
wereld en het zou wel eens een veel grotere impact op de samenleving kunnen 
hebben dan tot nu toe gedacht werd. Voor de start van het EuroPrevall project (juni 
2005) was de sociale impact van voedselallergie nog nooit eerder systematisch 
onderzocht met gevalideerde instrumenten. Op dat moment was er slechts één 
gevalideerde HRQL vragenlijsten beschikbaar, de Food Allergy Quality of Life-Parental 
Burden (FAQL-PB) vragenlijst. Deze vragenlijst wordt ingevuld door de ouders en 
meet de kwaliteit van leven die de ouder ervaart die het gevolg is van het hebben 
van een kind met voedselallergie. Hoewel dit een bruikbare en goed ontwikkelde 
vragenlijst is, kan men met deze vragenlijst niet de impact van voedselallergie op 
de kwaliteit van leven meten zoals dit door de patiënt zélf wordt ervaren. Hieruit 
blijkt dat er vraag is naar gevalideerde ziekte specifieke HRQL vragenlijsten die door 
de voedselallergische patiënt zélf kunnen worden ingevuld. Deze ziekte specifieke 
HRQL  vragenlijsten  zullen  ontwikkeld  worden  in  het  EuroPrevall  project  en 
kunnen vervolgens gebruikt worden om kwaliteit van leven problemen gerelateerd 
aan voedselallergie te identificeren. Daarnaast kunnen de instrumenten gebruikt 
worden om de effectiviteit van interventies te onderzoeken. Tevens kunnen zij als 
leidraad dienen voor de ontwikkeling van nieuw beleid rondom voedselallergie. Het 
combineren van informatie van kwaliteit van leven studies met epidemiologische 
informatie  over  prevalentie,  zal  uiteindelijk  een  indicatie  kunnen  geven  van  de 
grootte van de sociale impact van voedselallergie in Europa.Nederlandse samenvatting
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De ontwikkeling en validatie van drie vragenlijsten
In de hoofdstukken 3, 4 en 5 bespreken we de ontwikkeling en validatie van drie 
ziekte specifieke HRQL vragenlijsten voor kinderen (8-12 jaar), adolescenten (13-
17 jaar) en volwassenen (18 jaar en ouder) met een voedselallergie.
De ontwikkeling van de vragenlijsten startte met het verzamelen van items 
voor de nieuwe vragenlijsten (item generatie). Voedselallergische patiënten waren 
de belangrijkste bron voor items. In semi-gestructureerde interviews werden de 
patiënten gevraagd naar lastige of vervelende aspecten van hun voedselallergie in het 
dagelijkse leven. Daarnaast hebben we gezocht naar items in de wetenschappelijke 
literatuur over voedselallergie en hebben we klinische experts op het gebied van 
voedselallergie gevraagd naar aanvullende items. Op het moment dat er geen nieuwe 
belangrijke items meer naar voren kwamen, werd de item generatie als voltooid 
beschouwd.
De item generatie werd gevolgd door de fase van item reductie. In deze fase 
werd de lange lijst van items over voedselallergie voorgelegd aan een andere groep 
voedselallergische patiënten. Deze patiënten werd gevraagd om per item aan te geven 
of dat item ook op hen van toepassing was en zo ja, om aan te geven hoe vervelend 
dat item was op een schaal van 1 tot 5. Op basis van deze methode, die ook wel de 
klinische impact methode wordt genoemd, konden we de meest belangrijke items 
selecteren voor de vragenlijsten. Dit resulteerde in de volgende drie vragenlijsten:
Food Allergy Quality of Life Questionnaire - Child Form (FAQLQ-CF),  - 
Food Allergy Quality of Life Questionnaire - Teenager Form (FAQLQ-TF), - 
Food Allergy Quality of Life Questionnaire - Adult Form (FAQLQ-AF). - 
De item reductie fase werd gevolgd door de validatie fase. In deze fase 
werd onderzocht of de vragenlijsten datgene meten, wat zij behoren te meten 
(validatie). De beste manier om de validiteit vast te stellen, ook wel criterium 
validiteit genoemd, is het vergelijken van het nieuwe instrument met de bestaande 
‘gouden standaard’. Bijvoorbeeld wanneer er een nieuw instrument ontwikkeld 
is om bloeddruk mee te meten, dan worden de bloeddrukwaarden gemeten met 
dat nieuwe instrument vergeleken met de bloeddrukwaarden gemeten met het 
instrument dat momenteel algemeen gebruikt wordt in de medische praktijk. Bij 
kwaliteit van leven bestaat er echter geen ‘gouden standaard’. Daarom is construct 
validiteit de beste manier om de validiteit van een kwaliteit van leven vragenlijst 
vast te stellen. Bij construct validiteit wordt de nieuwe vragenlijst vergeleken met 
een onafhankelijke meting (independent measure) die gerelateerd is aan datgene 
wat je wil meten (het construct). Bij ziekte specifieke kwaliteit van leven kan dit een 
meting zijn van de ernst van de ziekte, zoals luchtweggevoeligheid bij astma. Maar 
voedselallergie wordt niet gekenmerkt door chronische klachten. Zolang men de 
voedingsmiddelen vermijdt waar men allergisch voor is, heeft men zelfs helemaal 
géén lichamelijke klachten. Daarom bestaat er bij voedselallergie (en andere ziekten 
die niet gekenmerkt worden door chronische klachten) geen onafhankelijke meting 
die de voortdurende mate of ernst van de ziekte kan meten. Om toch de construct 
validiteit van kwaliteit van leven vragenlijsten voor dit soort ziekten te kunnen 
evalueren, is gebleken dat de verwachting van wat er zal gebeuren (expectation 164
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of outcome) na blootstelling aan het allergene voedingsmiddel, als onafhankelijke 
meting gebruikt kan worden. Deze verwachting kan worden gemeten met de Food 
Allergy Independent Measure (FAIM) welke bestaat uit 6 vragen. Met behulp van 
het berekenen van correlaties tussen de FAQLQ’s en de FAIM hebben we acceptabele 
niveaus van construct validiteit kunnen aantonen voor alle drie de FAQLQ’s. De 
nieuw ontwikkelde FAQLQ’s meten dus wat ze behoren te meten. 
Naast de FAQLQ en de FAIM, hebben de patiënten ook een generieke kwaliteit 
van leven vragenlijst ingevuld (zie ook hoofdstuk 7). Met behulp van het berekenen 
van  correlaties  tussen  de  FAQLQ’s  en  de  generieke  vragenlijsten  hebben  we 
acceptabele niveaus van ‘convergent’ en ‘discriminant’ validiteit kunnen aantonen 
voor alle drie de FAQLQ’s. Verder kon worden aangetoond dat alle drie de FAQLQ’s 
een  uitstekende  interne  consistentie  hebben.  Dit  betekent  dat  alle  individuele 
vragen  van  de  FAQLQ  hetzelfde  construct  meten. Tenslotte  hebben  we  kunnen 
aantonen dat de FAQLQ’s verschillen kunnen meten tussen patiënten met meerdere 
voedselallergieën en patiënten met slechts enkele voedselallergieën, waarbij de eerste 
groep een significant slechtere kwaliteit van leven bleek te hebben. De FAQLQ-CF en 
FAQLQ-TF bleken geen significant verschil te meten tussen patiënten met anafylaxie 
(de meest ernstige vorm van allergische reacties) en patiënten met mildere vormen 
van allergische reacties. De FAQLQ-AF bleek dit verschil wel te meten. 
We kunnen concluderen dat de FAQLQ’s de belangrijkste problemen bevatten 
waar voedselallergische patiënten mee geconfronteerd worden in het dagelijkse 
leven. De vragenlijsten zijn valide en kunnen onderscheid meten tussen patiënten met 
verschillende ziekte karakteristieken. Tenslotte zijn de FAQLQ’s kort en gemakkelijk 
te gebruiken en daarom zeer geschikt voor klinisch onderzoek.
De betrouwbaarheid van de nieuwe vragenlijsten
In hoofdstuk 6 bespreken we het onderzoek naar de test-hertest betrouwbaarheid 
van de drie FAQLQ’s. Het onderzoeken van de betrouwbaarheid van een vragenlijst 
is  van  belang  om  aan  te  kunnen  tonen  dat  datgene  wat  de  vragenlijst  meet, 
reproduceerbaar is. Voor dit onderzoek hebben ruim 100 patiënten de vragenlijst 
twee keer ingevuld met daartussen een tijdsinterval van 10 tot 14 dagen. Deze 
periode is lang genoeg zodat de mensen hun eerder gegeven antwoorden niet 
zullen onthouden en kort genoeg zodat er geen grote verandering zullen optreden 
in  kwaliteit  van  leven.  Met  het  berekenen  van  verschillende  coëfficiënten  en 
grafische weergave hebben we kunnen aantonen dat de antwoorden die gegeven 
zijn op de twee verschillende tijdstippen goed overeen kwamen. Dit betekent dat 
alle drie de FAQLQ’s betrouwbaar zijn.
Een vergelijk met de algemene populatie en andere chronische ziekten
In hoofdstuk 7 wordt het onderzoek beschreven waarin we kwaliteit van leven van 
voedselallergische patiënten hebben gemeten met generieke en ziekte specifieke 
HRQL vragenlijsten. De scores op de generieke vragenlijsten werden vergeleken 
met scores van gepubliceerde studies over de algemene populatie en patiënten met 
astma, prikkelbare darm syndroom, diabetes (type 1) en reuma. We vonden dat de Nederlandse samenvatting
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generieke kwaliteit van leven van voedselallergische patiënten over het algemeen 
slechter is dan de generieke kwaliteit van leven van de algemene populatie. Echter, 
zowel kinderen als adolescenten rapporteerden significant minder beperkingen 
door gedragsproblemen in schoolwerk of activiteiten met vrienden. In vergelijking 
met andere chronische ziekten, bleken patiënten met diabetes een betere generieke 
kwaliteit van leven te hebben dan patiënten met voedselallergie. Patiënten met astma, 
prikkelbare darm syndroom en reuma bleken een slechtere generieke kwaliteit 
van leven te hebben dan patiënten met een voedselallergie. Tenslotte hebben we 
bij de voedselallergische patiënten gekeken naar hoe zij de generieke en ziekte 
specifieke kwaliteit van leven vragenlijsten (de FAQLQ’s) hadden ingevuld. Hieruit 
bleek dat de voedselallergische patiënten bij veel onderdelen van de generieke 
vragenlijsten de hoogst mogelijke score hadden (ceiling effect). Dit betekent dat 
deze vragenlijsten minder gevoelig zijn om verschillen in de tijd te meten, men kan 
immers niet hoger scoren. Dit geeft tegelijkertijd aan dat deze vragenlijsten minder 
geschikt zijn om specifieke aspecten van voedselallergie te meten.
Kwaliteit van leven bij voedselallergie: valide instrumenten voor 
kinderen tot volwassen
Hoofdstuk  8  bevat  een  overzichtsartikel  van  recente  bevindingen  over  hoe 
voedselallergie van invloed kan zijn op kwaliteit van leven en het geeft een overzicht 
van instrumenten die beschikbaar zijn om kwaliteit van leven bij mensen met een 
voedselallergie te meten. We beschrijven in dit artikel dat er in de recente literatuur, 
naast meer algemeen bekende lasten van voedselallergie, veel aandacht is besteed 
aan de psychosociale invloed van voedselallergie en het gebrek aan informatie 
met betrekking tot voedselallergie op bepaalde gebieden. Bij het overzicht van 
beschikbare instrumenten voor het meten van kwaliteit van leven bij voedselallergie, 
concluderen we dat de meeste ziekte specifieke HRQL vragenlijsten, die tot dan 
toe beschikbaar waren, niet of onvoldoende gevalideerd zijn. Echter zeer recent 
zijn er betrouwbare en valide ziekte specifieke HRQL vragenlijsten (de FAQLQ’s) 
beschikbaar gekomen om de impact van voedselallergie op kwaliteit van leven te 
meten bij alle leeftijdsgroepen. 
Conclusie
Met  het  onderzoek  beschreven  in  dit  proefschrift  hebben  we  een  belangrijke 
vooruitgang geboekt op het gebied van het meten van kwaliteit van leven bij 
mensen  met  een  voedselallergie.  Er  zijn  nu  valide  en  betrouwbare  kwaliteit 
van  leven  vragenlijsten  beschikbaar  voor  voedselallergische  patiënten  van  alle 
leeftijden. Deze vragenlijsten kunnen enerzijds gebruikt worden door artsen in de 
praktijk om beter inzicht te krijgen in de kwaliteit van leven van zijn patiënten en 
de behandeling hier op aan passen. Anderzijds zijn deze vragenlijsten uitermate 
geschikt om toe te passen in klinisch onderzoek bij voedselallergie waar kwaliteit 
van leven de uitkomst parameter is. Tenslotte is het van belang om te realiseren dat 
kwaliteit van leven de enige uitkomst parameter is die de voordurende ernst en 
impact van voedselallergie kan meten.Dankwoord
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